Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Abortion, Spontaneous
Differential Expression of EGFR-1, MMP-3, and MMP-9 in Spontaneous Abortions, Induced Abortions, and Tubal Pregnancies.
Acantholysis
Idiopathic gingival hypertrophy--a morphological study and a review of literature.
Acute Coronary Syndrome
Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development.
Acute Coronary Syndrome
Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome.
Acute Coronary Syndrome
Lack of an association between connexin-37, stromelysin-1, plasminogen activator-inhibitor type 1 and lymphotoxin-alpha genes and acute coronary syndrome in Czech Caucasians.
Acute Coronary Syndrome
Serum Levels of Matrix Metalloproteinase (MMP) 9, a Risk Factor for Acute Coronary Syndrome, Are Reduced Independently of Serum MMP-3 by Anti-TNF-? Antibody (Infliximab) Therapy in Patients With Rheumatoid Arthritis.
Acute Coronary Syndrome
Usefulness of Plasma Matrix Metalloproteinase-3 Levels to Predict Myocardial Infarction in Men With and Without Acute Coronary Syndrome.
Acute Kidney Injury
Distinct role of matrix metalloproteinase-3 in kidney injury molecule-1 shedding by kidney proximal tubular epithelial cells.
Acute Kidney Injury
Increased expression of kidney injury molecule-1 and matrix metalloproteinase-3 in severe Plasmodium falciparum malaria with acute kidney injury.
Acute Lung Injury
Role of stromelysin 1 and gelatinase B in experimental acute lung injury.
Acute Lung Injury
The effect of matrix metalloproteinase-3 deficiency on pulmonary surfactant in a mouse model of acute lung injury.
Acute Lung Injury
The importance of matrix metalloproteinase-3 in respiratory disorders.
Adenocarcinoma
Androgen-repressed phenotype in human prostate cancer.
Adenocarcinoma
Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.
Adenocarcinoma
Epimorphin overexpression in the mouse mammary gland promotes alveolar hyperplasia and mammary adenocarcinoma.
Adenocarcinoma
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Adenocarcinoma
Expression of metalloproteinase genes in human prostate cancer.
Adenocarcinoma
Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix.
Adenocarcinoma
Expression of the transin, c-fos, and c-jun genes in rat transplantable osteosarcomas and malignant fibrous histiocytomas.
Adenocarcinoma
Interleukin 1beta induces gastric epithelial cell matrix metalloproteinase secretion and activation during Helicobacter pylori infection.
Adenocarcinoma
The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
Adenocarcinoma
TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma.
Adenocarcinoma
[Changes in markers of proliferation, neoangiogenesis and plasminogen activation system in rectal cancer tissue].
Adenocarcinoma
[Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer]
Adenocarcinoma of Lung
Immunocytochemical detection of matrix metalloproteinase expression in prostate cancer.
Adenocarcinoma of Lung
Immunocytochemical detection of the expression of members of the matrix metalloproteinase family in adenocarcinomas of the pancreas.
Adenocarcinoma of Lung
Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells.
Adenocarcinoma of Lung
Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung.
Adenocarcinoma of Lung
MiR-22-3p Expression is down-regulated in lung adenocarcinoma.
Adenoma
Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
Adenoma
Prognostic and predictive potential molecular biomarkers in colon cancer.
Adenoma
TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma.
Adenomyosis
Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis.
Adenomyosis
[Expression of matrix metalloproteinase and tissue inhibitor of metalloproteinase in adenomyosis]
Adenomyosis
[Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis]
Aggressive Periodontitis
Pathogen profile and MMP-3 levels in areas with varied attachment loss in generalized aggressive and chronic periodontitis.
Airway Obstruction
Induced sputum metalloproteinases and their inhibitors in relation to exhaled nitrogen oxide and sputum nitric oxides and other inflammatory cytokines in patients with chronic obstructive pulmonary disease.
Albuminuria
Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus.
Albuminuria
Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.
Alveolar Bone Loss
Danzhi Jiangtang capsule alleviate hyperglycemia and periodontitis via Wnt/?-catenin signaling in diabetic rat.
Alzheimer Disease
A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology.
Alzheimer Disease
Analysis of Matrix Metallo-Proteases and the Plasminogen System in Mild Cognitive Impairment and Alzheimer's Disease Cerebrospinal Fluid.
Alzheimer Disease
Concentrations of Matrix Metalloproteinases and their Tissue Inhibitors in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
Alzheimer Disease
Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer's disease.
Alzheimer Disease
Interaction between matrix metalloproteinase 3 and the epsilon4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns.
Alzheimer Disease
Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease. The Rotterdam Study.
Alzheimer Disease
Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
Alzheimer Disease
Plasma gelsolin and matrix metalloproteinase 3 as potential biomarkers for Alzheimer disease.
Alzheimer Disease
Role of Matrix Metalloproteinase-3 in Neurodegeneration.
Alzheimer Disease
Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain.
Alzheimer Disease
Serum levels of matrix metalloproteinases: implications in clinical neurology.
Alzheimer Disease
The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain.
Amyloidosis
A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology.
Amyloidosis
Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis.
Amyloidosis
Serum matrix metalloproteinase-3 in hemodialysis patients with dialysis-related amyloidosis.
Anemia
Scoring Model to Predict a Low Disease Activity in Elderly Rheumatoid Arthritis Patients Initially Treated with Biological Disease-modifying Antirheumatic Drugs.
Aneurysm
An increased frequency of the 5A allele in the promoter region of the MMP3 gene is associated with abdominal aortic aneurysms.
Aneurysm
Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.
Aneurysm
Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury.
Aneurysm
Extracellular proteolysis in the development and progression of atherosclerosis.
Aneurysm
Genes predisposing to rapid aneurysm growth.
Aneurysm
Genetic kininogen deficiency contributes to aortic aneurysm formation but not to atherosclerosis.
Aneurysm
Homocysteine and metalloprotease-3 and -9 in patients with ascending Aorta Aneurysms.
Aneurysm
Inflammatory Smooth Muscle Cells Induce Endothelial Cell Alterations to Influence Cerebral Aneurysm Progression via Regulation of Integrin and VEGF Expression.
Aneurysm
Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease.
Aneurysm
Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation.
Aneurysm
Plasma matrix metalloproteinase levels do not predict tissue levels in abdominal aortic aneurysms suitable for elective repair.
Aneurysm
Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms.
Aneurysm
Structural studies of the MMP-3 interaction with triple-helical collagen introduce new roles for the enzyme in tissue remodelling.
Aneurysm
Upregulated sulfatase and downregulated MMP-3 in thoracic aortic aneurysm.
Aneurysm, Dissecting
Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia.
Angina, Stable
The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina.
Angina, Unstable
Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
Anthrax
A new role for old ligands: discerning chelators for zinc metalloproteinases.
Anthrax
Latent cytokines: development of novel cleavage sites and kinetic analysis of their differential sensitivity to MMP-1 and MMP-3.
Anthrax
Statistical analysis, optimization, and prioritization of virtual screening parameters for zinc enzymes including the anthrax toxin lethal factor.
Aortic Aneurysm
Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.
Aortic Aneurysm, Abdominal
An increased frequency of the 5A allele in the promoter region of the MMP3 gene is associated with abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall.
Aortic Aneurysm, Abdominal
Genes predisposing to rapid aneurysm growth.
Aortic Aneurysm, Abdominal
Genotype-phenotype relationships in an investigation of the role of proteases in abdominal aortic aneurysm expansion.
Aortic Aneurysm, Abdominal
HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
Immune cells and molecular mediators in the pathogenesis of the abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
Upregulated sulfatase and downregulated MMP-3 in thoracic aortic aneurysm.
Aortic Aneurysm, Thoracic
Upregulated sulfatase and downregulated MMP-3 in thoracic aortic aneurysm.
Aortic Valve Stenosis
Impact of several proinflammatory and cell degradation factors in patients with aortic valve stenosis.
Arrhythmias, Cardiac
MMP-1 and MMP-3 polymorphism and arrhythmia recurrence after electrical cardioversion in patients with persistent atrial fibrillation.
Arteriovenous Malformations
The rs522616 polymorphism in the matrix metalloproteinase-3 (MMP-3) gene is associated with sporadic brain arteriovenous malformation in a Chinese population.
Arthralgia
Proinflammatory Cytokines and Chemokines as Biomarkers of Persistent Arthralgia and Severe Disease After Chikungunya Virus Infection: A 5-Year Follow-Up Study in Southern Thailand.
Arthralgia
Serum matrix metalloproteinase-3 in systemic sclerosis.
Arthralgia
The gene expression profile of matrix metalloproteinases and their inhibitors in children with Henoch-Schönlein purpura.
Arthralgia
Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis.
Arthralgia
[Effect of acupoint heat-sensitive moxibustion intervention on serum osteopontin and matrix metalloproteinase-3 in patients with acute knee pain].
Arthralgia
[Effect of Gancao Fuzi Decoction on osteoarthritis and proteomics of articular cartilage in rats].
Arthritis
A case of idiopathic hypertrophic cranial pachymeningitis presenting high values of matrix metalloproteinase.
Arthritis
A correlation between knee cartilage degradation observed by arthroscopy and synovial proteinases activities.
Arthritis
Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation.
Arthritis
Active matrix metalloproteinases are present in cartilage during immune complex-mediated arthritis: a pivotal role for stromelysin-1 in cartilage destruction.
Arthritis
Adiponectin increases MMP-3 expression in human chondrocytes through adipor1 signaling pathway.
Arthritis
An orally bioavailable synthetic analogue of an active DHEA metabolite reduces established disease in rodent models of rheumatoid arthritis.
Arthritis
Anti-arthritic activity of Fu-Fang-Lu-Jiao-Shuang on collagen-induced arthritis in Balb/c mice and its underlying mechanisms.
Arthritis
Arthritis associated with Kawasaki disease: MRI findings and serum matrix metalloproteinase-3 profiles.
Arthritis
Biomarkers of joint tissue metabolism in canine osteoarthritic and arthritic joint disorders.
Arthritis
CCAAT/enhancer binding protein ? regulates expression of matrix metalloproteinase-3 in arthritis.
Arthritis
CCR5 silencing reduces inflammatory response, inhibits viability, and promotes apoptosis of synovial cells in rat models of rheumatoid arthritis through the MAPK signaling pathway.
Arthritis
Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms.
Arthritis
Chikungunya Fever in Japan Imported from the Caribbean Islands.
Arthritis
Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Arthritis
Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity.
Arthritis
Clinical significance of matrix metalloproteinase-3 in systemic lupus erythematosus patients: a potential biomarker for disease activity and damage.
Arthritis
Clinical, radiological, and biochemical characteristics in patients with diseases mimicking polymyalgia rheumatica.
Arthritis
Concomitant Treatment with Etanercept and Tacrolimus Synergistically Attenuates Arthritis Progression via Inhibition of Matrix Metalloproteinase-3 Production and Osteoclastogenesis in Human TNF-? Transgenic Mice.
Arthritis
Connective tissue metabolism in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity, bone mineral density, and radiographic outcome.
Arthritis
Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts.
Arthritis
Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.
Arthritis
Differential in vivo expression of collagenase messenger RNA in synovium and cartilage. Quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis.
Arthritis
Drug-induced inhibition of proteoglycanase activity in the Hulth-Telhag model.
Arthritis
Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis.
Arthritis
Effect of Mycoplasma bovis on expression of inflammatory cytokines and matrix metalloproteinases mRNA in bovine synovial cells.
Arthritis
Elevated plasma stromelysin levels in arthritis.
Arthritis
Highly increased levels of active stromelysin in rheumatoid synovial fluid determined by a selective fluorogenic assay.
Arthritis
Hyaluronan modulates accumulation of hypoxia-inducible factor-1 alpha, inducible nitric oxide synthase, and matrix metalloproteinase-3 in the synovium of rat adjuvant-induced arthritis model.
Arthritis
Immunofluorescence quantitation of stromelysin in human synovial fibroblasts by confocal laser scanning microscopy.
Arthritis
Increased serum proMMP-3 in inflammatory arthritides: a potential indicator of synovial inflammatory monokine activity.
Arthritis
Influence of Matrix metalloproteinase 1 and 3 genetic variations on susceptibility and severity of juvenile idiopathic arthritis.
Arthritis
Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes.
Arthritis
Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.
Arthritis
Inhibitory Effect of a Novel Antirheumatic Drug T-614 on the IL-6-Induced RANKL/OPG, IL-17, and MMP-3 Expression in Synovial Fibroblasts from Rheumatoid Arthritis Patients.
Arthritis
Inhibitory Effects of IL-6-Mediated Matrix Metalloproteinase-3 and -13 by Achyranthes japonica Nakai Root in Osteoarthritis and Rheumatoid Arthritis Mice Models.
Arthritis
Isolation and characterization of human monoclonal antibodies specific to MMP-1A, MMP-2 and MMP-3.
Arthritis
Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study.
Arthritis
Levels of rheumatoid factor isotypes, metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in synovial fluid from various arthritides.
Arthritis
Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis.
Arthritis
Link peptide cartilage growth factor is degraded by membrane proteinases.
Arthritis
Mammalian clock gene Cryptochrome regulates arthritis via proinflammatory cytokine TNF-alpha.
Arthritis
Mast cell-restricted, tetramer-forming tryptases induce aggrecanolysis in articular cartilage by activating matrix metalloproteinase-3 and -13 zymogens.
Arthritis
Matrix metalloproteinases: role in arthritis.
Arthritis
Mesenchymal stromal cells versus betamethasone can dampen disease activity in the collagen arthritis mouse model.
Arthritis
Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis.
Arthritis
Mice Deficient in CIZ/NMP4 Develop an Attenuated Form of K/BxN-Serum Induced Arthritis.
Arthritis
Modification of osteoarthritis by pulsed electromagnetic field--a morphological study.
Arthritis
Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health.
Arthritis
Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint.
Arthritis
Overlapping Features in Kawasaki Disease-Related Arthritis and Systemic-Onset Juvenile Idiopathic Arthritis: A Nationwide Study in Japan.
Arthritis
Periodontal bacterial colonization in synovial tissues exacerbates collagen-induced arthritis in B10.RIII mice.
Arthritis
Pharmacological efficacy of anti-IL-1? scFv, Fab and full-length antibodies in treatment of rheumatoid arthritis.
Arthritis
Porphyromonas gingivalis infection exacerbates the onset of rheumatoid arthritis in SKG mice.
Arthritis
Predicting duration of beneficial effect of joint injection among children with chronic arthritis by measuring biomarkers concentration in synovial fluid at the time of injection.
Arthritis
Prediction of Antiarthritic Drug Efficacies by Monitoring Active Matrix Metalloproteinase-3 (MMP-3) Levels in Collagen-Induced Arthritic Mice Using the MMP-3 Probe.
Arthritis
Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
Arthritis
Quantification of mRNA levels in joint capsule and articular cartilage of the murine knee joint by RT-PCR: kinetics of stromelysin and IL-1 mRNA levels during arthritis.
Arthritis
Rabbit models of arthritis: immunolocalization of matrix metalloproteinases and tissue inhibitor of metalloproteinase in synovium and cartilage.
Arthritis
Selective inhibition of PBEF/Visfatin/NAMPT suppresses leukocyte infiltration and cartilage degradation.
Arthritis
Serum and synovial fluid concentrations of matrix metalloproteinases 3 and its tissue inhibitor 1 in juvenile idiopathic arthritides.
Arthritis
Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study.
Arthritis
Serum microRNAs as Potential Biomarkers of Juvenile Idiopathic Arthritis.
Arthritis
Soluble Siglec-9 suppresses arthritis in a collagen-induced arthritis mouse model and inhibits M1 activation of RAW264.7 macrophages.
Arthritis
Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.
Arthritis
Solution structures of stromelysin complexed to thiadiazole inhibitors.
Arthritis
Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.
Arthritis
Structural studies of the MMP-3 interaction with triple-helical collagen introduce new roles for the enzyme in tissue remodelling.
Arthritis
Synergistic effects of interleukin-1? and interleukin-17A antibodies on collagen-induced arthritis mouse model.
Arthritis
Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not.
Arthritis
Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis.
Arthritis
Synovial membrane expression of matrix metalloproteinases and tissue inhibitor 1 in juvenile idiopathic arthritides.
Arthritis
The 'RASor's' edge: Ras proteins and matrix destruction in arthritis.
Arthritis
The bispecific antibody aimed at the vicious circle of IL-1? and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-?B signaling pathway.
Arthritis
The diagnostic utility of matrix metalloproteinase-3 and high-sensitivity C-reactive protein for predicting rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-negative patients with recent-onset undifferentiated arthritis.
Arthritis
The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis.
Arthritis
Tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-3 in Japanese healthy children and in Kawasaki disease and their clinical usefulness in juvenile rheumatoid arthritis.
Arthritis
Transin/stromelysin expression in the synovium of rats with experimental erosive arthritis. In situ localization and kinetics of expression of the transformation-associated metalloproteinase in euthymic and athymic Lewis rats.
Arthritis
Triptolide decreases rheumatoid arthritis fibroblast-like synoviocyte proliferation, invasion, inflammation and presents a therapeutic effect in collagen-induced arthritis rats via inactivating lncRNA RP11-83J16.1 mediated URI1 and ?-catenin signaling.
Arthritis
Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis.
Arthritis
Vanadate, an inhibitor of stromelysin and collagenase expression, suppresses collagen induced arthritis.
Arthritis
Venlafaxine alleviates complete Freund's adjuvant-induced arthritis in rats: Modulation of STAT-3/IL-17/RANKL axis.
Arthritis
[Electroacupuncture at "Zusanli"(ST36) and "Xuanzhong"(GB39) improves inflammatory reactions and reduces levels of serum MMP-3 and MMP-9 in adjuvant arthritis rats].
Arthritis
[Expression of matrix metalloproteinase-3 in patients with reheumatoid arthritis and its correlation with chronic periodontitis and rheumatoid arthritis].
Arthritis
[Matrix metalloproteinase-3 in patients with systemic lupus erythematosus and its significance in differentiating disease activity from pulmonary infections].
Arthritis
[Serum metalloproteinase-3 levels in assessing efficacy of Etanercept in patients with ankylosing spondylitis].
Arthritis
[Stromelysin-1 (MMP-3) level in the sera from patients with rheumatoid arthritis and other connective tissue diseases--clinical significances in early onset rheumatoid arthritis]
Arthritis
[Usefulness of serum matrix metalloproteinase-3(MMP-3) level in the diagnosis of rheumatoid arthritis]
Arthritis, Experimental
Aliskiren, tadalafil, and cinnamaldehyde alleviate joint destruction biomarkers; MMP-3 and RANKL; in complete Freund's adjuvant arthritis model: Downregulation of IL-6/JAK2/STAT3 signaling pathway.
Arthritis, Experimental
Cyr61 participates in the pathogenesis of rheumatoid arthritis via promoting MMP-3 expression by fibroblast-like synoviocytes.
Arthritis, Experimental
Detection of active matrix metalloproteinase-3 in serum and fibroblast-like synoviocytes of collagen-induced arthritis mice.
Arthritis, Experimental
Macrophage-Derived Delta-like Protein 1 Enhances Interleukin-6 and Matrix Metalloproteinase 3 Production by Fibroblast-like Synoviocytes in Mice With Collagen-Induced Arthritis.
Arthritis, Experimental
Matrix metalloproteinases as targets for the immune system during experimental arthritis.
Arthritis, Experimental
Oral administration of curcumin suppresses production of matrix metalloproteinase (MMP)-1 and MMP-3 to ameliorate collagen-induced arthritis: inhibition of the PKCdelta/JNK/c-Jun pathway.
Arthritis, Experimental
Prediction of Antiarthritic Drug Efficacies by Monitoring Active Matrix Metalloproteinase-3 (MMP-3) Levels in Collagen-Induced Arthritic Mice Using the MMP-3 Probe.
Arthritis, Experimental
Red ginseng saponin extract attenuates murine collagen-induced arthritis by reducing pro-inflammatory responses and matrix metalloproteinase-3 expression.
Arthritis, Experimental
Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction.
Arthritis, Experimental
The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis.
Arthritis, Experimental
Therapeutic effects of the total lignans from Vitex negundo seeds on collagen-induced arthritis in rats.
Arthritis, Experimental
Transin/stromelysin expression in the synovium of rats with experimental erosive arthritis. In situ localization and kinetics of expression of the transformation-associated metalloproteinase in euthymic and athymic Lewis rats.
Arthritis, Experimental
[Effect of electroacupuncture on articular morphological changes and serum inflammatory factors and synovial MMPs in collagen-induced arthritis rats].
Arthritis, Experimental
[Electroacupuncture at "Zusanli"(ST36) and "Xuanzhong"(GB39) improves inflammatory reactions and reduces levels of serum MMP-3 and MMP-9 in adjuvant arthritis rats].
Arthritis, Gouty
Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis.
Arthritis, Gouty
Levels of rheumatoid factor isotypes, metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in synovial fluid from various arthritides.
Arthritis, Gouty
Matrix Metalloproteinase-3 induces proteoglycan degradation in gouty arthritis model.
Arthritis, Gouty
[Stromelysin-1 (MMP-3) level in the sera from patients with rheumatoid arthritis and other connective tissue diseases--clinical significances in early onset rheumatoid arthritis]
Arthritis, Infectious
Dexamethasone attenuation of cytokine-mediated articular cartilage degradation in experimental lapine Haemophilus arthritis.
Arthritis, Infectious
Longitudinal and cross-sectional variability in markers of joint metabolism in patients with knee pain and articular cartilage abnormalities.
Arthritis, Infectious
Purified staphylococcal culture medium stimulates neutral metalloprotease secretion from human articular cartilage.
Arthritis, Juvenile
Influence of Matrix metalloproteinase 1 and 3 genetic variations on susceptibility and severity of juvenile idiopathic arthritis.
Arthritis, Juvenile
Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study.
Arthritis, Juvenile
Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis.
Arthritis, Juvenile
Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health.
Arthritis, Juvenile
Tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-3 in Japanese healthy children and in Kawasaki disease and their clinical usefulness in juvenile rheumatoid arthritis.
Arthritis, Psoriatic
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Arthritis, Psoriatic
Increased serum TWEAK levels in Psoriatic arthritis: relationship with disease activity and matrix metalloproteinase-3 serum levels.
Arthritis, Psoriatic
Lipoma arborescens co-existing with psoriatic arthritis releases tumour necrosis factor alpha and matrix metalloproteinase 3.
Arthritis, Psoriatic
Possible molecular mechanisms to account for the involvement of tryptase in the pathogenesis of psoriasis.
Arthritis, Psoriatic
Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study.
Arthritis, Psoriatic
Ultrasound assessment, unlike clinical assessment, reflects enthesitis in patients with psoriatic arthritis.
Arthritis, Reactive
Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not.
Arthritis, Rheumatoid
A high throughput fluorogenic substrate for stromelysin (MMP-3).
Arthritis, Rheumatoid
A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies.
Arthritis, Rheumatoid
Activation of progelatinase B in synovial fluids of patients with rheumatoid arthritis, with reference to stromelysin-1 and tissue inhibitor of matrix metalloproteinase-1.
Arthritis, Rheumatoid
Alteration of matrix metalloproteinase-3 O-glycan structure as a biomarker for disease activity of rheumatoid arthritis.
Arthritis, Rheumatoid
Amelioration of rheumatoid arthritis in a breast cancer patient treated with palbociclib: a case report.
Arthritis, Rheumatoid
Anti-inflammatory and anti-arthritic effects of the ethanolic extract of Aralia continentalis Kitag. in IL-1?-stimulated human fibroblast-like synoviocytes and rodent models of polyarthritis and nociception.
Arthritis, Rheumatoid
Argatroban more effectively inhibits the thrombin activity in synovial fluid than naturally occurring thrombin inhibitors.
Arthritis, Rheumatoid
Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
Arthritis, Rheumatoid
Association of heterogeneity of the thyroid gland with matrix metalloproteinase-3 in rheumatoid arthritis patients with Hashimoto's thyroiditis.
Arthritis, Rheumatoid
Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis.
Arthritis, Rheumatoid
Association of the 5A/6A Promoter Polymorphism of the MMP-3 Gene with the Radiographic Progression of Rheumatoid Arthritis.
Arthritis, Rheumatoid
Association Study of Matrix Metalloproteinases Gene Polymorphisms with Susceptibility to Rheumatoid Arthritis: A Meta-Analysis.
Arthritis, Rheumatoid
Associations of Changes in Serum Inflammatory Factors, MMP-3, 25(OH)D and Intestinal Flora with Osteoporosis and Disease Activity in Rheumatoid Arthritis Patients.
Arthritis, Rheumatoid
Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis.
Arthritis, Rheumatoid
Autocrine induction of gliostatin/platelet-derived endothelial cell growth factor (GLS/PD-ECGF) and GLS-induced expression of matrix metalloproteinases in rheumatoid arthritis synoviocytes.
Arthritis, Rheumatoid
Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients.
Arthritis, Rheumatoid
Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up.
Arthritis, Rheumatoid
Biomarkers for diagnosing and monitoring autoimmune diseases.
Arthritis, Rheumatoid
Cartilage damaging activities of fibronectin fragments derived from cartilage and synovial fluid.
Arthritis, Rheumatoid
Caution is needed when interpreting changes of matrix metalloproteinase-3 in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Cinnamomulactone, a new butyrolactone from the twigs of Cinnamomum cassia and its inhibitory activity of matrix metalloproteinases.
Arthritis, Rheumatoid
Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Arthritis, Rheumatoid
Cloning of the genes for human stromelysin and stromelysin 2: differential expression in rheumatoid synovial fibroblasts.
Arthritis, Rheumatoid
Comment on "Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks" by Yokoe et al.
Arthritis, Rheumatoid
Comment on 'Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients'.
Arthritis, Rheumatoid
Comparative studies of collagenase and stromelysin-1 expression by rheumatoid synoviocytes in vitro.
Arthritis, Rheumatoid
Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks.
Arthritis, Rheumatoid
Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study.
Arthritis, Rheumatoid
Cordycepin inhibits IL-1beta-induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts.
Arthritis, Rheumatoid
Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Correlation between the appearance of gelatinases in the synovial fluid of patients with rheumatoid arthritis and polymorphonuclear elastase, stromelysin-1, and the tissue inhibitor of metalloproteinase-1.
Arthritis, Rheumatoid
Cyr61 participates in the pathogenesis of rheumatoid arthritis via promoting MMP-3 expression by fibroblast-like synoviocytes.
Arthritis, Rheumatoid
Decrease of CD68 and MMP-3 expression in synovium by treatment of adalimumab for rheumatoid arthritis.
Arthritis, Rheumatoid
Decrement of serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis (RA) patients achieving remission after 6 months of etanercept treatment: comparison with CRP, IgM-RF, MMP-3 and anti-CCP Ab.
Arthritis, Rheumatoid
Detection of high levels of 2 specific isoforms of 14-3-3 proteins in synovial fluid from patients with joint inflammation.
Arthritis, Rheumatoid
Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury.
Arthritis, Rheumatoid
Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis.
Arthritis, Rheumatoid
Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Dexmedetomidine inhibits the invasion, migration, and inflammation of rheumatoid arthritis fibroblast-like synoviocytes by reducing the expression of NLRC5.
Arthritis, Rheumatoid
Differential in vivo expression of collagenase messenger RNA in synovium and cartilage. Quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis.
Arthritis, Rheumatoid
Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression.
Arthritis, Rheumatoid
DMARD aurothiomalate inhibits COX-2, MMP-3 and IL-6 expression in chondrocytes by increasing MKP-1 expression and decreasing p38 phosphorylation.
Arthritis, Rheumatoid
Does gamma-aminobutyric acid (GABA) influence the development of chronic inflammation in rheumatoid arthritis?
Arthritis, Rheumatoid
Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis.
Arthritis, Rheumatoid
Effect of downregulation of serum MMP-3 levels by traditional Chinese medicine ingredients combined with methotrexate on the progression of bone injury in patients with rheumatoid arthritis: A protocol for a systematic review and meta-analysis.
Arthritis, Rheumatoid
Effect of Moxibustion on the Serum Levels of MMP-1, MMP-3, and VEGF in Patients with Rheumatoid Arthritis.
Arthritis, Rheumatoid
Effect of Tenidap on Metalloproteinase Gene Expression in Rheumatoid Arthritis: A Synovial Biopsy Study.
Arthritis, Rheumatoid
Effects of Alpha-Lipoic Acid Supplementation on Inflammatory Biomarkers and Matrix Metalloproteinase-3 in Rheumatoid Arthritis Patients.
Arthritis, Rheumatoid
Effects of celecoxib on human chondrocytes--enhanced production of chemokines.
Arthritis, Rheumatoid
Effects of Vitamin K on Matrix Metalloproteinase-3 and Rheumatoid Factor in Women with Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Trial.
Arthritis, Rheumatoid
Elevated levels of soluble Fas (APO-1, CD95), soluble Fas ligand, and matrix metalloproteinase-3 in sera from patients with active untreated adult onset Still's disease.
Arthritis, Rheumatoid
Elevated matrix metalloproteinase-3 level may affect hearing function in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Elevated oxidative stress monitored via the albumin-thiol redox state is correlated with matrix metalloproteinase-3 elevation in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Elevated plasma stromelysin levels in arthritis.
Arthritis, Rheumatoid
Elevation of serum matrix metalloproteinase-3 as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA.
Arthritis, Rheumatoid
Erosive pustular dermatosis of the scalp arising concomitantly with elevation of serum matrix metalloproteinase-3 in a patient with rheumatoid arthritis.
Arthritis, Rheumatoid
Erratum to: Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study.
Arthritis, Rheumatoid
Erratum to: Reply to: Comment on ''Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks'' by Yokoe et al.
Arthritis, Rheumatoid
Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
Arthritis, Rheumatoid
Expression of interleukin-1 beta, tumor necrosis factor alpha, interleukins-6, -10 and -4, and metalloproteases by freshly isolated mononuclear cells from early never-treated and non-acute treated rheumatoid arthritis patients.
Arthritis, Rheumatoid
Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium.
Arthritis, Rheumatoid
Expression of T follicular helper lymphocytes with different subsets and analysis of serum IL-6, IL-17, TGF-? and MMP-3 contents in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Fluorogenic Probe for Detecting Active Matrix Metalloproteinase-3 (MMP-3) in Plasma and Peripheral Blood Neutrophils to Indicate the Severity of Rheumatoid Arthritis.
Arthritis, Rheumatoid
Heat shock of rabbit synovial fibroblasts increases expression of mRNAs for two metalloproteinases, collagenase and stromelysin.
Arthritis, Rheumatoid
High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis.
Arthritis, Rheumatoid
High rate of improvement in serum matrix metalloproteinase-3 levels at 4 weeks predicts remission at 52 weeks in RA patients treated with adalimumab.
Arthritis, Rheumatoid
High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
Arthritis, Rheumatoid
Higher levels of matrix metalloproteinase-3 in patients with RA reflect disease activity and structural damage.
Arthritis, Rheumatoid
Highly increased levels of active stromelysin in rheumatoid synovial fluid determined by a selective fluorogenic assay.
Arthritis, Rheumatoid
Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3).
Arthritis, Rheumatoid
Identification of new autolytic sites of recombinant truncated mature human fibroblast stromelysin by mass spectrometry.
Arthritis, Rheumatoid
IgG anti-hinge antibodies against IgG4 F(ab')2 fragments generated using pepsin are useful diagnostic markers for rheumatoid arthritis: implications of the possible roles of metalloproteinases and IgG subclasses in generating immunogenic hinge epitopes.
Arthritis, Rheumatoid
IL-1 regulation of transin/stromelysin transcription in rheumatoid synovial fibroblasts appears to involve two antagonistic transduction pathways, an inhibitory, prostaglandin-dependent pathway mediated by cAMP, and a stimulatory, protein kinase C-dependent pathway.
Arthritis, Rheumatoid
IL-33 regulates TNF-? dependent effects in synovial fibroblasts.
Arthritis, Rheumatoid
Immunofluorescence quantitation of stromelysin in human synovial fibroblasts by confocal laser scanning microscopy.
Arthritis, Rheumatoid
Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis.
Arthritis, Rheumatoid
Impact of disease activity on impaired glucose metabolism in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Improvement in matrix metalloproteinase-3 independently predicts low disease activity at 52 weeks in bio-switch rheumatoid arthritis patients treated with abatacept.
Arthritis, Rheumatoid
In situ hybridization of stromelysin mRNA in the synovial biopsies from rheumatoid arthritis.
Arthritis, Rheumatoid
In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium.
Arthritis, Rheumatoid
Increased level of heme oxygenase-1 in rheumatoid arthritis synovial fluid.
Arthritis, Rheumatoid
Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis.
Arthritis, Rheumatoid
Increased levels of matrix metalloproteinase-3 in the sera and synovial fluids of patients with pustulotic arthro-osteitis associated with palmoplantar pustulosis: report of 2 cases.
Arthritis, Rheumatoid
Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis.
Arthritis, Rheumatoid
Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Arthritis, Rheumatoid
Inflammatory cytokines induced down-regulation of m-calpain mRNA expression in fibroblastic synoviocytes from patients with osteoarthritis and rheumatoid arthritis.
Arthritis, Rheumatoid
Infliximab Induced a Dissociated Response of Severe Periodontal Biomarkers in Rheumatoid Arthritis Patients.
Arthritis, Rheumatoid
Infliximab reduces CD147, MMP-3, and MMP-9 expression in peripheral blood monocytes in patients with active rheumatoid arthritis.
Arthritis, Rheumatoid
Inhibitory Effect of a Novel Antirheumatic Drug T-614 on the IL-6-Induced RANKL/OPG, IL-17, and MMP-3 Expression in Synovial Fibroblasts from Rheumatoid Arthritis Patients.
Arthritis, Rheumatoid
Inhibitory Effects of IL-6-Mediated Matrix Metalloproteinase-3 and -13 by Achyranthes japonica Nakai Root in Osteoarthritis and Rheumatoid Arthritis Mice Models.
Arthritis, Rheumatoid
Interleukin-1 or phorbol induction of the stromelysin promoter requires an element that cooperates with AP-1.
Arthritis, Rheumatoid
Interleukin-16 in synovial fluids from cases of various types of arthritis.
Arthritis, Rheumatoid
Lack of association of matrix metalloproteinase-3 gene polymorphism with susceptibility to rheumatoid arthritis: a meta-analysis.
Arthritis, Rheumatoid
Lectin-like oxidized low-density lipoprotein receptor 1 mediates matrix metalloproteinase 3 synthesis enhanced by oxidized low-density lipoprotein in rheumatoid arthritis cartilage.
Arthritis, Rheumatoid
Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation.
Arthritis, Rheumatoid
Levels of rheumatoid factor isotypes, metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in synovial fluid from various arthritides.
Arthritis, Rheumatoid
Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis.
Arthritis, Rheumatoid
Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis.
Arthritis, Rheumatoid
Matrix metalloproteinase-3 and the 7-joint ultrasound score in the assessment of disease activity and therapeutic efficacy in patients with moderate to severe rheumatoid arthritis.
Arthritis, Rheumatoid
Matrix metalloproteinase-3 gene polymorphism and its mRNA expression in rheumatoid arthritis.
Arthritis, Rheumatoid
Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
Arthritis, Rheumatoid
Matrix metalloproteinase-3 levels in relation to disease activity and radiological progression in rheumatoid arthritis.
Arthritis, Rheumatoid
Matrix Metalloproteinase-3 Producing Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Associated With Rheumatoid Arthritis.
Arthritis, Rheumatoid
Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis.
Arthritis, Rheumatoid
Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Arthritis, Rheumatoid
Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications.
Arthritis, Rheumatoid
Mechanism of action of celastrol against rheumatoid arthritis: A network pharmacology analysis.
Arthritis, Rheumatoid
Mechanisms of methotrexate action in rheumatoid arthritis. Selective decrease in synovial collagenase gene expression.
Arthritis, Rheumatoid
Messenger-RNA expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases, and transcription factors in rheumatic synovial cells under mechanical stimuli.
Arthritis, Rheumatoid
Metalloprotease activity, phospholipase A2 activity and cytokine concentration in osteoarthritis synovial fluids.
Arthritis, Rheumatoid
MMP-3 expression and release by rheumatoid arthritis fibroblast-like synoviocytes induced with a bacterial ligand of integrin alpha5beta1.
Arthritis, Rheumatoid
MMP3 is a reliable marker for disease activity, radiological monitoring, disease outcome predictability, and therapeutic response in rheumatoid arthritis.
Arthritis, Rheumatoid
mu-Calpain is involved in the regulation of TNF-alpha-induced matrix metalloproteinase-3 release in a rheumatoid synovial cell line.
Arthritis, Rheumatoid
No increase in synovial fluid level of matrix metalloproteinase-3 by systemic administration of glucocorticoids in rheumatoid arthritis.
Arthritis, Rheumatoid
Normal serum matrix metalloproteinase-3 levels can be used to predict clinical remission and normal physical function in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Omentin concentrations are independently associated with those of matrix metalloproteinase-3 in patients with mild but not severe rheumatoid arthritis.
Arthritis, Rheumatoid
Pannus invasion and cartilage degradation in rheumatoid arthritis: involvement of MMP-3 and interleukin-1beta.
Arthritis, Rheumatoid
Pharmacologic inhibition of tpl2 blocks inflammatory responses in primary human monocytes, synoviocytes, and blood.
Arthritis, Rheumatoid
Polymorphism in the stromelysin 1 (matrix metalloproteinase 3) promoter gene and severity of rheumatoid arthritis: comment on the article by Constantin et al.
Arthritis, Rheumatoid
Polymorphisms of MMP-1 and MMP-3 and susceptibility to rheumatoid arthritis. A meta-analysis.
Arthritis, Rheumatoid
Possible involvement of matrix metalloproteinase-3 in the pathogenesis of macroprolactinaemia in some patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Possible role of shared epitope status in the relationship between matrix metalloproteinase 3 genotype and radiographic progression of rheumatoid arthritis: comment on the article by Constantin et al.
Arthritis, Rheumatoid
Prediction of Antiarthritic Drug Efficacies by Monitoring Active Matrix Metalloproteinase-3 (MMP-3) Levels in Collagen-Induced Arthritic Mice Using the MMP-3 Probe.
Arthritis, Rheumatoid
Production of anti-CCP antibodies and matrix metalloproteinase-3 by human rheumatoid arthritis synovial tissues using SCID mice.
Arthritis, Rheumatoid
Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B.
Arthritis, Rheumatoid
Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy.
Arthritis, Rheumatoid
Relationship between matrix metalloproteinase-3 serum level and pulmonary artery systolic pressure in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Relationship of epigenetic variability of miR-124 to extracellular matrix remodelling and age-related MMP-3 expression in rheumatoid arthritis.
Arthritis, Rheumatoid
Reply to: Comment on "Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks" by Yokoe et al.
Arthritis, Rheumatoid
Resveratrol inhibits TNF-?-induced IL-1?, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway.
Arthritis, Rheumatoid
Rheumatoid arthritis: MMP-3 levels predict 8-year joint damage.
Arthritis, Rheumatoid
S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases.
Arthritis, Rheumatoid
Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 change predictably in rheumatoid arthritis patients who have begun activity after a night of bed rest.
Arthritis, Rheumatoid
Serum Levels of Matrix Metalloproteinase (MMP) 9, a Risk Factor for Acute Coronary Syndrome, Are Reduced Independently of Serum MMP-3 by Anti-TNF-? Antibody (Infliximab) Therapy in Patients With Rheumatoid Arthritis.
Arthritis, Rheumatoid
Serum levels of matrix metalloproteinase 3 (stromelysin 1) for monitoring synovitis in rheumatoid arthritis.
Arthritis, Rheumatoid
Serum levels of matrix metalloproteinase-3 and autoantibodies related to rheumatoid arthritis in the general Japanese population and their association with osteoporosis and osteoarthritis: the ROAD study.
Arthritis, Rheumatoid
Serum levels of matrix metalloproteinase-3 in relation to the development of radiological damage in patients with early rheumatoid arthritis.
Arthritis, Rheumatoid
Serum matrix metalloproteinase 3 as a predictor of joint destruction in rheumatoid arthritis: comment on the article by Yamanaka et al.
Arthritis, Rheumatoid
Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis.
Arthritis, Rheumatoid
Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression.
Arthritis, Rheumatoid
Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
Arthritis, Rheumatoid
Serum matrix metalloproteinase 3 levels in comparison to C-reactive protein in periods with and without progression of radiological damage in patients with early rheumatoid arthritis.
Arthritis, Rheumatoid
Serum matrix metalloproteinase-3 and fibrin degradation product levels correlate with clinical disease activity in rheumatoid arthritis.
Arthritis, Rheumatoid
Serum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis.
Arthritis, Rheumatoid
Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological disease modifying anti-rheumatic drugs.
Arthritis, Rheumatoid
Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis.
Arthritis, Rheumatoid
Serum matrix metalloproteinase-3 in systemic sclerosis.
Arthritis, Rheumatoid
Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
Arthritis, Rheumatoid
Serum metalloproteinases and their inhibitors: markers for malignant potential.
Arthritis, Rheumatoid
Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis.
Arthritis, Rheumatoid
Serum MMP-3 in rheumatoid arthritis: correlation with systemic inflammation but not with erosive status.
Arthritis, Rheumatoid
Serum pro-matrix metalloproteinase-3 as an indicator of disease activity and severity in rheumatoid arthritis: comparison with traditional markers.
Arthritis, Rheumatoid
Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis.
Arthritis, Rheumatoid
Steroid therapy and renal dysfunction are independently associated with serum levels of matrix metalloproteinase-3 in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Stromelysin (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase (TIMP-1) mRNA expression in scleritis.
Arthritis, Rheumatoid
Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: Association with severity and progression of rheumatoid arthritis in a prospective study.
Arthritis, Rheumatoid
Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium.
Arthritis, Rheumatoid
Stromelysin synthesizing cells in the synovial tissues of rheumatoid arthritis demonstrated by in situ hybridization and immunohistochemical methods.
Arthritis, Rheumatoid
Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand.
Arthritis, Rheumatoid
Stromelysin-1 expression is activated in vivo by Ets-1 through palindromic head-to-head Ets binding sites present in the promoter.
Arthritis, Rheumatoid
Suppression of active, but not total MMP-3, is associated with treatment response in a phase III clinical study of rheumatoid arthritis.
Arthritis, Rheumatoid
Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase-inhibitor.
Arthritis, Rheumatoid
Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.
Arthritis, Rheumatoid
Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction.
Arthritis, Rheumatoid
Synergistic effect of glucosamine and vitamin E against experimental rheumatoid arthritis in neonatal rats.
Arthritis, Rheumatoid
Synovial MMP-3 and TIMP-1 levels and their correlation with cytokine expression in canine rheumatoid arthritis.
Arthritis, Rheumatoid
Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?
Arthritis, Rheumatoid
The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases.
Arthritis, Rheumatoid
The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity.
Arthritis, Rheumatoid
The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
Arthritis, Rheumatoid
The diagnostic utility of matrix metalloproteinase-3 and high-sensitivity C-reactive protein for predicting rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-negative patients with recent-onset undifferentiated arthritis.
Arthritis, Rheumatoid
The effects of leflunomide on clinical parameters and serum levels of IL-6, IL-10, MMP-1 and MMP-3 in patients with resistant rheumatoid arthritis.
Arthritis, Rheumatoid
The involvement of matrix metalloproteinases and inflammation in lumbar disc herniation.
Arthritis, Rheumatoid
The JNK pathway represents a novel target in the treatment of rheumatoid arthritis through the suppression of MMP-3.
Arthritis, Rheumatoid
The Ras guanine nucleotide exchange factor RasGRF1 promotes matrix metalloproteinase-3 production in rheumatoid arthritis synovial tissue.
Arthritis, Rheumatoid
Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone.
Arthritis, Rheumatoid
Transin/stromelysin expression in rheumatoid synovium. A transformation-associated metalloproteinase secreted by phenotypically invasive synoviocytes.
Arthritis, Rheumatoid
Treating to target matrix metalloproteinase 3 normalisation together with disease activity score below 2.6 yields better effects than each alone in rheumatoid arthritis patients: T-4 Study.
Arthritis, Rheumatoid
Variation in the matrix metalloproteinase-3, -7, -12 and -13 genes is associated with functional status in rheumatoid arthritis.
Arthritis, Rheumatoid
Weighting with the Lansbury articular index improves the correlation of ultrasound score with serum matrix metalloproteinase-3 level in rheumatoid arthritis patients.
Arthritis, Rheumatoid
[A basic study of determination matrix metalloproteinase-3 and carbohydrate in rheumatoid factor in serum for diagnosis of rheumatoid arthritis]
Arthritis, Rheumatoid
[Clinical significance of MMP-3 in patients with rheumatoid arthritis: comparison with other inflammatory markers(IL-6, IL-8)]
Arthritis, Rheumatoid
[Clinical value of serum matrix metalloproteinase-3 in evaluating joint destruction and therapeutic effect in rheumatoid arthritis patients].
Arthritis, Rheumatoid
[Correlations between serum matrix metalloproteinase (MMP-1, MMP-3, MMP-9, MMP-13) concentrations and markers of disease activity in early rheumatoid arthritis]
Arthritis, Rheumatoid
[Cytokines, prostaglandin E2, phospholipase A and metalloproteases in synovial fluid in osteoarthritis]
Arthritis, Rheumatoid
[Effects of TWEAK on the synthesis of MMP-3 in fibroblast-like synoviocytes of rheumatoid arthritis.]
Arthritis, Rheumatoid
[Efficacy of Hebi Formula Combined Methotrexate on Early Rheumatoid Arthritis Patients with Dis- harmony of Gan and Pi Syndrome and Its Effects on Serum MMP-3 and RANK/RANKL/OPG Expressions].
Arthritis, Rheumatoid
[Expression of matrix metalloproteinase-3 in patients with reheumatoid arthritis and its correlation with chronic periodontitis and rheumatoid arthritis].
Arthritis, Rheumatoid
[Immunological and serological tests for diagnosis of rheumatoid arthritis: MMP-3]
Arthritis, Rheumatoid
[Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis]
Arthritis, Rheumatoid
[Matrix metalloproteinase (MMP)-3 is not effective for evaluating hemophilic arthropathy].
Arthritis, Rheumatoid
[MMP-3 as a Biomarker of Disease Activity of Rheumatoid Arthritis].
Arthritis, Rheumatoid
[Relationship between matrix metalloproteinase-3 levels and articular destructive changes in early and extended rheumatoid arthritis].
Arthritis, Rheumatoid
[Role of matrix metalloproteinase-3 in joint destruction in rheumatoid arthritis]
Arthritis, Rheumatoid
[Serum markers of synovitis and bone metabolism in rheumatoid arthritis]
Arthritis, Rheumatoid
[Significance of serum MMP-3, TIMP-1, and monocyte CD147 in rheumatoid arthritis patients of damp-heat Bi-syndrome and of cold-damp Bi-syndrome].
Arthritis, Rheumatoid
[Stromelysin-1 (MMP-3) level in the sera from patients with rheumatoid arthritis and other connective tissue diseases--clinical significances in early onset rheumatoid arthritis]
Arthritis, Rheumatoid
[Stromelysin-1 in inflammatory disease: significance, specificity, and regulation elements]
Arthritis, Rheumatoid
[The application of matrix metalloproteinase-3 and 7 joints ultrasonic score in assessment of disease activity in patients with rheumatoid arthritis].
Arthritis, Rheumatoid
[Usefulness of examinations of serum levels of matrix metalloproteinases 1, MMP-3, MMP-9, tissue inhibitor of metalloproteinases 1, hyaluronic acid and antibodies against cyclic citrullinated peptide in Lyme arthritis, rheumatoid arthritis and patients with arthritic complaints].
Arthritis, Rheumatoid
[Usefulness of serum matrix metalloproteinase-3(MMP-3) level in the diagnosis of rheumatoid arthritis]
Arthritis, Rheumatoid
[Value of serum matrix metalloproteinase 3 in the assessment of early rheumatoid arthritis].
Arthritis, Rheumatoid
[Value of serum matrix metalloproteinase-3 in the assessment of active disease in patients with rheumatoid arthritis].
Asthma
Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus.
Asthma
Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma.
Asthma
Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
Asthma
Relationship between matrix production by bronchial fibroblasts and lung function and AHR in asthma.
Asthma
[Regulatory effects of inhaled steroids on expression of matrix metalloproteinase-9 and its inhibitor in asthmatic rats]
Astrocytoma
Expression of stromelysin 1 in human astrocytoma cell lines.
Astrocytoma
Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression.
Astrocytoma
Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China.
Astrocytoma
[Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma]
Atherosclerosis
A role for MMP-3 genetic variation in atherosclerosis susceptibility?
Atherosclerosis
Activation of inflammatory mediators and potential role of ah-receptor ligands in foam cell formation.
Atherosclerosis
Association of Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Gene Variants with Ischemic Stroke and Its Subtype.
Atherosclerosis
Association of matrix metalloproteinase-3 gene 5A/6A polymorphism with the recurrence of ischemic stroke: A prospective observational study.
Atherosclerosis
Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis.
Atherosclerosis
Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.
Atherosclerosis
Correlations of MMP-1, MMP-3, and MMP-12 with the degree of atherosclerosis, plaque stability and cardiovascular and cerebrovascular events.
Atherosclerosis
Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury.
Atherosclerosis
Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis.
Atherosclerosis
Enhanced cell cycle entry and mitogen-activated protein kinase-signaling and downregulation of matrix metalloproteinase-1 and -3 in human diabetic arterial vasculature.
Atherosclerosis
Enhanced expression of matrix metalloproteinase-3, -12, and -13 mRNAs in the aortas of apolipoprotein E-deficient mice with advanced atherosclerosis.
Atherosclerosis
Genetic contribution to carotid vascular disease in patients with systemic lupus erythematosus.
Atherosclerosis
Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects.
Atherosclerosis
Genistein supplementation inhibits atherosclerosis with stabilization of the lesions in hypercholesterolemic rabbits.
Atherosclerosis
Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population. The Beijing atherosclerosis study.
Atherosclerosis
Haplotype Analysis of the Stromelysin-1 (MMP3) and Gelatinase B (MMP9) Genes in Relation to Coronary Heart Disease.
Atherosclerosis
Lower serum concentration of matrix metalloproteinase-3 in the acute stage of myocardial infarction.
Atherosclerosis
Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits.
Atherosclerosis
Macrophages: an elusive yet emerging therapeutic target of atherosclerosis.
Atherosclerosis
Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.
Atherosclerosis
Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.
Atherosclerosis
Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia.
Atherosclerosis
Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels.
Atherosclerosis
Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis.
Atherosclerosis
The Role of Matrix Metalloproteinase-3 In the Development of Atherosclerosis and Cardiovascular Events.
Atherosclerosis
The role of matrix metalloproteinases in acute coronary syndromes.
Atherosclerosis
The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina.
Atherosclerosis
Tissue inhibitor of matrix metalloproteinase-3 levels in the extracellular matrix of lung, kidney, and eye increase with age.
Atherosclerosis
[Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease]
Atherosclerosis
[Establishment and analysis of chronic periodontitis and atherosclerosis model in Wistar rat]
Atrial Fibrillation
Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
Atrial Fibrillation
MMP-1 and MMP-3 polymorphism and arrhythmia recurrence after electrical cardioversion in patients with persistent atrial fibrillation.
Autoimmune Diseases
Matrix metalloproteinase-3 in myasthenia gravis compared to other neurological disorders and healthy controls.
Axial Spondyloarthritis
ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNF? inhibitors.
Axial Spondyloarthritis
Elevated Serum Levels of Sclerostin are Associated with High Disease Activity and Functional Impairment in Patients with Axial Spondyloarthritis.
Bacterial Infections
General and specific host responses to bacterial infection in Peyer's patches: a role for stromelysin-1 (matrix metalloproteinase-3) during Salmonella enterica infection.
Bacterial Infections
Impaired immunity to intestinal bacterial infection in stromelysin-1 (matrix metalloproteinase-3)-deficient mice.
Basal Cell Nevus Syndrome
Increased expression of matrix metalloproteinase-3 (stromelysin-1) in cultured fibroblasts and basal cell carcinomas of nevoid basal cell carcinoma syndrome.
Bile Duct Neoplasms
Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease.
Biliary Atresia
High serum matrix metalloproteinase-3 and liver stiffness in postoperative biliary atresia.
Biliary Atresia
Immunological investigation of the hepatic tissue from infants with biliary atresia.
Blister
Effects of matrix metalloproteinase-3 gene transfer by electroporation in glaucoma filter surgery.
Blister
Enhanced expression of interstitial collagenase, stromelysin-1, and urokinase plasminogen activator in lesions of dermatitis herpetiformis.
Blister
Gene expression of collagenase and stromelysin in skin fibroblasts derived from dystrophic epidermolysis bullosa.
Blister
Increased gene expression of matrix metalloproteinase-3 (stromelysin) in skin fibroblasts from patients with severe recessive dystrophic epidermolysis bullosa.
Blister
Matrix metalloproteinases (MMP-1, MMP-2, MMP-3 and MMP-9, and TIMP-1, TIMP-2 and TIMP-3) and markers for vascularization in functioning and non-functioning bleb capsules of glaucoma drainage implants.
Blister
Parallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of patients with dermatitis herpetiformis.
Blister
Photosensitization of uroporphyrin augments the ultraviolet A-induced synthesis of matrix metalloproteinases in human dermal fibroblasts.
Blister
Urokinase plasminogen activator is expressed by basal keratinocytes before interstitial collagenase, stromelysin-1, and laminin-5 in experimentally induced dermatitis herpetiformis lesions.
Bone Resorption
3D osteoarthritic changes in TMJ condylar morphology correlates with specific systemic and local biomarkers of disease.
Bone Resorption
Differential regulation of MMP-13 (collagenase-3) and MMP-3 (stromelysin-1) in mouse calvariae.
Bone Resorption
Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study.
Bone Resorption
Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis.
Bone Resorption
Mice Deficient in CIZ/NMP4 Develop an Attenuated Form of K/BxN-Serum Induced Arthritis.
Bone Resorption
MMP-3 response to compressive forces in vitro and in vivo.
Bone Resorption
Osteoporosis in rheumatoid arthritis: a molecular biological aspect of connective tissue gene activation.
Bone Resorption
Postmenopausal women with rheumatoid arthritis who are treated with raloxifene or alendronate or glucocorticoids have lower serum undercarboxylated osteocalcin (ucOC) levels.
Bone Resorption
PP121 suppresses RANKL-Induced osteoclast formation in vitro and LPS-Induced bone resorption in vivo.
Bone Resorption
Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone.
Brain Contusion
Study on changes of MMP-3 expression after brain contusion in rats.
Brain Contusion
[Expression of matrix metalloproteinase-3 after brain contusion in rats]
Brain Diseases
Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia.
Brain Injuries
Peroxynitrite-Induced Tyrosine Nitration Contributes to Matrix Metalloprotease-3 Activation: Relevance to Hyperglycemic Ischemic Brain Injury and Tissue Plasminogen Activator.
Brain Injuries, Traumatic
Agrin expression during synaptogenesis induced by traumatic brain injury.
Brain Injuries, Traumatic
Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis.
Brain Injuries, Traumatic
Matrix metalloproteinase-3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury.
Brain Injuries, Traumatic
Multi-Potent Adult Progenitor Cells, but not Tissue Inhibitor of Matrix Metalloproteinase-3, Increase Tissue Sparing and Reduce Urological Complications following Spinal Cord Injury.
Brain Ischemia
Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation.
Brain Neoplasms
Expression of stromelysin 1 in human astrocytoma cell lines.
Brain Neoplasms
Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
Brain Neoplasms
Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines.
Breast Diseases
Inhibition of human MDA-MB-231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogen.
Breast Neoplasms
A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations.
Breast Neoplasms
A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
Breast Neoplasms
Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery.
Breast Neoplasms
Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/?-Catenin Signaling.
Breast Neoplasms
Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer.
Breast Neoplasms
CXCR7 protein expression correlates with elevated mmp-3 secretion in breast cancer cells.
Breast Neoplasms
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Breast Neoplasms
Elucidating cancer-vascular paracrine signaling using a human organotypic breast cancer cell extravasation model.
Breast Neoplasms
Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells.
Breast Neoplasms
Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.
Breast Neoplasms
Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development.
Breast Neoplasms
Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines.
Breast Neoplasms
Expression of proteinases and inhibitors in human breast cancer progression and survival.
Breast Neoplasms
Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.
Breast Neoplasms
Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer.
Breast Neoplasms
Human cytomegalovirus interleukin-10 enhances matrigel invasion of MDA-MB-231 breast cancer cells.
Breast Neoplasms
Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
Breast Neoplasms
Immunolocalization of matrix metallo-proteinases and their tissue inhibitor in human mammary pathology.
Breast Neoplasms
In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.
Breast Neoplasms
Inhibition of breast cancer growth and invasion by single-minded 2s.
Breast Neoplasms
Inhibition of human MDA-MB-231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogen.
Breast Neoplasms
Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids.
Breast Neoplasms
Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion.
Breast Neoplasms
Low-volume multiplexed proteolytic activity assay and inhibitor analysis through a pico-injector array.
Breast Neoplasms
Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1.
Breast Neoplasms
Matrix metalloproteinase (MMP)-1 and MMP-3 gene variations affect MMP-1 and -3 serum concentration and associates with breast cancer.
Breast Neoplasms
Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices.
Breast Neoplasms
Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material.
Breast Neoplasms
Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.
Breast Neoplasms
Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features.
Breast Neoplasms
Matrix metalloproteinases and metastatic cancer.
Breast Neoplasms
Metalloproteinases 1 and 3 as Potential Biomarkers in Breast Cancer Development.
Breast Neoplasms
No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study.
Breast Neoplasms
Novel effects of sphingosylphosphorylcholine on invasion of breast cancer: Involvement of matrix metalloproteinase-3 secretion leading to WNT activation.
Breast Neoplasms
Overexpression of MMP-3 and uPA with Diminished PAI-1 Related to Metastasis in Ductal Breast Cancer Patients Attending a Public Hospital in Mexico City.
Breast Neoplasms
Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
Breast Neoplasms
Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer.
Breast Neoplasms
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability.
Breast Neoplasms
Retinoids interfere with the AP1 signalling pathway in human breast cancer cells.
Breast Neoplasms
Sphingosylphosphorylcholine Induces Thrombospondin-1 Secretion in MCF10A Cells via ERK2.
Breast Neoplasms
Spontaneous metastasis in matrix metalloproteinase 3-deficient mice.
Breast Neoplasms
Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
Breast Neoplasms
The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
Breast Neoplasms
The inhibitory effect of turmeric curcuminoids on matrix metalloproteinase-3 secretion in human invasive breast carcinoma cells.
Breast Neoplasms
Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.
Breast Neoplasms
[The expression of MMPs and TIMPs in human breast cancer tissues and importance of their balance in cancer invasion and metastasis]
Bronchiolitis
Proteins involved in extracellular matrix dynamics are associated with RSV disease severity.
Bronchiolitis Obliterans
Proteomic characterization reveals that MMP-3 correlates with bronchiolitis obliterans syndrome following allogeneic hematopoietic cell and lung transplantation.
Bronchopulmonary Dysplasia
Bronchoalveolar lavage fluid peptidomics suggests a possible matrix metalloproteinase-3 role in bronchopulmonary dysplasia.
Bursitis
A Study of IL-1?, MMP-3, TGF-?1, and GDF5 Polymorphisms and Their Association with Primary Frozen Shoulder in a Chinese Han Population.
Bursitis
Association of MMP3 genotype with susceptibility to frozen shoulder: a case-control study in a Chinese Han population.
Carcinogenesis
A protective role for matrix metalloproteinase-3 in squamous cell carcinoma.
Carcinogenesis
A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma.
Carcinogenesis
A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression.
Carcinogenesis
Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis.
Carcinogenesis
Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
Carcinogenesis
Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.
Carcinogenesis
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Carcinogenesis
Expression of stromelysin-1 and TIMP-1 in the involuting mammary gland and in early invasive tumors of the mouse.
Carcinogenesis
Induction of the putative protective protein ferritin by infrared radiation: implications in skin repair.
Carcinogenesis
Matrix-degrading metalloproteinases in tumor progression.
Carcinogenesis
Spontaneous metastasis in matrix metalloproteinase 3-deficient mice.
Carcinogenesis
Stromelysin in tumor progression and metastasis.
Carcinogenesis
The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
Carcinogenesis
The role of matrix metalloproteinases in acute coronary syndromes.
Carcinogenesis
WNT-5A, but not matrix metalloproteinase 3 or beta-catenin protein, expression is related to early stages of lip carcinogenesis.
Carcinoma
A protective role for matrix metalloproteinase-3 in squamous cell carcinoma.
Carcinoma
A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression.
Carcinoma
alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression.
Carcinoma
Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Carcinoma
Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.
Carcinoma
Autocrine and paracrine regulation of tissue inhibitor of metalloproteinases, transin, and urokinase gene expression in metastatic and nonmetastatic mammary carcinoma cells.
Carcinoma
Cancer-Specific Survival Stratification Derived from Tumor Expression of Tissue Inhibitor of Metalloproteinase-2 in Non-Metastatic Renal Cell Carcinoma.
Carcinoma
Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Carcinoma
Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
Carcinoma
Constitutive expression and secretion of proteases in non-metastatic SP1 mammary carcinoma cells and its metastatic sublines.
Carcinoma
Cyr61 increases matrix metalloproteinase-3 expression and cell motility in human oral squamous cell carcinoma cells.
Carcinoma
Detection of mRNAs encoding collagenase I and stromelysin 2 in carcinomas of the head and neck by in situ hybridization.
Carcinoma
Development of recombinant matrix metalloproteinase-3 based sandwich ELISA for sero-diagnosis of canine mammary carcinomas.
Carcinoma
Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.
Carcinoma
Effect of tumor-associated mutant E-cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3.
Carcinoma
Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma.
Carcinoma
Enhanced Expression but Decreased Specific Activity of Matrix Metalloproteinase 10 (MMP-10) in Comparison with Matrix Metalloproteinase 3 (MMP-3) in Human Urinary Bladder Carcinoma.
Carcinoma
Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
Carcinoma
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Carcinoma
Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas.
Carcinoma
Expression of ?v?6 integrin and collagen fibre in oral squamous cell carcinoma: association with clinical outcomes and prognostic implications.
Carcinoma
Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours.
Carcinoma
Expression of ets-1 transcription factor in human head and neck squamous cell carcinoma and effect of histamine on metastatic potential of invasive tumor through the regulation of expression of ets-1 and matrix metalloproteinase-3.
Carcinoma
Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis.
Carcinoma
Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity.
Carcinoma
Expression of MMP-3, MMP-13, TIMP-2 and TIMP-3 in the VX2 carcinoma of the New Zealand white rabbit.
Carcinoma
Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Carcinoma
Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Carcinoma
Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression.
Carcinoma
Gene expression of matrix metalloproteinase-1 (interstitial collagenase) and matrix metalloproteinase-3 (stromelysin-1) in basal cell carcinoma by in situ hybridization using chondroitin ABC lyase.
Carcinoma
Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer.
Carcinoma
Human stromelysin gene promoter activity is modulated by transcription factor ZBP-89.
Carcinoma
Identification of a metalloproteinase co-purifying with rat tumour collagenase and the characteristics of fragments of both enzymes.
Carcinoma
Increased expression of matrix metalloproteinase-3 (stromelysin-1) in cultured fibroblasts and basal cell carcinomas of nevoid basal cell carcinoma syndrome.
Carcinoma
Interactions of alpha2-HS-glycoprotein (fetuin) with MMP-3 and murine squamous cell carcinoma cells.
Carcinoma
Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption.
Carcinoma
Mammary carcinoma in aged gerbil mothers after endocrine disruption in pregnancy and lactation.
Carcinoma
Matrix metalloproteinase 3 polymorphism: a predictive factor of response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma.
Carcinoma
Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features.
Carcinoma
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions.
Carcinoma
Matrix-degrading metalloproteinases in tumor progression.
Carcinoma
Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression.
Carcinoma
MMP-3 mRNA and MMP-3 and MMP-1 proteins in bladder cancer: a comparison with clinicopathologic features and survival.
Carcinoma
mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas.
Carcinoma
NFAT1 promotes cell motility through MMP-3 in esophageal squamous cell carcinoma.
Carcinoma
Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study.
Carcinoma
Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
Carcinoma
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability.
Carcinoma
Requirement of MMP-3 in anchorage-independent growth of oral squamous cell carcinomas.
Carcinoma
Salivary MMP-1, MMP-2, MMP-3 and MMP-13 Levels in Patients with Oral Lichen Planus and Squamous Cell Carcinoma
Carcinoma
Serum and Saliva MMP-3 in Patients with OLP and Oral SCC.
Carcinoma
Signal transducer and activator of transcription 1 and matrix metalloproteinase 3 genetic expression and clinical significance on urothelial tumors after renal transplantation.
Carcinoma
Stromelysin-1 activation correlates with invasiveness in squamous cell carcinoma.
Carcinoma
The 2G allele of promoter region of Matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma.
Carcinoma
The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
Carcinoma
The inhibitor of kappa B kinase-epsilon regulates MMP-3 expression levels and can promote lung metastasis.
Carcinoma
The malignant conversion step of mouse skin carcinogenesis.
Carcinoma
The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors.
Carcinoma
The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas.
Carcinoma
The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity.
Carcinoma
Transcriptional modulation of transin gene expression by epidermal growth factor and transforming growth factor beta.
Carcinoma
Upregulation of serum vascular endothelial growth factor and matrix metalloproteinase-3 in patients with oral squamous cell carcinoma.
Carcinoma
[Detection of stromelysin mRNA expression in human hepatocellular carcinoma by in situ hybridization]
Carcinoma
[Study of the expression of nuclear factor-kappa B, matrix metalloproteinase-3, -9 on nasopharygeal carcinoma and their clinical significance].
Carcinoma in Situ
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions.
Carcinoma, Basal Cell
Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
Carcinoma, Basal Cell
Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Carcinoma, Basal Cell
Gene expression of matrix metalloproteinase-1 (interstitial collagenase) and matrix metalloproteinase-3 (stromelysin-1) in basal cell carcinoma by in situ hybridization using chondroitin ABC lyase.
Carcinoma, Basal Cell
Increased expression of matrix metalloproteinase-3 (stromelysin-1) in cultured fibroblasts and basal cell carcinomas of nevoid basal cell carcinoma syndrome.
Carcinoma, Ductal
Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features.
Carcinoma, Hepatocellular
AMF/PGI transactivates the MMP-3 gene through the activation of Src-RhoA-phosphatidylinositol 3-kinase signaling to induce hepatoma cell migration.
Carcinoma, Hepatocellular
Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Carcinoma, Hepatocellular
Expression of the transin, c-fos, and c-jun genes in rat transplantable osteosarcomas and malignant fibrous histiocytomas.
Carcinoma, Hepatocellular
Expression pattern of matrix metalloproteinases in human liver.
Carcinoma, Hepatocellular
Functional polymorphisms in the promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 are not associated with hepatocellular carcinoma risk.
Carcinoma, Hepatocellular
Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3.
Carcinoma, Hepatocellular
Immunocytochemical detection of MMP-3 and -10 expression in hepatocellular carcinomas.
Carcinoma, Hepatocellular
Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3.
Carcinoma, Hepatocellular
No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population.
Carcinoma, Hepatocellular
Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chronic liver disease.
Carcinoma, Hepatocellular
The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma.
Carcinoma, Hepatocellular
[Detection of stromelysin mRNA expression in human hepatocellular carcinoma by in situ hybridization]
Carcinoma, Intraductal, Noninfiltrating
Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.
Carcinoma, Medullary
Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.
Carcinoma, Medullary
Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study.
Carcinoma, Non-Small-Cell Lung
Expression of metastasis-associated molecules in non-small cell lung cancer and their prognostic significance.
Carcinoma, Non-Small-Cell Lung
The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
[Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer]
Carcinoma, Renal Cell
Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Carcinoma, Renal Cell
Cancer-Specific Survival Stratification Derived from Tumor Expression of Tissue Inhibitor of Metalloproteinase-2 in Non-Metastatic Renal Cell Carcinoma.
Carcinoma, Renal Cell
mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas.
Carcinoma, Squamous Cell
A protective role for matrix metalloproteinase-3 in squamous cell carcinoma.
Carcinoma, Squamous Cell
Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
Carcinoma, Squamous Cell
Expression of ets-1 transcription factor in human head and neck squamous cell carcinoma and effect of histamine on metastatic potential of invasive tumor through the regulation of expression of ets-1 and matrix metalloproteinase-3.
Carcinoma, Squamous Cell
Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis.
Carcinoma, Squamous Cell
Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity.
Carcinoma, Squamous Cell
Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression.
Carcinoma, Squamous Cell
Interactions of alpha2-HS-glycoprotein (fetuin) with MMP-3 and murine squamous cell carcinoma cells.
Carcinoma, Squamous Cell
Matrix metalloproteinase 3 polymorphism: a predictive factor of response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Matrix-degrading metalloproteinases in tumor progression.
Carcinoma, Squamous Cell
Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study.
Carcinoma, Squamous Cell
Salivary MMP-1, MMP-2, MMP-3 and MMP-13 Levels in Patients with Oral Lichen Planus and Squamous Cell Carcinoma
Carcinoma, Squamous Cell
Stromelysin-1 activation correlates with invasiveness in squamous cell carcinoma.
Carcinoma, Squamous Cell
The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors.
Carcinoma, Squamous Cell
The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas.
Carcinoma, Squamous Cell
The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity.
Carcinoma, Squamous Cell
[Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer]
Cardiomyopathies
Comparison of levels of matrix metalloproteinase-2 and -3 in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy.
Cardiomyopathies
Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction.
Cardiomyopathy, Dilated
Comparison of levels of matrix metalloproteinase-2 and -3 in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy.
Cardiomyopathy, Dilated
Serum matrix metalloproteinase-3 as a novel marker for risk stratification of patients with nonischemic dilated cardiomyopathy.
Cardiovascular Diseases
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.
Cardiovascular Diseases
Functional polymorphisms in matrix metalloproteinases-1, -3, -9 are associated with arteriovenous fistula patency in hemodialysis patients.
Cardiovascular Diseases
Genetic contribution to carotid vascular disease in patients with systemic lupus erythematosus.
Cardiovascular Diseases
Redundancy of IL-1 Isoform Signaling and Its Implications for Arterial Remodeling.
Carotid Artery Diseases
Association of blood active matrix metalloproteinase-3 with carotid plaque score from a community population in Taiwan.
Carotid Artery Diseases
Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis.
Carotid Artery Diseases
Correlations of MMP-1, MMP-3, and MMP-12 with the degree of atherosclerosis, plaque stability and cardiovascular and cerebrovascular events.
Carotid Artery Diseases
Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.
Carotid Artery Diseases
Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia.
Carotid Stenosis
Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis.
Cataract
Correlations Between MMPs and TIMPs Levels in Aqueous Humor from High Myopia and Cataract Patients.
Cataract
Human aqueous humor levels of transforming growth factor-?2: Association with matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases.
Cataract
MMP-2, MMP-3, TIMP-1, TIMP-2, and TIMP-3 protein levels in human aqueous humor: relationship with axial length.
Cataract
The role of oxidative stress and inflammation in conjunctivochalasis.
Cataract
[Effects of matrix metalloproteinase-3, osteopontin, and tissue inhibitor of metalloproteinase-1 in the formation of cataract]
Celiac Disease
Association of the matrix metalloproteinase-3 (MMP-3) promoter polymorphism with celiac disease in male subjects.
Cell Transformation, Neoplastic
Involvement of hnRNP A1 in the matrix metalloprotease-3-dependent regulation of Rac1 pre-mRNA splicing.
Central Nervous System Infections
Neurotrophic factor levels in the serum and cerebrospinal fluid of neonates infected with human cytomegalovirus.
Cerebellar Ataxia
Exclusion of stromelysin-1, stromelysin-2, interstitial collagenase and fibronectin genes as the mutant loci in a family with recessive epidermolysis bullosa dystrophica and a form of cerebellar ataxia.
Cerebral Infarction
White matter damage is associated with matrix metalloproteinases in vascular dementia.
Cerebral Infarction
[Association of matrix metalloproteinase-3 serum level and the promoter 5A/6A polymorphism of the MMP-3 gene with atherosclerotic cerebral infarction]
Cholangiocarcinoma
Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.
Cholangitis, Sclerosing
A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis.
Cholangitis, Sclerosing
Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis.
Cholera
Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone.
Cholesteatoma
Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3.
Cholesteatoma
Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas.
Chondrocalcinosis
Clinical, radiological, and biochemical characteristics in patients with diseases mimicking polymyalgia rheumatica.
Chondrocalcinosis
Low prevalence of knee chondrocalcinosis and its catabolic association by use of serum matrix metalloproteinase 3: A rural Japanese population study.
Chondrocalcinosis
MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.
Chondrosarcoma
Activin A suppresses interleukin-1-induced matrix metalloproteinase 3 secretion in human chondrosarcoma cells.
Chondrosarcoma
Chondroprotective effects of glucosamine involving the p38 MAPK and Akt signaling pathways.
Chondrosarcoma
Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expression.
Chondrosarcoma
Expression of MMP-9 decreases metastatic potential of Chondrosarcoma: an immunohistochemical study.
Chondrosarcoma
Human chondrosarcoma cells stably transfected with a stromelysin (MMP-3) promoter reporter construct provide a method of assessing transcriptional inhibitors.
Chondrosarcoma
Immunohistochemical analysis of matrix metalloproteinase-1, -3, and -13 in naturally occurring cartilaginous tumors of dogs.
Chondrosarcoma
Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.
Chondrosarcoma
In vitro suppression of the MMP-3 gene in normal and cytokine-treated human chondrosarcoma using small interfering RNA.
Chondrosarcoma
Involvement of matrix metalloproteinase-3 in CCL5/CCR5 pathway of chondrosarcomas metastasis.
Chondrosarcoma
Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes.
Chondrosarcoma
Roxatidine Attenuates Degradation of Extracellular Matrix.
Choriocarcinoma
Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
Chronic Periodontitis
Association of matrix metalloproteinase (MMP-1, MMP-3 and MMP-9) and cyclooxygenase-2 gene polymorphisms and their proteins with chronic periodontitis.
Chronic Periodontitis
CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts.
Chronic Periodontitis
Cytokine and metalloproteinases in gingival fluid from patients with chronic periodontitis.
Chronic Periodontitis
Effect of phase 1 periodontal therapy on gingival crevicular fluid levels of matrix metalloproteinases-3 and -13 in chronic periodontitis patients.
Chronic Periodontitis
Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population.
Chronic Periodontitis
Gingival Tissue and Crevicular Fluid Co-operation in Adult Periodontitis.
Chronic Periodontitis
Immunohistochemical study of neutrophil- and fibroblast-type collagenases and stromelysin-1 in adult periodontitis.
Chronic Periodontitis
Pathogen profile and MMP-3 levels in areas with varied attachment loss in generalized aggressive and chronic periodontitis.
Chronic Periodontitis
[Expression of matrix metalloproteinase-3 in patients with reheumatoid arthritis and its correlation with chronic periodontitis and rheumatoid arthritis].
Chronic Periodontitis
[Expression of MMP-2 and MMP-3 in periodontal tissues of rat periodontitis model]
Colitis
Increased Expression of Matrix Metalloproteinase-1 and 3 in Remission Patients of Steroid-Dependent Ulcerative Colitis.
Colitis
Serotonin-Exacerbated DSS-Induced Colitis Is Associated with Increase in MMP-3 and MMP-9 Expression in the Mouse Colon.
Colitis
Therapeutic implications of the specific inhibition of causative matrix metalloproteinases in experimental colitis induced by dextran sulphate sodium.
Colitis, Ulcerative
Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.
Colitis, Ulcerative
Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine.
Colitis, Ulcerative
Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.
Colitis, Ulcerative
Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.
Colitis, Ulcerative
Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
Colitis, Ulcerative
Leucine-rich alpha-2 glycoprotein 1, high mobility group box 1, matrix metalloproteinase 3 and annexin A1 as biomarkers of ulcerative colitis endoscopic and histological activity.
Colitis, Ulcerative
Metalloproteinase-3 and -9 as novel markers in the evaluation of ulcerative colitis activity in children.
Colitis, Ulcerative
P088. Serum matrix metalloproteinase-3 concentration correlates with clinical and endoscopic evidence of ulcerative colitis.
Colitis, Ulcerative
Phenotype of cells expressing matrix metalloproteinase-3 in ulcerative colitis.
Colitis, Ulcerative
Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis.
Colitis, Ulcerative
Role of macrophage metalloelastase in gut inflammation.
Colitis-Associated Neoplasms
Protein kinase D1 mediates synergistic MMP-3 expression induced by TNF-? and bradykinin in human colonic myofibroblasts.
Colonic Neoplasms
Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
Colonic Neoplasms
Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor.
Colonic Neoplasms
EFEMP2 promotes colon cancer cell invasion and growth through the ERK1/2 signaling pathway.
Colonic Neoplasms
Glycine-extended gastrin induces matrix metalloproteinase-1- and -3-mediated invasion of human colon cancer cells through type I collagen gel and Matrigel.
Colonic Neoplasms
Matrix-degrading metalloproteinases in tumor progression.
Colonic Neoplasms
Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.
Colonic Neoplasms
Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers.
Colorectal Neoplasms
Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer.
Colorectal Neoplasms
Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability.
Colorectal Neoplasms
Expression and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases as a prognostic factor in advanced colorectal carcinomas.
Colorectal Neoplasms
Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer.
Colorectal Neoplasms
Impairment of stromelysin-1 transcriptional activity by promoter mutations in high microsatellite instability colorectal tumors.
Colorectal Neoplasms
Involvement of hnRNP A1 in the matrix metalloprotease-3-dependent regulation of Rac1 pre-mRNA splicing.
Colorectal Neoplasms
Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
Colorectal Neoplasms
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
Colorectal Neoplasms
Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
Colorectal Neoplasms
Minimally invasive colorectal resection is associated with significantly elevated levels of plasma matrix metalloproteinase 3 (MMP-3) during the first month after surgery which may promote the growth of residual metastases.
Colorectal Neoplasms
No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in chinese.
Colorectal Neoplasms
Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice.
Colorectal Neoplasms
Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.
Colorectal Neoplasms
Role of matrix metalloproteinases (MMPs) in colorectal cancer.
Colorectal Neoplasms
Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
Colorectal Neoplasms
Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.
Colorectal Neoplasms
Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors.
Colorectal Neoplasms
The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer.
Colorectal Neoplasms
The stromelysin-1 5A/5A genotype enhances colorectal cancer cell invasion in Iranian population.
Colorectal Neoplasms
[Polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 in colorectal cancer]
Communicable Diseases
Differential expression of matrix metalloproteinases in bacterial meningitis.
Congenital Abnormalities
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B.
Connective Tissue Diseases
Elevated plasma stromelysin levels in arthritis.
Connective Tissue Diseases
[Stromelysin-1 (MMP-3) level in the sera from patients with rheumatoid arthritis and other connective tissue diseases--clinical significances in early onset rheumatoid arthritis]
Contracture
Inducement of mitogen-activated protein kinases in frozen shoulders.
Corneal Opacity
An intact complement system dampens cornea inflammation during acute primary HSV-1 infection.
Coronary Aneurysm
Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.
Coronary Aneurysm
Elevated levels of matrix metalloprotein-3 in patients with coronary aneurysm: A case control study.
Coronary Artery Disease
Association between MMP-3 and MMP-9 polymorphisms and coronary artery disease.
Coronary Artery Disease
Association of MMP-1 (rs1799750)-1607 2G/2G and MMP-3 (rs3025058)-1612 6A/6A genotypes with coronary artery disease risk among Iranian Turks.
Coronary Artery Disease
Circulating matrix metalloproteinase 3 due to myocardial ischemia.
Coronary Artery Disease
Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
Coronary Artery Disease
Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis.
Coronary Artery Disease
Elevated levels of matrix metalloprotein-3 in patients with coronary aneurysm: A case control study.
Coronary Artery Disease
Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects.
Coronary Artery Disease
Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome.
Coronary Artery Disease
Induction of stromelysin-1 (MMP-3) by fibroblast growth factor-2 (FGF-2) in FGF-2-/- microvascular endothelial cells requires prolonged activation of extracellular signal-regulated kinases-1 and -2 (ERK-1/2).
Coronary Artery Disease
Influence of genetic polymorphism in matrix metalloproteinase-3 on extent of coronary atherosclerosis and risk of coronary artery stenosis.
Coronary Artery Disease
Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction.
Coronary Artery Disease
Large artery stiffness: structural and genetic aspects.
Coronary Artery Disease
Matrix metalloproteinase-3 (MMP-3) -1612 5A/6A promoter polymorphism in coronary artery disease in Indian population.
Coronary Artery Disease
Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.
Coronary Artery Disease
Matrix metalloproteinase-3 predicts clinical cardiovascular outcomes in patients with coronary artery disease: a 5 years cohort study.
Coronary Artery Disease
Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
Coronary Artery Disease
Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.
Coronary Artery Disease
Potential role of selected biomarkers for predicting the presence and extent of coronary artery disease.
Coronary Artery Disease
Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.
Coronary Artery Disease
Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression.
Coronary Artery Disease
Relationship of blood levels of inflammatory and destructive biomarkers in coronary atherosclerosis with long-term results of surgical revascularization.
Coronary Artery Disease
Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction.
Coronary Artery Disease
Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis.
Coronary Artery Disease
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial.
Coronary Artery Disease
The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina.
Coronary Artery Disease
The stromelysin-1 (MMP-3) gene and risk of coronary artery disease: a candidate gene that has won the election?
Coronary Artery Disease
The stromelysin-1 5A/6A promoter polymorphism is a disease marker for the extent of coronary heart disease.
Coronary Artery Disease
Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease.
Coronary Artery Disease
[Association between single nucleotide polymorphisms of matrix metalloproteinase-3 gene and the severity of coronary atherosclerosis in patients with coronary artery disease]
Coronary Disease
Haplotype Analysis of the Stromelysin-1 (MMP3) and Gelatinase B (MMP9) Genes in Relation to Coronary Heart Disease.
Coronary Disease
Haplotypes and 5A/6A polymorphism of the matrix metalloproteinase-3 gene in coronary disease: Case-control study and a meta-analysis.
Coronary Disease
Interaction between smoking and the stromelysin-1 (MMP3) gene 5A/6A promoter polymorphism and risk of coronary heart disease in healthy men.
Coronary Disease
Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease.
Coronary Disease
Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression.
Coronary Disease
The stromelysin-1 5A/6A promoter polymorphism is a disease marker for the extent of coronary heart disease.
Coronary Disease
Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease.
Coronary Disease
[Assessment of the role of matrix metalloproteinase-3 gene polymorphism in the development of chronic heart failure].
Coronary Disease
[Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease]
Coronary Stenosis
Influence of genetic polymorphism in matrix metalloproteinase-3 on extent of coronary atherosclerosis and risk of coronary artery stenosis.
Coronary Stenosis
Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease.
Coronary Stenosis
Risk of coronary artery stenosis in Iranian type 2 diabetics: is there a role for matrix metalloproteinase-3 gene (-1612 5A/6A) polymorphism?
COVID-19
Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).
COVID-19
Matrix metalloproteinase 3 as a valuable marker for patients with COVID-19.
COVID-19
Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019.
Crohn Disease
Correlation of MMP-3 and MMP-9 with Crohn's Disease Activity in Children.
Crohn Disease
Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.
Crohn Disease
Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine.
Crohn Disease
Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.
Crohn Disease
Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease.
Crohn Disease
Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.
Crohn Disease
Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.
Crohn Disease
Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
Crohn Disease
Role of macrophage metalloelastase in gut inflammation.
Crohn Disease
Stromelysin-1 and macrophage metalloelastase expression in the intestinal mucosa of Crohn's disease patients treated with infliximab.
Crohn Disease
Transmission disequilibrium test of stromelysin-1 gene variation in relation to Crohn's disease.
Crystal Arthropathies
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Cutis Laxa
Cutis Laxa: analysis of metalloproteinases and extracellular matrix expression by immunohistochemistry and histochemistry.
Cutis Laxa
Regulation of matrix metalloproteinase (MMP) expression in cutis laxa fibroblasts: upregulation of MMP-1, MMP-3 and MMP-9 genes but not of the MMP-2 gene.
Dementia
Concentrations of Matrix Metalloproteinases and their Tissue Inhibitors in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
Dementia
Impact of the matrix metalloproteinase MMP-3 on dementia.
Dementia
Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease. The Rotterdam Study.
Demyelinating Diseases
Matrix metalloproteinase-12 deficiency ameliorates the clinical course and demyelination in Theiler's murine encephalomyelitis.
Demyelinating Diseases
MMP-12, MMP-3, and TIMP-1 are markedly upregulated in chronic demyelinating theiler murine encephalomyelitis.
Demyelinating Diseases
The up-regulation of stromelysin-1 (MMP-3) in a spontaneously demyelinating transgenic mouse precedes onset of disease.
Dermatitis
Expression of matrix metalloproteinases (MMP-2, MMP-3, and MMP-9) and fibronectin in lichen planus.
Dermatitis Herpetiformis
Enhanced expression of interstitial collagenase, stromelysin-1, and urokinase plasminogen activator in lesions of dermatitis herpetiformis.
Dermatitis Herpetiformis
Urokinase plasminogen activator is expressed by basal keratinocytes before interstitial collagenase, stromelysin-1, and laminin-5 in experimentally induced dermatitis herpetiformis lesions.
Dermatitis, Atopic
Increased levels of serum tissue inhibitor of metalloproteinase-1 but not metalloproteinase-3 in atopic dermatitis.
Dermatitis, Contact
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response.
Dermatomyositis
Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.
Dermatomyositis
Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Diabetes Complications
Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy Boys.
Diabetes Mellitus
Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus.
Diabetes Mellitus
Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development.
Diabetes Mellitus
Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women.
Diabetes Mellitus
Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.
Diabetes Mellitus
Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus.
Diabetes Mellitus
Risk of coronary artery stenosis in Iranian type 2 diabetics: is there a role for matrix metalloproteinase-3 gene (-1612 5A/6A) polymorphism?
Diabetes Mellitus
Scoring Model to Predict a Low Disease Activity in Elderly Rheumatoid Arthritis Patients Initially Treated with Biological Disease-modifying Antirheumatic Drugs.
Diabetes Mellitus, Type 1
The skin remodeling in type 1 diabetes and insulin resistance animal models.
Diabetes Mellitus, Type 2
Association between Genetic Variants and Diabetes Mellitus in Iranian Populations: A Systematic Review of Observational Studies.
Diabetes Mellitus, Type 2
Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus.
Diabetes Mellitus, Type 2
Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetes in a Korean population.
Diabetes Mellitus, Type 2
Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus.
Diabetes Mellitus, Type 2
Risk of coronary artery stenosis in Iranian type 2 diabetics: is there a role for matrix metalloproteinase-3 gene (-1612 5A/6A) polymorphism?
Diabetic Nephropathies
Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus.
Diabetic Nephropathies
Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy.
Diabetic Nephropathies
In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy.
Diabetic Retinopathy
Correlations of MMP-3 and MMP-9 gene polymorphisms with diabetic retinopathy.
Dry Eye Syndromes
Dexamethasone nanowafer as an effective therapy for dry eye disease.
Duodenal Ulcer
Elevated Serum Matrix Metalloproteinase-3 and -7 in H. pylori-Related Gastric Cancer Can Be Biomarkers Correlating with a Poor Survival.
Duodenal Ulcer
Matrix metalloproteinase-3 promoter polymorphisms but not dupA-H. pylori correlate to duodenal ulcers in H. pylori-infected females.
Duodenal Ulcer
[Role of Allelic Genes of Matrix Metalloproteinases and Their Tissue Inhibitors in the Peptic Ulcer Disease Development].
Dysentery, Amebic
The parasite Entamoeba histolytica exploits the activities of human matrix metalloproteinases to invade colonic tissue.
Encephalitis
Chemokines and matrix metalloproteinases in cerebrospinal fluid of patients with central nervous system complications caused by varicella-zoster virus.
Encephalitis
Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis.
Encephalomyelitis
MMP-12, MMP-3, and TIMP-1 are markedly upregulated in chronic demyelinating theiler murine encephalomyelitis.
Endoleak
Plasma Matrix Metalloproteinase 9 Levels May Predict Endoleaks After Endovascular Aortic Aneurysm Repair.
Endometrial Neoplasms
Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility.
Endometrial Neoplasms
No Association between Matrix Metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and Endometrial Cancer Risk.
Endometriosis
Curcumin as anti-endometriotic agent: implication of MMP-3 and intrinsic apoptotic pathway.
Endometriosis
Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium.
Endometriosis
Down-regulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget.
Endometriosis
Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis.
Endometriosis
Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2.
Endometriosis
Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems.
Endometriosis
Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis.
Endometriosis
Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis.
Endometriosis
Matrix Metalloproteinase-3 mRNA: A Promising Peripheral Blood Marker for Diagnosis of Endometriosis.
Endometriosis
Melatonin protects against endometriosis via regulation of matrix metalloproteinase-3 and an apoptotic pathway.
Endometriosis
mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT-PCR assay.
Endometriosis
Performance of peripheral (serum and molecular) blood markers for diagnosis of endometriosis.
Endometriosis
Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis.
Endometriosis
Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice.
Endometriosis
[Expression of matrix metalloproteinase and tissue inhibitor of metalloproteinase in adenomyosis]
Endometriosis
[Expression of MMP-3 and TIMP-1 in the endometriosis and the influence of danazol]
Endometriosis
[Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis]
Endometritis
Increasing of matrix metalloproteinase 3 in bovine endometritis.
Ependymoma
Medulloblastoma displays distinct regional matrix metalloprotease expression.
Epidermolysis Bullosa Dystrophica
Exclusion of stromelysin-1, stromelysin-2, interstitial collagenase and fibronectin genes as the mutant loci in a family with recessive epidermolysis bullosa dystrophica and a form of cerebellar ataxia.
Epidermolysis Bullosa Dystrophica
Expression of collagenase and stromelysin in skin fibroblasts from recessive dystrophic epidermolysis bullosa.
Epidermolysis Bullosa Dystrophica
Gene expression of collagenase and stromelysin in skin fibroblasts derived from dystrophic epidermolysis bullosa.
Epidermolysis Bullosa Dystrophica
Increased gene expression of matrix metalloproteinase-3 (stromelysin) in skin fibroblasts from patients with severe recessive dystrophic epidermolysis bullosa.
Epidermolysis Bullosa Dystrophica
Skin expression of metalloproteinases and tissue inhibitor of metalloproteinases in sibling patients with recessive dystrophic epidermolysis and intrafamilial phenotypic variation.
Epilepsy
Evaluation of serum matrix metalloproteinase-3 as a biomarker for diagnosis of epilepsy.
Epilepsy
Matrix metalloproteinase-3 in myasthenia gravis compared to other neurological disorders and healthy controls.
Epilepsy
Matrix metalloproteinases during and outside of migraine attacks without aura.
Epiretinal Membrane
Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy.
Erythema
Detection of active matrix metalloproteinase-3 in serum and fibroblast-like synoviocytes of collagen-induced arthritis mice.
Esophageal Squamous Cell Carcinoma
Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
NFAT1 promotes cell motility through MMP-3 in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
Exanthema
Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis.
Fibroadenoma
Immunolocalization of matrix metallo-proteinases and their tissue inhibitor in human mammary pathology.
Fibromyalgia
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Fibrosarcoma
Autotaxin promotes the expression of matrix metalloproteinase-3 via activation of the MAPK cascade in human fibrosarcoma HT-1080 cells.
Fibrosarcoma
Okadaic acid-elicited transcriptional activation of collagenase gene expression in HT-1080 fibrosarcoma cells is mediated by JunB.
Fibrosarcoma
Repression of stromelysin metalloprotease expression in rat fibrosarcoma cells by dimethylsulfoxide.
Fibrosarcoma
Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
Fibrosarcoma
Tumorigenic and metastatic properties of two ras-oncogene transfected rat fibrosarcoma cell lines defective in c-jun.
Gastritis
Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis.
Gastritis
Elevated Serum Matrix Metalloproteinase-3 and -7 in H. pylori-Related Gastric Cancer Can Be Biomarkers Correlating with a Poor Survival.
Gastritis
Matrix metalloproteinase-3 promoter polymorphisms but not dupA-H. pylori correlate to duodenal ulcers in H. pylori-infected females.
Gastrointestinal Diseases
Elevated Serum Matrix Metalloproteinase-3 and -7 in H. pylori-Related Gastric Cancer Can Be Biomarkers Correlating with a Poor Survival.
gelatinase b deficiency
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response.
gelatinase b deficiency
Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice.
Gingival Overgrowth
Immunolocalization of collagenase (MMP-1) and stromelysin (MMP-3) in the gingival tissues of organ transplant patients medicated with cyclosporin.
Gingival Overgrowth
Matrix metalloproteinase-3 gene polymorphism in renal transplant patients with gingival overgrowth.
Gingivitis
Gingival crevicular stromelysin, collagenase and tissue inhibitor of metalloproteinases levels in healthy and diseased sites.
Gingivitis
Immunohistochemical analysis of the gingiva with periodontitis of type I plasminogen deficiency compared to gingiva with gingivitis and periodontitis and healthy gingiva.
Gingivitis
[Expression of MMP-2 and MMP-3 in periodontal tissues of rat periodontitis model]
Glaucoma
Alteration of MCP-1 and MMP-9 in aqueous humor is associated with secondary glaucoma in Fuchs uveitis syndrome.
Glaucoma
Effects of matrix metalloproteinase-3 gene transfer by electroporation in glaucoma filter surgery.
Glaucoma
Matrix metalloproteinase and cytokine expression in Tenon fibroblasts during scar formation after glaucoma filtration or implant surgery in rats.
Glaucoma
Sustained release of matrix metalloproteinase-3 to trabecular meshwork cells using biodegradable PLGA microparticles.
Glaucoma
Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucoma.
Glaucoma, Open-Angle
Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshwork.
Glaucoma, Open-Angle
IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
Glioblastoma
Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas.
Glioblastoma
Interleukin-1?-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration.
Glioma
A novel NF-?B/MMP-3 signal pathway involves in the aggressivity of glioma promoted by Bmi-1.
Glioma
A role of matrix metalloproteinases produced by glioma-cells.
Glioma
Effects of dexmedetomidine on glioma cells in the presence or absence of cisplatin.
Glioma
Expressions of matrilysin and stromelysin in human glioma cells.
Glioma
Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression.
Glioma
Interferon-gamma regulation of TNFalpha-induced matrix metalloproteinase 3 expression and migration of human glioma T98G cells.
Glioma
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Glioma
Medulloblastoma displays distinct regional matrix metalloprotease expression.
Glioma
MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3.
Glioma
Proteolysis of the matricellular protein hevin by matrix metalloproteinase-3 produces a SPARC-like fragment (SLF) associated with neovasculature in a murine glioma model.
Glioma
Suppression of CLC-3 chloride channel reduces the aggressiveness of glioma through inhibiting nuclear factor-?B pathway.
Glioma
Suppressor of Fused Inhibits Skin Wound Healing.
Glioma
Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression.
Glioma
[Increased expression of gelatinases A and B, matrilysin and TIMP-1 genes in human malignant gliomas ]
Glomerulonephritis
Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis.
Glomerulonephritis
Stromelysin-1 expression is activated in vivo by Ets-1 through palindromic head-to-head Ets binding sites present in the promoter.
Glomerulonephritis, IGA
Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis.
Glomerulonephritis, IGA
Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy.
Gout
Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis.
Gout
Elevated plasma stromelysin levels in arthritis.
Granuloma
Expression kinetics of metalloproteinases and their tissue inhibitors in experimental murine pulmonary tuberculosis.
Granuloma
Interstitial collagenase (MMP-1), gelatinase (MMP-2) and stromelysin (MMP-3) released by human fibroblasts cultured on acellular sarcoid granulomas (sarcoid matrix complex, SMC).
Guillain-Barre Syndrome
Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barré syndrome.
Hearing Loss
Elevated matrix metalloproteinase-3 level may affect hearing function in patients with rheumatoid arthritis.
Hearing Loss, Sensorineural
Elevated matrix metalloproteinase-3 level may affect hearing function in patients with rheumatoid arthritis.
Heart Diseases
Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development.
Heart Diseases
The matrix metalloproteinase-3 (MMP-3) 5A/6A promoter polymorphism is not associated with ischaemic heart disease: analysis employing a family based approach.
Heart Failure
Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
Heart Failure
Circulating Stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction.
Heart Failure
Comparison of levels of matrix metalloproteinase-2 and -3 in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy.
Heart Failure
Differential expression of MMPs and TIMPs in moderate and severe heart failure in a transgenic model.
Heart Failure
Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexia.
Heart Failure
Myocardial matrix metalloproteinase-3 and matrix metalloproteinase inhibitor-1 expression in congestive heart failure.
Heart Failure
Progression of matrixin and cardiokine expression patterns in an ovine model of heart failure and recovery.
Heart Failure
Reverse remodeling is associated with changes in extracellular matrix proteases and tissue inhibitors after mesenchymal stem cell (MSC) treatment of pressure overload hypertrophy.
Heart Failure
Structural studies of the MMP-3 interaction with triple-helical collagen introduce new roles for the enzyme in tissue remodelling.
Heart Failure
[Assessment of the role of matrix metalloproteinase-3 gene polymorphism in the development of chronic heart failure].
Heart Failure
[Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion]
Heart Failure, Systolic
Circulating matrix metalloproteinase-3 and metalloproteinase-9 and tissue Doppler measures of diastolic dysfunction to risk stratify patients with systolic heart failure.
Hemochromatosis
Evidence for altered hepatic matrix degradation in genetic haemochromatosis.
Hemophilia A
[Matrix metalloproteinase (MMP)-3 is not effective for evaluating hemophilic arthropathy].
Hemorrhagic Stroke
Apolipoprotein A-I and Paraoxonase-1 Are Potential Blood Biomarkers for Ischemic Stroke Diagnosis.
Hemorrhagic Stroke
Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke.
Hepatitis
Clinical significance of serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in chronic liver disease.
Hepatitis
Matrix metalloproteinases and their inhibitors in acute viral hepatitis.
Hepatitis B
Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3.
Hepatitis B
Matrix metalloproteinase-3 genotypes influence recovery from hepatitis B virus infection.
Hepatitis B
[Comparisons of the characteristics and mechanisms of HBV replication in QSG-7701 and HepG2 cell lines]
Hepatitis B, Chronic
Matrix metalloproteinase (MMP)-3 polymorphism in patients with HBV related chronic liver disease.
Hepatitis C
The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma.
Hepatitis C, Chronic
Association of genetic polymorphisms with histological grading of necroinflammation, staging of fibrosis, and liver function in mexicans with chronic hepatitis C virus infection.
Hepatitis, Chronic
Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Hepatitis, Chronic
Clinical significance of serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in chronic liver disease.
Hepatitis, Chronic
Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chronic liver disease.
Herpes Simplex
Molecular characterization of a novel transcription factor that controls stromelysin expression.
Histiocytoma, Malignant Fibrous
Expression of the transin, c-fos, and c-jun genes in rat transplantable osteosarcomas and malignant fibrous histiocytomas.
Hydrocephalus
Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury.
Hydrocephalus, Normal Pressure
Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury.
Hyperalgesia
Physiologic facet capsule stretch can induce pain & upregulate matrix metalloproteinase-3 in the dorsal root ganglia when preceded by a physiological mechanical or nonpainful chemical exposure.
Hyperalgesia
Spinal matrix metalloproteinase 3 mediates inflammatory hyperalgesia via a tumor necrosis factor-dependent mechanism.
Hyperglycemia
Danzhi Jiangtang capsule alleviate hyperglycemia and periodontitis via Wnt/?-catenin signaling in diabetic rat.
Hyperlipidemias
CD11c+ macrophages and levels of TNF-? and MMP-3 are increased in synovial and adipose tissues of osteoarthritic mice with hyperlipidemia.
Hyperlipidemias
Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
Hyperlipidemias
Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia.
Hypersensitivity
Spinal matrix metalloproteinase 3 mediates inflammatory hyperalgesia via a tumor necrosis factor-dependent mechanism.
Hypertension
Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development.
Hypertension
Biomechanical strain causes maladaptive gene regulation, contributing to Alport glomerular disease.
Hypertension
Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
Hypertension
Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients.
Hypertension
Endothelial NOS G894 T and MMP-3 5A/6A gene polymorphisms and hypertension in Serbian population.
Hypertension
Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women.
Hypertension
Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.
Hypertension
Polymorphisms of MMP-3 and TIMP-4 genes affect angiographic coronary plaque progression in non-diabetic and type 2 diabetic patients.
Hypertension
The effect of antihypertensive treatment on arterial stiffness and serum concentration of selected matrix metalloproteinases.
Hypertension
The Use of Serum Matrix Metalloproteinases in Cerebral Amyloid Angiopathy-Related Intracerebral Hemorrhage and Cognitive Impairment.
Hypertension, Portal
High serum matrix metalloproteinase-3 and liver stiffness in postoperative biliary atresia.
Hypertension, Pulmonary
Immunohistochemical study of endothelin-1 and matrix metalloproteinases in plexogenic pulmonary arteriopathy.
Hypertension, Pulmonary
Relationship between matrix metalloproteinase-3 serum level and pulmonary artery systolic pressure in patients with rheumatoid arthritis.
Hypoalbuminemia
Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis.
Hypoxia-Ischemia, Brain
MMP-9 and MMP-3 gene polymorphisms in neonatal hypoxic ischemic encephalopathy.
Infarction, Middle Cerebral Artery
Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion.
Infarction, Middle Cerebral Artery
Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice.
Infections
Borrelia burgdorferi-induced expression of matrix metalloproteinases from human chondrocytes requires mitogen-activated protein kinase and Janus kinase/signal transducer and activator of transcription signaling pathways.
Infections
Comparison of cytokine profiles induced by nonlethal and lethal doses of influenza A virus in mice.
Infections
Curcumin alleviates matrix metalloproteinase-3 and -9 activities during eradication of Helicobacter pylori infection in cultured cells and mice.
Infections
Dissociation of ras oncogene-induced gene expression and anchorage-independent growth in a series of somatic cell mutants.
Infections
Doxycycline treatment prevents alveolar destruction in VEGF-deficient mouse lung.
Infections
Effect of adenovirus-mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts.
Infections
Epithelial and bacterial metalloproteinases and their inhibitors in H. pylori infection of human gastric cells.
Infections
Expression kinetics of metalloproteinases and their tissue inhibitors in experimental murine pulmonary tuberculosis.
Infections
Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis.
Infections
General and specific host responses to bacterial infection in Peyer's patches: a role for stromelysin-1 (matrix metalloproteinase-3) during Salmonella enterica infection.
Infections
Ginkgo biloba extract may alleviate viral myocarditis by suppression of S100A4 and MMP-3.
Infections
Helicobacter pylori CagA protein induces factors involved in the epithelial to mesenchymal transition (EMT) in infected gastric epithelial cells in an EPIYA- phosphorylation-dependent manner.
Infections
Heparanase-Regulated Syndecan-1 Shedding Facilitates Herpes Simplex Virus 1 Egress.
Infections
Host metalloproteinases in Lyme arthritis.
Infections
Human cytomegalovirus induces MMP-1 and MMP-3 expression in aortic smooth muscle cells.
Infections
Increased production of matrix metalloproteinases 1 and 3 by smooth muscle cells upon infection with Chlamydia pneumoniae.
Infections
Interleukin 1beta induces gastric epithelial cell matrix metalloproteinase secretion and activation during Helicobacter pylori infection.
Infections
Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity.
Infections
Matrix metalloproteinase expression correlates with virulence following neurotropic mouse hepatitis virus infection.
Infections
Matrix metalloproteinase-3 genotypes influence recovery from hepatitis B virus infection.
Infections
Matrix metalloproteinase-3 promoter polymorphisms but not dupA-H. pylori correlate to duodenal ulcers in H. pylori-infected females.
Infections
MMP-12, MMP-3, and TIMP-1 are markedly upregulated in chronic demyelinating theiler murine encephalomyelitis.
Infections
Modified Profile of Matrix Metalloproteinase 2 and 9 Production by Human Fallopian Tube Epithelial Cells After Infection In Vitro With Neisseria gonorrhoeae.
Infections
Neisseria gonorrhoeae Challenge Increases Matrix Metalloproteinase-8 Expression in Fallopian Tube Explants.
Infections
Neurotrophic factor levels in the serum and cerebrospinal fluid of neonates infected with human cytomegalovirus.
Infections
Periodontal bacterial colonization in synovial tissues exacerbates collagen-induced arthritis in B10.RIII mice.
Infections
Proteins involved in extracellular matrix dynamics are associated with RSV disease severity.
Infections
Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase.
Infections
[Matrix metalloproteinase-3 in patients with systemic lupus erythematosus and its significance in differentiating disease activity from pulmonary infections].
Inflammatory Bowel Diseases
CC-10004 but not thalidomide or lenalidomide inhibits lamina propria mononuclear cell TNF-? and MMP-3 production in patients with inflammatory bowel disease.
Inflammatory Bowel Diseases
Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease.
Inflammatory Bowel Diseases
Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.
Inflammatory Bowel Diseases
Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine.
Inflammatory Bowel Diseases
Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.
Inflammatory Bowel Diseases
Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
Inflammatory Bowel Diseases
Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With Infliximab.
Inflammatory Bowel Diseases
Matrix metalloproteinase-3 production by gut IgG plasma cells in chronic inflammatory bowel disease.
Insulin Resistance
Impact of disease activity on impaired glucose metabolism in patients with rheumatoid arthritis.
Insulin Resistance
The skin remodeling in type 1 diabetes and insulin resistance animal models.
Intervertebral Disc Degeneration
17?-Estradiol inhibits intervertebral disc degeneration by down-regulating MMP-3 and MMP-13 and up-regulating type II collagen in a rat model.
Intervertebral Disc Degeneration
Age-related expression of MCP-1 and MMP-3 in mouse intervertebral disc in relation to TWEAK and TNF-? stimulation.
Intervertebral Disc Degeneration
Alendronate retards the progression of lumbar intervertebral disc degeneration in ovariectomized rats.
Intervertebral Disc Degeneration
APOE-knockout in rabbits causes loss of cells in nucleus pulposus and enhances the levels of inflammatory catabolic cytokines damaging the intervertebral disc matrix.
Intervertebral Disc Degeneration
Assessment of the Matrix Degenerative Effects of MMP-3, ADAMTS-4 and HTRA1 injected into a bovine Intervertebral Disc Organ Culture Model.
Intervertebral Disc Degeneration
Correlation of Matrix Metalloproteinase-3 Expression with Patient Age, Magnetic Resonance Imaging and Histopathological Grade in Lumbar Disc Degeneration.
Intervertebral Disc Degeneration
Effects of MMP-1 and MMP-3 gene polymorphisms on gene expression and protein level in lumbar disc herniation.
Intervertebral Disc Degeneration
Genetic Dimension of Intervertebral Disc Degeneration: Polymorphism of Matrix Metalloproteinase 1 and 3 in the North Iranian Population.
Intervertebral Disc Degeneration
Genetic Influence in Disc Degeneration - Systematic Review of Literature.
Intervertebral Disc Degeneration
Genetic risk factors for lumbar disc disease.
Intervertebral Disc Degeneration
Immunohistochemical study of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 human intervertebral discs.
Intervertebral Disc Degeneration
Interleukin-1? exacerbates the catabolic effects of human nucleus pulposus cells through activation of the Nuclear Factor kappa B signaling pathway under hypoxic conditions.
Intervertebral Disc Degeneration
Kinetics of tissue and serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 in intervertebral disc degeneration and disc herniation.
Intervertebral Disc Degeneration
Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration.
Intervertebral Disc Degeneration
Matrix metalloproteinase-3 and vitamin d receptor genetic polymorphisms, and their interactions with occupational exposure in lumbar disc degeneration.
Intervertebral Disc Degeneration
Matrix metalloproteinase-3 production by human degenerated intervertebral disc.
Intervertebral Disc Degeneration
Matrix Metalloproteinase-3, Vitamin D Receptor Gene Polymorphisms, and Occupational Risk Factors in Lumbar Disc Degeneration.
Intervertebral Disc Degeneration
Sequence variations in the collagen IX and XI genes are associated with degenerative lumbar spinal stenosis.
Intervertebral Disc Degeneration
Syndecan 4 signaling and intervertebral disc degeneration.
Intervertebral Disc Degeneration
The genetics of intervertebral disc degeneration. Associated genes.
Intervertebral Disc Degeneration
Tumor necrosis factor-?- and interleukin-1?-dependent matrix metalloproteinase-3 expression in nucleus pulposus cells requires cooperative signaling via syndecan 4 and mitogen-activated protein kinase-NF-?B axis: implications in inflammatory disc disease.
Intervertebral Disc Degeneration
TWEAK and TSLP in disc degeneration and spontaneous hernia resorption.
Intervertebral Disc Degeneration
Vitamin D Receptor Gene, Matrix Metalloproteinase 3 Polymorphisms and the Risk of Intervertebral Disc Degeneration Susceptibility: Meta-Analysis.
Intervertebral Disc Degeneration
[Effects of electroacupuncture at Jiaji (EX-B 2) on extracellular matrix MMP-1, MMP-3 and TIMP-1 levels in the degenerated cervical intervertebral disc in rats]
Intervertebral Disc Degeneration
[Synergistic interaction between MMP-3, VDR gene polymorphisms and occupational risk factors on lumbar disc degeneration]
Intervertebral Disc Displacement
Chemokine profile of disc degeneration with acute or chronic pain.
Intervertebral Disc Displacement
Correlation of Matrix Metalloproteinase-3 Expression with Patient Age, Magnetic Resonance Imaging and Histopathological Grade in Lumbar Disc Degeneration.
Intervertebral Disc Displacement
Correlation of matrix metalloproteinases-1 and -3 with patient age and grade of lumbar disc herniation.
Intervertebral Disc Displacement
Effects of MMP-1 and MMP-3 gene polymorphisms on gene expression and protein level in lumbar disc herniation.
Intervertebral Disc Displacement
Experimental studies on the effects of recombinant human matrix metalloproteinases on herniated disc tissues--how to facilitate the natural resorption process of herniated discs.
Intervertebral Disc Displacement
Herniated and spondylotic intervertebral discs of the human cervical spine: histological and immunohistological findings in 500 en bloc surgical samples. Laboratory investigation.
Intervertebral Disc Displacement
Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation.
Intervertebral Disc Displacement
Influence of macrophage infiltration of herniated disc tissue on the production of matrix metalloproteinases leading to disc resorption.
Intervertebral Disc Displacement
Interactions between the MMP-3 gene rs591058 polymorphism and occupational risk factors contribute to the increased risk for lumbar disk herniation: A case-control study.
Intervertebral Disc Displacement
Kinetics of tissue and serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 in intervertebral disc degeneration and disc herniation.
Intervertebral Disc Displacement
The increased expression of matrix metalloproteinases associated with elastin degradation and fibrosis of the ligamentum flavum in patients with lumbar spinal stenosis.
Intervertebral Disc Displacement
The involvement of matrix metalloproteinases and inflammation in lumbar disc herniation.
Intervertebral Disc Displacement
Transcript levels of major MMPs and ADAMTS-4 in relation to the clinicopathological profile of patients with lumbar disc herniation.
Intervertebral Disc Displacement
[Determination on contents of matrix metalloproteinase 3 and interleukin 1 in tissues of lumbar disc herniation and their roles in pathogenesis]
Intracranial Hemorrhages
Role of tissue-type plasminogen activator in ischemic stroke.
Ischemic Stroke
Apolipoprotein A-I and Paraoxonase-1 Are Potential Blood Biomarkers for Ischemic Stroke Diagnosis.
Ischemic Stroke
Association Between Matrix Metalloproteinase Family Gene Polymorphisms and Ischemic Stroke: a Meta-analysis.
Ischemic Stroke
Association of Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Gene Variants with Ischemic Stroke and Its Subtype.
Ischemic Stroke
Association of matrix metalloproteinase-3 gene 5A/6A polymorphism with the recurrence of ischemic stroke: A prospective observational study.
Ischemic Stroke
Association of the matrix metalloproteinase-3 polymorphisms rs679620 and rs3025058 with ischemic stroke risk: a meta-analysis.
Ischemic Stroke
Impact of 5A/6A polymorphism of matrix metalloproteinase-3 on recurrent atherosclerotic ischemic stroke in Chinese.
Ischemic Stroke
Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke.
Ischemic Stroke
Matrix metalloproteinase-3 gene polymorphisms are associated with ischemic stroke.
Ischemic Stroke
Novel situations of endothelial injury in stroke--mechanisms of stroke and strategy of drug development: Intracranial bleeding associated with the treatment of ischemic stroke: thrombolytic treatment of ischemia-affected endothelial cells with tissue-type plasminogen activator.
Ischemic Stroke
Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies.
Ischemic Stroke
Role of tissue-type plasminogen activator in ischemic stroke.
Ischemic Stroke
Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice.
Ischemic Stroke
The rtPA increases MMP-9 activity in serum during ischaemic stroke.
Ischemic Stroke
[Association of matrix metalloproteinase-3 gene polymorphisms with subtypes of ischemic stroke].
Ischemic Stroke
[Association of matrix metalloproteinase-3 serum level and the promoter 5A/6A polymorphism of the MMP-3 gene with atherosclerotic cerebral infarction]
Ischemic Stroke
[Evaluation for antithrombotic agents by a thrombotic model in animals].
Joint Diseases
Beta 2-microglobulin induces stromelysin production by human synovial fibroblasts.
Joint Diseases
Biomarkers of joint tissue metabolism in canine osteoarthritic and arthritic joint disorders.
Joint Diseases
Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Joint Diseases
Effect of selected antirheumatic drugs on the metabolism of cartilage and synovial tissue in experimental arthropathy.
Joint Diseases
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern.
Joint Diseases
Increased serum stromelysin-1 levels in systemic lupus erythematosus: lack of correlation with disease activity.
Joint Diseases
Infliximab Induced a Dissociated Response of Severe Periodontal Biomarkers in Rheumatoid Arthritis Patients.
Joint Diseases
Molecular characteristics of equine stromelysin and the tissue inhibitor of metalloproteinase 1.
Joint Diseases
Serum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis.
Joint Diseases
Simvastatin reduces MMP-3 level in interleukin 1beta stimulated human chondrocyte culture.
Joint Diseases
Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage.
Joint Diseases
Superantigen-induced stromelysin production from rheumatoid synovial cells.
Joint Diseases
Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not.
Joint Diseases
The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases.
Joint Diseases
Transin/stromelysin expression in the synovium of rats with experimental erosive arthritis. In situ localization and kinetics of expression of the transformation-associated metalloproteinase in euthymic and athymic Lewis rats.
Joint Diseases
[Matrix metalloproteinase (MMP)-3 is not effective for evaluating hemophilic arthropathy].
Keloid
Epigenetically altered wound healing in keloid fibroblasts.
Keratoconjunctivitis
Overexpression of Matrix Metalloproteinase-1 (MMP-1) and MMP-3 in Superior Limbic Keratoconjunctivitis.
Keratoconus
Is the corneal degradation in keratoconus caused by matrix-metalloproteinases?
Keratosis, Actinic
Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis.
Leg Ulcer
Induction of MMP-1, MMP-3 and TIMP-1 in normal dermal fibroblasts by chronic venous leg ulcer wound fluid*.
Legg-Calve-Perthes Disease
Increased levels of proteoglycan fragments and stromelysin in hip joint fluid in Legg-Calvé-Perthes disease.
Leiomyoma
Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression.
Leiomyoma
Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium.
Leiomyoma
Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells.
Leukemia
Freshly isolated osteoarthritic chondrocytes are catabolically more active than normal chondrocytes, but less responsive to catabolic stimulation with interleukin-1beta.
Leukemia
High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis.
Leukemia
Inflammatory responses induced by interleukin-17 family members in human colonic subepithelial myofibroblasts.
Leukemia
MMP-3 expression and release by rheumatoid arthritis fibroblast-like synoviocytes induced with a bacterial ligand of integrin alpha5beta1.
Leukemia
[Comparisons of the characteristics and mechanisms of HBV replication in QSG-7701 and HepG2 cell lines]
Leukoplakia
Galectin-9 as an important marker in the differential diagnosis between oral squamous cell carcinoma, oral leukoplakia and oral lichen planus.
Lichen Planus
Expression of matrix metalloproteinases (MMP-2, MMP-3, and MMP-9) and fibronectin in lichen planus.
Lichen Planus
Galectin-9 as an important marker in the differential diagnosis between oral squamous cell carcinoma, oral leukoplakia and oral lichen planus.
Lichen Planus, Oral
Salivary MMP-1, MMP-2, MMP-3 and MMP-13 Levels in Patients with Oral Lichen Planus and Squamous Cell Carcinoma
Lichen Planus, Oral
Serum and Saliva MMP-3 in Patients with OLP and Oral SCC.
Lichen Planus, Oral
Serum level of matrix metalloproteinase-3 in patients with oral lichen planus.
Lipoma
Lipoma arborescens co-existing with psoriatic arthritis releases tumour necrosis factor alpha and matrix metalloproteinase 3.
Liver Cirrhosis
Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats.
Liver Cirrhosis
Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Liver Cirrhosis
Association of genetic polymorphisms with histological grading of necroinflammation, staging of fibrosis, and liver function in mexicans with chronic hepatitis C virus infection.
Liver Cirrhosis
Clinical significance of serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in chronic liver disease.
Liver Cirrhosis
Collagenases and liver fibrosis.
Liver Cirrhosis
Immunological investigation of the hepatic tissue from infants with biliary atresia.
Liver Cirrhosis
Matrix metalloproteinase (MMP)-3 polymorphism in patients with HBV related chronic liver disease.
Liver Cirrhosis
No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver disease.
Liver Cirrhosis
Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chronic liver disease.
Liver Cirrhosis, Biliary
Common variants of the matrix metalloproteinase-3 (stromelysin) gene promoter in primary biliary cirrhosis.
Liver Diseases
Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Liver Diseases
Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chronic liver disease.
Liver Neoplasms
Macrovascular Endothelial Cells Enhance the Motility of Liver Cancer Cells by Up-regulation of MMP-3, Activation of Integrin/FAK Signaling Pathway and Induction of Non-classical Epithelial-mesenchymal Transition.
Lung Diseases
Amelioration of rheumatoid arthritis in a breast cancer patient treated with palbociclib: a case report.
Lung Diseases
Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury.
Lung Injury
Lack of matrix metalloproteinase 3 in mouse models of lung injury ameliorates the pulmonary inflammatory response in female but not in male mice.
Lung Injury
Matrix metalloproteinase-3 (stromelysin-1) in acute inflammatory tissue injury.
Lung Injury
Role of stromelysin 1 and gelatinase B in experimental acute lung injury.
Lung Neoplasms
Berkeleydione and berkeleytrione, new bioactive metabolites from an acid mine organism.
Lung Neoplasms
Carcinogenesis-related changes in iron metabolism in chronic obstructive pulmonary disease subjects with lung cancer.
Lung Neoplasms
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma.
Lung Neoplasms
Expression of metastasis-associated molecules in non-small cell lung cancer and their prognostic significance.
Lung Neoplasms
Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer.
Lung Neoplasms
Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.
Lung Neoplasms
Matrix metalloproteinase 3 polymorphisms as a potential marker of enhanced susceptibility to lung cancer in chronic obstructive pulmonary disease subjects.
Lung Neoplasms
Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.
Lung Neoplasms
The importance of matrix metalloproteinase-3 in respiratory disorders.
Lung Neoplasms
The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer.
Lung Neoplasms
Thromboxane A2 receptor-mediated release of matrix metalloproteinase-1 (MMP-1) induces expression of monocyte chemoattractant protein-1 (MCP-1) by activation of protease-activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cells.
Lung Neoplasms
[Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer]
Lupus Erythematosus, Systemic
Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.
Lupus Erythematosus, Systemic
Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Lupus Erythematosus, Systemic
Clinical significance of matrix metalloproteinase-3 in systemic lupus erythematosus patients: a potential biomarker for disease activity and damage.
Lupus Erythematosus, Systemic
Elevated plasma stromelysin levels in arthritis.
Lupus Erythematosus, Systemic
Elevated serum levels of MMP-2, MMP-3, and MMP-13 in Chinese patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Genetic contribution to carotid vascular disease in patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern.
Lupus Erythematosus, Systemic
Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis.
Lupus Erythematosus, Systemic
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Lupus Erythematosus, Systemic
Increased serum stromelysin-1 levels in systemic lupus erythematosus: lack of correlation with disease activity.
Lupus Erythematosus, Systemic
Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications.
Lupus Erythematosus, Systemic
The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity.
Lupus Erythematosus, Systemic
[Matrix metalloproteinase-3 in patients with systemic lupus erythematosus and its significance in differentiating disease activity from pulmonary infections].
Lupus Erythematosus, Systemic
[Stromelysin-1 (MMP-3) level in the sera from patients with rheumatoid arthritis and other connective tissue diseases--clinical significances in early onset rheumatoid arthritis]
Lupus Nephritis
Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis.
Lupus Nephritis
Glomerular expression of matrix metalloproteinases in systemic lupus erythematosus in association with activity index and renal function.
Lupus Nephritis
Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis.
Lyme Disease
Borrelia burgdorferi-induced expression of matrix metalloproteinases from human chondrocytes requires mitogen-activated protein kinase and Janus kinase/signal transducer and activator of transcription signaling pathways.
Lyme Disease
Host metalloproteinases in Lyme arthritis.
Lyme Disease
[Usefulness of examinations of serum levels of matrix metalloproteinases 1, MMP-3, MMP-9, tissue inhibitor of metalloproteinases 1, hyaluronic acid and antibodies against cyclic citrullinated peptide in Lyme arthritis, rheumatoid arthritis and patients with arthritic complaints].
Lyme Neuroborreliosis
Upregulation of matrix metalloproteinase-9 in the cerebrospinal fluid of patients with acute Lyme neuroborreliosis.
Lymphangioleiomyomatosis
Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).
Lymphatic Metastasis
Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity.
Lymphatic Metastasis
Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis.
Lymphatic Metastasis
Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material.
Lymphatic Metastasis
The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
Lymphatic Metastasis
[Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer]
Lymphatic Metastasis
[Expression and correlation with metastasis of E-cadherin, CD44H, matrix metalloproteinase-3, nm23H1 and VEGF in nasopharyngeal carcinoma]
Lymphoma
Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas.
Lymphoma
Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo.
Lymphoma, B-Cell
Matrix Metalloproteinase-3 Producing Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Associated With Rheumatoid Arthritis.
Lymphoma, B-Cell
Resveratrol inhibits oxygen-glucose deprivation-induced MMP-3 expression and cell apoptosis in primary cortical cells via the NF-?B pathway.
Lymphoma, Large B-Cell, Diffuse
Matrix Metalloproteinase-3 Producing Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Associated With Rheumatoid Arthritis.
Macrophage Activation Syndrome
Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles.
Macular Degeneration
Age-related macular degeneration: a perspective on genetic studies.
Macular Degeneration
Does matrix metalloproteinase-3 polymorphism play a role in age-related macular degeneration in patients with myocardial infarction?
Macular Degeneration
The Role of Matrix Metalloproteinases Polymorphisms in Age-Related Macular Degeneration.
Malaria
Increased expression of kidney injury molecule-1 and matrix metalloproteinase-3 in severe Plasmodium falciparum malaria with acute kidney injury.
Malaria, Falciparum
Increased expression of kidney injury molecule-1 and matrix metalloproteinase-3 in severe Plasmodium falciparum malaria with acute kidney injury.
Marfan Syndrome
Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome.
Mastocytoma
Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B.
Medulloblastoma
Medulloblastoma displays distinct regional matrix metalloprotease expression.
Melanoma
Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts.
Melanoma
Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma.
Melanoma
High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma.
Melanoma
Immunolocalisation studies of matrix metalloproteinases-1, -2 and -3 in human melanoma.
Melanoma
Induction of Matrix Metalloproteinase-3 (MMP-3) Expression in the Microglia by Lipopolysaccharide (LPS) via Upregulation of Glycoprotein Nonmetastatic Melanoma B (GPNMB) Expression.
Melanoma
Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor.
Melanoma
Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Melanoma
MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma.
Melanoma
NFAT1 directly regulates IL-8 and MMP-3 to promote melanoma tumor growth and metastasis.
Melanoma
Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma.
Melanoma
SOX2 contributes to melanoma cell invasion.
Melanoma
Targeting TGF-?-Mediated SMAD Signaling Pathway via Novel Recombinant Cytotoxin II: A Potent Protein from Naja naja oxiana Venom in Melanoma.
Melanoma
Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.
Meningioma
The Effect of Matrix Metalloproteinase-3 on the Prognosis and Biological Behaviour of Meningiomas.
Meningitis
A case of idiopathic hypertrophic cranial pachymeningitis presenting high values of matrix metalloproteinase.
Meningitis
Chemokines and matrix metalloproteinases in cerebrospinal fluid of patients with central nervous system complications caused by varicella-zoster virus.
Meningitis, Bacterial
Differential expression of matrix metalloproteinases in bacterial meningitis.
Meningitis, Bacterial
Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
Meningitis, Viral
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid.
Mesothelioma
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma.
Mesothelioma, Malignant
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma.
Mesothelioma, Malignant
Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors.
Metrorrhagia
Endometrial histology, microvascular density and caliber, and matrix metalloproteinase-3 in users of the Nestorone-releasing contraceptive implant with and without endometrial breakthrough bleeding.
Migraine Disorders
Combined effects of ACE and MMP-3 polymorphisms on migraine development.
Migraine Disorders
Low fetuin-A level in migraine: a case-control study.
Migraine Disorders
Matrix metalloproteinases during and outside of migraine attacks without aura.
Migraine without Aura
Matrix metalloproteinases during and outside of migraine attacks without aura.
Mitral Valve Insufficiency
Promoter polymorphism of the matrix metalloproteinase 3 gene is associated with regurgitation and left ventricular remodelling in mitral valve prolapse patients.
Mitral Valve Prolapse
Promoter polymorphism of the matrix metalloproteinase 3 gene is associated with regurgitation and left ventricular remodelling in mitral valve prolapse patients.
Mixed Connective Tissue Disease
[Stromelysin-1 (MMP-3) level in the sera from patients with rheumatoid arthritis and other connective tissue diseases--clinical significances in early onset rheumatoid arthritis]
Mouth Neoplasms
Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
Mouth Neoplasms
Biomarkers in saliva for the detection of oral squamous cell carcinoma and their potential use for early diagnosis: a systematic review.
Mouth Neoplasms
Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression.
Moyamoya Disease
Association between matrix metalloproteinase-3 gene polymorphism and moyamoya disease.
Moyamoya Disease
Association of a Functional Polymorphism in the MMP-3 Gene with Moyamoya Disease in the Chinese Han Population.
Moyamoya Disease
Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of Moyamoya disease in Han Chinese human subjects.
Mucocutaneous Lymph Node Syndrome
Arthritis associated with Kawasaki disease: MRI findings and serum matrix metalloproteinase-3 profiles.
Mucocutaneous Lymph Node Syndrome
Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.
Mucocutaneous Lymph Node Syndrome
Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease.
Mucocutaneous Lymph Node Syndrome
Tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-3 in Japanese healthy children and in Kawasaki disease and their clinical usefulness in juvenile rheumatoid arthritis.
Multiple Sclerosis
Association of the MMP-3 5A/6A gene polymorphism with multiple sclerosis in patients from Serbia.
Multiple Sclerosis
Differences in Susceptibility of MBP Charge Isomers to Digestion by Stromelysin-1 (MMP-3) and Release of an Immunodominant Epitope.
Multiple Sclerosis
Matrix metalloproteinase-3 in myasthenia gravis compared to other neurological disorders and healthy controls.
Multiple Sclerosis
Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
Multiple Sclerosis
Serum levels of matrix metalloproteinases: implications in clinical neurology.
Multiple Sclerosis, Relapsing-Remitting
Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis.
Multiple Sclerosis, Relapsing-Remitting
The Role of Matrix Metalloproteinase 3 and 9 in the Pathogenesis of Acute Neuroinflammation. Implications for Disease Modifying Therapy.
Muscle Weakness
Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis.
Muscular Dystrophies
Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexia.
Myasthenia Gravis
Matrix metalloproteinase-3 in myasthenia gravis compared to other neurological disorders and healthy controls.
Myasthenia Gravis
Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis.
Myocardial Infarction
An association analysis between genetic polymorphisms of matrix metalloproteinase-3 and methylenetetrahydrofolate reductase and myocardial infarction in Japanese.
Myocardial Infarction
Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice.
Myocardial Infarction
Circulating matrix metalloproteinase 3 due to myocardial ischemia.
Myocardial Infarction
Circulating Stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction.
Myocardial Infarction
Does matrix metalloproteinase-3 polymorphism play a role in age-related macular degeneration in patients with myocardial infarction?
Myocardial Infarction
Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population. The Beijing atherosclerosis study.
Myocardial Infarction
Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction.
Myocardial Infarction
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure.
Myocardial Infarction
Lower serum concentration of matrix metalloproteinase-3 in the acute stage of myocardial infarction.
Myocardial Infarction
Matrix Metalloproteinase 3 Gene Polymorphism and Its Level Predict Morbidity After Acute Myocardial Infarction.
Myocardial Infarction
Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke.
Myocardial Infarction
Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.
Myocardial Infarction
Prediction of the risk of myocardial infarction from polymorphisms in candidate genes.
Myocardial Infarction
Prognostic value of biological markers in myocardial infarction patients.
Myocardial Infarction
Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction.
Myocardial Infarction
Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction.
Myocardial Infarction
Stromelysin-1 promoter 5A/6A polymorphism is an independent genetic prognostic risk factor and interacts with smoking cessation after index premature myocardial infarction.
Myocardial Infarction
Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction.
Myocardial Infarction
The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina.
Myocardial Infarction
The stromelysin-1 5A/6A promoter polymorphism is a disease marker for the extent of coronary heart disease.
Myocardial Infarction
TIMP3 or VEGF transfection of aged human MSCs enhances cell therapy after myocardial infarction.
Myocardial Infarction
Usefulness of Plasma Matrix Metalloproteinase-3 Levels to Predict Myocardial Infarction in Men With and Without Acute Coronary Syndrome.
Myocardial Infarction
[Cardiovascular research in the era of genome medicine and EBM]
Myocardial Ischemia
Circulating matrix metalloproteinase 3 due to myocardial ischemia.
Myocardial Ischemia
Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia.
Myocarditis
Ginkgo biloba extract may alleviate viral myocarditis by suppression of S100A4 and MMP-3.
Myopia
Assessment of the association of matrix metalloproteinases with myopia, refractive error and ocular biometric measures in an Australian cohort.
Myopia
Correlations Between MMPs and TIMPs Levels in Aqueous Humor from High Myopia and Cataract Patients.
Myopia
Human aqueous humor levels of transforming growth factor-?2: Association with matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases.
Myopia
MMP-2, MMP-3, TIMP-1, TIMP-2, and TIMP-3 protein levels in human aqueous humor: relationship with axial length.
Myopia
Myopia and polymorphisms in genes for matrix metalloproteinases.
Myxoma
Increased expression and activity of matrix metalloproteinases characterize embolic cardiac myxomas.
Myxoma
The expression of apoptotic proteins and matrix metalloproteinases in odontogenic myxomas.
Nasal Polyps
Involvement of the extracellular matrix proteins periostin and tenascin C in nasal polyp remodeling by regulating the expression of MMPs.
Nasopharyngeal Carcinoma
Combination of serum matrix metalloproteinase-3 activity and EBV antibodies improves the diagnostic performance of nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins.
Nasopharyngeal Carcinoma
[Clinical significance of quantitative analysis of serum VEGF, CD44s, and MMP-3 protein in nasopharyngeal carcinoma]
Nasopharyngeal Carcinoma
[Expression and correlation with metastasis of E-cadherin, CD44H, matrix metalloproteinase-3, nm23H1 and VEGF in nasopharyngeal carcinoma]
Nasopharyngeal Carcinoma
[Expressions and correlation with radiotherapy's effect of five kinds of genes in nasopharyngeal carcinoma]
Nasopharyngeal Carcinoma
[Study of the expression of nuclear factor-kappa B, matrix metalloproteinase-3, -9 on nasopharygeal carcinoma and their clinical significance].
Neoplasm Metastasis
A high throughput fluorogenic substrate for stromelysin (MMP-3).
Neoplasm Metastasis
A novel NF-?B/MMP-3 signal pathway involves in the aggressivity of glioma promoted by Bmi-1.
Neoplasm Metastasis
A protective role for matrix metalloproteinase-3 in squamous cell carcinoma.
Neoplasm Metastasis
Alphavbeta6-Fyn signaling promotes oral cancer progression.
Neoplasm Metastasis
Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
Neoplasm Metastasis
Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma.
Neoplasm Metastasis
Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer.
Neoplasm Metastasis
Caveolin-1 is an important factor for the metastasis and proliferation of human small cell lung cancer NCI-H446 cell.
Neoplasm Metastasis
CCAAT/Enhancer Binding Protein ?-Mediated MMP3 Upregulation Promotes Esophageal Squamous Cell Cancer Invasion In Vitro and Is Associated with Metastasis in Human Patients.
Neoplasm Metastasis
Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
Neoplasm Metastasis
Collagenase is expressed by rabbit VX2 tumour cells in syngeneic and xenogeneic hosts.
Neoplasm Metastasis
Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract.
Neoplasm Metastasis
Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
Neoplasm Metastasis
Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene.
Neoplasm Metastasis
CXCR7 protein expression correlates with elevated mmp-3 secretion in breast cancer cells.
Neoplasm Metastasis
Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology.
Neoplasm Metastasis
Differential gene expression during multistage carcinogenesis.
Neoplasm Metastasis
Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasis.
Neoplasm Metastasis
Elevated expression of matrix metalloproteinase-3 in human osteosarcoma and its association with tumor metastasis.
Neoplasm Metastasis
Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells.
Neoplasm Metastasis
Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma.
Neoplasm Metastasis
Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity.
Neoplasm Metastasis
Expression of MMP-3 and TIMP-3 in gastric cancer tissue and its clinical significance.
Neoplasm Metastasis
Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression.
Neoplasm Metastasis
High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma.
Neoplasm Metastasis
High-throughput functional profiling of single adherent cells via hydrogel drop-screen.
Neoplasm Metastasis
Human stromelysin gene promoter activity is modulated by transcription factor ZBP-89.
Neoplasm Metastasis
Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis.
Neoplasm Metastasis
Immunohistochemical expression of matrix metalloproteinases 1, 2, 9, and 14 in dermatofibrosarcoma protuberans and common fibrous histiocytoma (dermatofibroma).
Neoplasm Metastasis
Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3.
Neoplasm Metastasis
Inhibition of breast cancer growth and invasion by single-minded 2s.
Neoplasm Metastasis
Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids.
Neoplasm Metastasis
Involvement of matrix metalloproteinase-3 in CCL5/CCR5 pathway of chondrosarcomas metastasis.
Neoplasm Metastasis
Isolation, characterization, and expression of feline stromelysin-1 in naturally developing tumors in cats.
Neoplasm Metastasis
Isolation, characterization, and expression of stromelysin-1 in primary tumors of dogs.
Neoplasm Metastasis
Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material.
Neoplasm Metastasis
Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation.
Neoplasm Metastasis
Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer.
Neoplasm Metastasis
Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas.
Neoplasm Metastasis
Minimally invasive colorectal resection is associated with significantly elevated levels of plasma matrix metalloproteinase 3 (MMP-3) during the first month after surgery which may promote the growth of residual metastases.
Neoplasm Metastasis
Monoclonal antibodies against human collagenase and stromelysin.
Neoplasm Metastasis
NFAT1 directly regulates IL-8 and MMP-3 to promote melanoma tumor growth and metastasis.
Neoplasm Metastasis
No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in chinese.
Neoplasm Metastasis
Notch3 promotes prostate cancer-induced bone lesion development via MMP-3.
Neoplasm Metastasis
Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.
Neoplasm Metastasis
Overexpression of MMP-3 and uPA with Diminished PAI-1 Related to Metastasis in Ductal Breast Cancer Patients Attending a Public Hospital in Mexico City.
Neoplasm Metastasis
Overexpression of protein kinase C-alpha and -beta isozymes by stromal dendritic cells in basal and squamous cell carcinoma.
Neoplasm Metastasis
Pachymic acid modified carbon nanoparticles reduced angiogenesis via inhibition of MMP-3.
Neoplasm Metastasis
Phospholipase Cgamma1 stimulates transcriptional activation of the matrix metalloproteinase-3 gene via the protein kinase C/Raf/ERK cascade.
Neoplasm Metastasis
Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3.
Neoplasm Metastasis
Platelet-activating factor receptor activation promotes prostate cancer cell growth, invasion and metastasis via ERK1/2 pathway.
Neoplasm Metastasis
Prognostic Impact of Tissue Inhibitor of Metalloproteinase-1 in Non-Small Cell Lung Cancer: Systematic Review and Meta-Analysis.
Neoplasm Metastasis
Prostate cancer-derived MMP-3 controls intrinsic cell growth and extrinsic angiogenesis.
Neoplasm Metastasis
Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma.
Neoplasm Metastasis
Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
Neoplasm Metastasis
Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.
Neoplasm Metastasis
Spontaneous metastasis in matrix metalloproteinase 3-deficient mice.
Neoplasm Metastasis
Stromelysin in tumor progression and metastasis.
Neoplasm Metastasis
The inhibitor of kappa B kinase-epsilon regulates MMP-3 expression levels and can promote lung metastasis.
Neoplasm Metastasis
The inhibitory effect of turmeric curcuminoids on matrix metalloproteinase-3 secretion in human invasive breast carcinoma cells.
Neoplasm Metastasis
The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.
Neoplasm Metastasis
The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas.
Neoplasm Metastasis
The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity.
Neoplasm Metastasis
The Stromal Overexpression of CD10 in Invasive Breast Cancer and its Association with Clincophathologic Factors.
Neoplasm Metastasis
[Clinical significance of quantitative analysis of serum VEGF, CD44s, and MMP-3 protein in nasopharyngeal carcinoma]
Neoplasm Metastasis
[Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer]
Neoplasm Metastasis
[Detection of stromelysin mRNA expression in human hepatocellular carcinoma by in situ hybridization]
Neoplasm Metastasis
[Expression and correlation with metastasis of E-cadherin, CD44H, matrix metalloproteinase-3, nm23H1 and VEGF in nasopharyngeal carcinoma]
Neoplasms
(18)F-Fluorodeoxyglucose positron emission tomography and serum cytokines and matrix metalloproteinases in the assessment of disease activity in Takayasu's arteritis.
Neoplasms
?2-Adrenoceptor is involved in connective tissue remodeling in regenerating muscles by decreasing the activity of MMP-9.
Neoplasms
A comparative pilot study of oral diacerein and locally treated diacerein-loaded nanoparticles in a model of osteoarthritis.
Neoplasms
A high throughput fluorogenic substrate for stromelysin (MMP-3).
Neoplasms
A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes.
Neoplasms
A protective role for matrix metalloproteinase-3 in squamous cell carcinoma.
Neoplasms
A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression.
Neoplasms
Accelerated atherosclerosis in premenopausal women with rheumatoid arthritis - 15-year follow-up.
Neoplasms
Activation of inflammatory mediators and potential role of ah-receptor ligands in foam cell formation.
Neoplasms
Activation of p38 alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization.
Neoplasms
Active leflunomide metabolite inhibits interleukin 1beta, tumour necrosis factor alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures.
Neoplasms
Activin A suppresses interleukin-1-induced matrix metalloproteinase 3 secretion in human chondrosarcoma cells.
Neoplasms
ADAMTS5 Functions as an Anti-Angiogenic and Anti-Tumorigenic Protein Independent of Its Proteoglycanase Activity.
Neoplasms
Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness.
Neoplasms
Advanced oxidation protein products induce inflammatory responses and invasive behaviour in fibroblast-like synoviocytes via the RAGE-NF-?B pathway.
Neoplasms
Adverse Reaction of Dextran Sodium Sulfate-Induced Colitis in a Collagen-Induced Mouse Arthritis Model.
Neoplasms
Age-Related Adverse Inflammatory and Metabolic Changes Begin Early in Adulthood.
Neoplasms
Alogliptin inhibits IL-1?-induced inflammatory response in fibroblast-like synoviocytes.
Neoplasms
alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression.
Neoplasms
Alterations in the matrix metalloproteinase-3 promoter methylation after common chemotherapeutics: in vitro study of paclitaxel, cisplatin and methotrexate in the MCF-7 and SH-SY5Y cell lines.
Neoplasms
Altered Gene and Protein Expressions in Torn Rotator Cuff Tendon Tissues in Diabetic Patients.
Neoplasms
Altered matrix metalloproteinase expression associated with oncogene-mediated cellular transformation and metastasis formation.
Neoplasms
An ex vivo ruminal ovine model to study the immediate immune response in the context of bacterial lipopolysaccharide.
Neoplasms
Analysis of early biochemical markers and regulation by tin protoporphyrin IX in a model of spontaneous osteoarthritis.
Neoplasms
Analysis of Gene Expression in Experimental Pressure Ulcers in the Rat with Special Reference to Inflammatory Cytokines.
Neoplasms
Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis.
Neoplasms
Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery.
Neoplasms
Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex.
Neoplasms
Anti-photoaging potential of Botulinum Toxin Type A in UVB-induced premature senescence of human dermal fibroblasts in vitro through decreasing senescence-related proteins.
Neoplasms
Anti-Vascular Endothelial Growth Factor (VEGF) Antibody Ameliorates Cartilage Degradation in a Rat Model of Chronic Sports Arthritic Injury.
Neoplasms
Antitumor efficacy of hypothemycin, a new Ras-signaling inhibitor.
Neoplasms
ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNF? inhibitors.
Neoplasms
Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Neoplasms
Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer.
Neoplasms
Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.
Neoplasms
Association of matrix metalloproteinase-3 -1171(5A>6A) polymorphism with cancer risk: a meta-analysis of 41 studies.
Neoplasms
Association of Oral Cavity and Oropharyngeal Cancer Biomarkers in Surgical Drain Fluid With Patient Outcomes.
Neoplasms
Association of tumor necrosis factor-? and matrix metalloproteinase-3 gene variants with stroke.
Neoplasms
Atherosclerotic plaque identification by virtual histology intravascular ultrasound in a rabbit abdominal aorta model of vulnerable plaque.
Neoplasms
Atsttrin reduces lipopolysaccharide-induced neuroinflammation by inhibiting the nuclear factor kappa B signaling pathway.
Neoplasms
Attachment to laminin-111 facilitates transforming growth factor beta-induced expression of matrix metalloproteinase-3 in synovial fibroblasts.
Neoplasms
Autoantibody and Biopsy Grading Are Associated with Expression of ICAM-1, MMP-3, and TRAIL in Salivary Gland Mononuclear Cells of Chinese Patients with Sjogren's Syndrome.
Neoplasms
Autocrine and paracrine regulation of tissue inhibitor of metalloproteinases, transin, and urokinase gene expression in metastatic and nonmetastatic mammary carcinoma cells.
Neoplasms
Autocrine motility factor stimulates the invasiveness of malignant cells as well as up-regulation of matrix metalloproteinase-3 expression via a MAPK pathway.
Neoplasms
Bioactive secondary metabolites from acid mine waste extremophiles.
Neoplasms
Biological implications of growth factors on the mechanism of invasion in gynecological tumor cells.
Neoplasms
Biomarkers for diagnosing and monitoring autoimmune diseases.
Neoplasms
Biomarkers of inflammation and hemostasis associated with left ventricular mass: The Multiethnic Study of Atherosclerosis (MESA).
Neoplasms
Black tea theaflavins attenuate Porphyromonas gingivalis virulence properties, modulate gingival keratinocyte tight junction integrity and exert anti-inflammatory activity.
Neoplasms
Blockade of tumor necrosis factor-alpha-converting enzyme improves experimental small intestinal damage by decreasing matrix metalloproteinase-3 production in rats.
Neoplasms
Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model.
Neoplasms
Borrelia burgdorferi-induced expression of matrix metalloproteinases from human chondrocytes requires mitogen-activated protein kinase and Janus kinase/signal transducer and activator of transcription signaling pathways.
Neoplasms
Butyrate upregulates stromelysin-1 production by intestinal mesenchymal cells.
Neoplasms
Cancer biology: extracellular proteinases in malignancy.
Neoplasms
Cancer-Specific Survival Stratification Derived from Tumor Expression of Tissue Inhibitor of Metalloproteinase-2 in Non-Metastatic Renal Cell Carcinoma.
Neoplasms
Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke.
Neoplasms
Canine Natural Killer Cell-Derived Exosomes Exhibit Antitumor Activity in a Mouse Model of Canine Mammary Tumor.
Neoplasms
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis.
Neoplasms
Carnosine Prevents Type 2 Diabetes-Induced Osteoarthritis Through the ROS/NF-?B Pathway.
Neoplasms
Case of primary malignant hemangiopericytoma of the heart expressing basement membrane-degradable enzymes.
Neoplasms
Cathepsin G and alpha 1-antichymotrypsin in the local host reaction to loosening of total hip prostheses.
Neoplasms
CCAAT/Enhancer Binding Protein ?-Mediated MMP3 Upregulation Promotes Esophageal Squamous Cell Cancer Invasion In Vitro and Is Associated with Metastasis in Human Patients.
Neoplasms
CCL20 Stimulates Proinflammatory Mediator Synthesis in Human Fibroblast-like Synoviocytes Through a MAP Kinase-dependent Process with Transcriptional and Posttranscriptional Control.
Neoplasms
CCR5 silencing reduces inflammatory response, inhibits viability, and promotes apoptosis of synovial cells in rat models of rheumatoid arthritis through the MAPK signaling pathway.
Neoplasms
CD11c+ macrophages and levels of TNF-? and MMP-3 are increased in synovial and adipose tissues of osteoarthritic mice with hyperlipidemia.
Neoplasms
Celecoxib does not affect the release of hyaluronic acid in end stage osteoarthritic joints.
Neoplasms
Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice.
Neoplasms
Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extract.
Neoplasms
Central and peripheral region tibial plateau chondrocytes respond differently to in vitro dynamic compression.
Neoplasms
Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritis.
Neoplasms
Changes of synovial fluid biomarker levels after opening wedge high tibial osteotomy in patients with knee osteoarthritis.
Neoplasms
Characterization of gene expression induced by RET with MEN2A or MEN2B mutation.
Neoplasms
Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progression.
Neoplasms
Chemokine profile of disc degeneration with acute or chronic pain.
Neoplasms
Cinnamomulactone, a new butyrolactone from the twigs of Cinnamomum cassia and its inhibitory activity of matrix metalloproteinases.
Neoplasms
Circ-Sirt1 inhibits proliferation, induces apoptosis, and ameliorates inflammation in human rheumatoid arthritis fibroblast-like synoviocytes.
Neoplasms
Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNF? inhibitors.
Neoplasms
Cloning of the genes for human stromelysin and stromelysin 2: differential expression in rheumatoid synovial fibroblasts.
Neoplasms
Collagen induced arthritis: reversal by mercaptoethylguanidine, a novel antiinflammatory agent with a combined mechanism of action.
Neoplasms
Collagenase is expressed by rabbit VX2 tumour cells in syngeneic and xenogeneic hosts.
Neoplasms
Collagenase-1, stromelysin-1 and 92 kDa gelatinase are associated with tumor necrosis factor-alpha induced morphological change of human endothelial cells in vitro.
Neoplasms
Comparison of interface membranes obtained from failed cemented and cementless hip and knee prostheses.
Neoplasms
Constitutive expression and secretion of proteases in non-metastatic SP1 mammary carcinoma cells and its metastatic sublines.
Neoplasms
Constitutive migration and expression of three protease systems define in vitro the malignant phenotype of Ha-ras transformed rat liver epithelial cells.
Neoplasms
Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes.
Neoplasms
Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
Neoplasms
Crocin exerts anti-inflammatory and anti-catabolic effects on rat intervertebral discs by suppressing the activation of JNK.
Neoplasms
Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene.
Neoplasms
CXCR7 protein expression correlates with elevated mmp-3 secretion in breast cancer cells.
Neoplasms
Cyclophilin C-associated protein is a mediator for fibronectin fragment-induced matrix metalloproteinase-13 expression.
Neoplasms
Cytokine inducible matrix metalloproteinase expression in immortalized rat chondrocytes is independent of nitric oxide stimulation.
Neoplasms
Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.
Neoplasms
Cytokines in fluids from polycystic kidneys.
Neoplasms
Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients.
Neoplasms
Decrease of CD68 and MMP-3 expression in synovium by treatment of adalimumab for rheumatoid arthritis.
Neoplasms
Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.
Neoplasms
Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology.
Neoplasms
Detection of mRNAs encoding collagenase I and stromelysin 2 in carcinomas of the head and neck by in situ hybridization.
Neoplasms
Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: Sustained release of a local antiinflammatory therapeutic.
Neoplasms
Development of recombinant matrix metalloproteinase-3 based sandwich ELISA for sero-diagnosis of canine mammary carcinomas.
Neoplasms
Dexamethasone attenuation of cytokine-mediated articular cartilage degradation in experimental lapine Haemophilus arthritis.
Neoplasms
Differential gene expression during multistage carcinogenesis.
Neoplasms
Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.
Neoplasms
Differential regulation of MMP-9 and TIMP-2 expression in malignant melanoma developed in metallothionein/RET transgenic mice.
Neoplasms
Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability.
Neoplasms
Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression.
Neoplasms
Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.
Neoplasms
Drosophila TIMP is a potent inhibitor of MMPs and TACE: similarities in structure and function to TIMP-3.
Neoplasms
Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
Neoplasms
Effect of ?-anhydroicaritin on the expression levels of tumor necrosis factor-? and matrix metalloproteinase-3 in periodontal tissue of diabetic rats.
Neoplasms
Effect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cells.
Neoplasms
Effect of body-weight loading onto the articular cartilage on the occurrence of quinolone-induced chondrotoxicity in juvenile rats.
Neoplasms
Effect of Chondroitin Sulphate on Pro-Inflammatory Mediators and Disease Activity in Patients with Inflammatory Bowel Disease.
Neoplasms
Effect of doxycycline and meloxicam on cytokines, brain-derived neurotrophic factor, matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-3 and cyclooxygenase-2 in brain.
Neoplasms
Effect of IL-13 on cytokines, cytokine receptors and inhibitors on human osteoarthritis synovium and synovial fibroblasts.
Neoplasms
Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasis.
Neoplasms
Effect of Moxibustion on the Serum Levels of MMP-1, MMP-3, and VEGF in Patients with Rheumatoid Arthritis.
Neoplasms
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Neoplasms
Effect of Proinflammatory Gene Polymorphisms on the Risk of Alzheimer's Disease.
Neoplasms
Effects of Alpha-Lipoic Acid Supplementation on Inflammatory Biomarkers and Matrix Metalloproteinase-3 in Rheumatoid Arthritis Patients.
Neoplasms
Effects of chlorella on activities of protein tyrosine phosphatases, matrix metalloproteinases, caspases, cytokine release, B and T cell proliferations, and phorbol ester receptor binding.
Neoplasms
Effects of Cytokine Activation and Oxidative Stress on the Function of the Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells.
Neoplasms
Effects of dexmedetomidine on glioma cells in the presence or absence of cisplatin.
Neoplasms
Effects of exercise therapy on knee joint function and synovial fluid cytokine levels in patients with knee osteoarthritis.
Neoplasms
Effects of JNK1/2 on the inflammation cytokine TNF-?-enhanced production of MMP-3 in human dental pulp fibroblast-like cells.
Neoplasms
Effects of rambutan (Nephelium lappaceum) peel phenolics and Leu-Ser-Gly-Tyr-Gly-Pro on hairless mice skin photoaging induced by ultraviolet irradiation.
Neoplasms
Effects of sex steroids and growth factors on invasive activity and 5'-deoxy-5-fluorouridine sensitivity in ovarian adenocarcinoma OMC-3 cells.
Neoplasms
Effects of sulfasalazine and its metabolites on steady state messenger RNA concentrations for inflammatory cytokines, matrix metalloproteinases, and tissue inhibitors of metalloproteinase in rheumatoid synovial fibroblasts.
Neoplasms
Efficient purification of TIMP-2 from culture medium conditioned by human hepatoma cell line, and its inhibitory effects on metalloproteinases and in vitro tumor invasion.
Neoplasms
Electroacupuncture Delays Cartilage Degeneration by Modulating Nuclear Factor-?B Signaling Pathway.
Neoplasms
Elevated expression of matrix metalloproteinase-3 in human osteosarcoma and its association with tumor metastasis.
Neoplasms
Elevated interleukin-12 in pseudosynovial fluid in patients with aseptic loosening of hip prosthesis.
Neoplasms
Elevated plasma stromelysin levels in arthritis.
Neoplasms
EMMPRIN-mediated MMP regulation in tumor and endothelial cells.
Neoplasms
Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model.
Neoplasms
Enhanced Expression but Decreased Specific Activity of Matrix Metalloproteinase 10 (MMP-10) in Comparison with Matrix Metalloproteinase 3 (MMP-3) in Human Urinary Bladder Carcinoma.
Neoplasms
Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
Neoplasms
Enhanced tendon restoration effects of anti-inflammatory, lactoferrin-immobilized, heparin-polymeric nanoparticles in an Achilles tendinitis rat model.
Neoplasms
Epithelial cells up-regulate matrix metalloproteinases in cells within the same mammary carcinoma that have undergone an epithelial-mesenchymal transition.
Neoplasms
Euodia pasteuriana Methanol Extract Exerts Anti-Inflammatory Effects by Targeting TAK1 in the AP-1 Signaling Pathway.
Neoplasms
Evaluation of the post-treatment anti-inflammatory capacity of osteoarthritic chondrocytes: An in vitro study using baicalein.
Neoplasms
Evodiamine Induces Apoptosis and Inhibits Migration of HCT-116 Human Colorectal Cancer Cells.
Neoplasms
Excessive reactive oxygen species are therapeutic targets for intervertebral disc degeneration.
Neoplasms
Exposure of cartilage to a fibronectin fragment amplifies catabolic processes while also enhancing anabolic processes to limit damage.
Neoplasms
Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer.
Neoplasms
Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer.
Neoplasms
Expression of ?v?6 integrin and collagen fibre in oral squamous cell carcinoma: association with clinical outcomes and prognostic implications.
Neoplasms
Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
Neoplasms
Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease.
Neoplasms
Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours.
Neoplasms
Expression of ets-1 transcription factor in human head and neck squamous cell carcinoma and effect of histamine on metastatic potential of invasive tumor through the regulation of expression of ets-1 and matrix metalloproteinase-3.
Neoplasms
Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells.
Neoplasms
Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis.
Neoplasms
Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity.
Neoplasms
Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.
Neoplasms
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Neoplasms
Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix.
Neoplasms
Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis.
Neoplasms
Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis.
Neoplasms
Expression of metastasis-associated molecules in non-small cell lung cancer and their prognostic significance.
Neoplasms
Expression of microRNA-21 and TIMP-3 in paradoxical psoriasiform reactions during treatment with antitumor necrosis factor agents.
Neoplasms
Expression of MMP-2 and TIMP-3 with incidence and prognosis of giant-cell tumor of the bone.
Neoplasms
Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.
Neoplasms
Expression of stromelysin 1 in human astrocytoma cell lines.
Neoplasms
Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Neoplasms
Expression of stromelysin-1 and TIMP-1 in the involuting mammary gland and in early invasive tumors of the mouse.
Neoplasms
Expression of the IL-6 family cytokines in human brain tumors.
Neoplasms
Expression of the transcription factor c-Ets1 correlates with the occurrence of invasive processes during normal and pathological development.
Neoplasms
Expression of the transin, c-fos, and c-jun genes in rat transplantable osteosarcomas and malignant fibrous histiocytomas.
Neoplasms
Expression of TNF-?, VEGF, and MMP-3 mRNAs in synovial tissues and their roles in fibroblast-mediated osteogenesis in ankylosing spondylitis.
Neoplasms
Expression pattern and circulating levels of endostatin in patients with pancreas cancer.
Neoplasms
Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression.
Neoplasms
Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
Neoplasms
Expressions of matrix metalloproteinase-9 (MMP-9), dentin sialophosphoprotein (DSPP), and osteopontin (OPN) at histologically negative surgical margins may predict recurrence of oral squamous cell carcinoma.
Neoplasms
Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis.
Neoplasms
Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells.
Neoplasms
Fibronectin III 13-14 domains induce joint damage via Toll-like receptor 4 activation and synergize with interleukin-1 and tumour necrosis factor.
Neoplasms
Fire acupuncture for mild to moderate knee osteoarthritis: a protocol for a randomized controlled pilot trial.
Neoplasms
Galectin-3 deficiency protects lipopolysaccharide-induced chondrocytes injury via regulation of TLR4 and PPAR-?-mediated NF-?B signaling pathway.
Neoplasms
Gene expression of matrix metalloproteinase-1 (interstitial collagenase) and matrix metalloproteinase-3 (stromelysin-1) in basal cell carcinoma by in situ hybridization using chondroitin ABC lyase.
Neoplasms
Genipin inhibits MMP-1 and MMP-3 release from TNF-a-stimulated human periodontal ligament cells.
Neoplasms
Heme oxygenase-1 mediates protective effects on inflammatory, catabolic and senescence responses induced by interleukin-1? in osteoarthritic osteoblasts.
Neoplasms
Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas.
Neoplasms
Heterozygosity of stromelysin-1 (rs3025058) promoter polymorphism is associated with gastric cancer.
Neoplasms
High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma.
Neoplasms
High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer.
Neoplasms
High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis.
Neoplasms
High serum matrix metalloproteinase 3 is characteristic of patients with paraneoplastic remitting seronegative symmetrical synovitis with pitting edema syndrome.
Neoplasms
High-Frequency Near-Infrared Diode Laser Irradiation Attenuates IL-1?-Induced Expression of Inflammatory Cytokines and Matrix Metalloproteinases in Human Primary Chondrocytes.
Neoplasms
High-throughput functional profiling of single adherent cells via hydrogel drop-screen.
Neoplasms
Histological analysis of synovium by treatment of etanercept for rheumatoid arthritis.
Neoplasms
Histological analysis of synovium in cases of effect attenuation associated with infliximab therapy in rheumatoid arthritis.
Neoplasms
Human and rat malignant-tumor-associated mRNAs encode stromelysin-like metalloproteinases.
Neoplasms
Human collagenase-3 is expressed in malignant squamous epithelium of the skin.
Neoplasms
Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer.
Neoplasms
Human stromelysin gene promoter activity is modulated by transcription factor ZBP-89.
Neoplasms
Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture.
Neoplasms
Hyaluronan Up-Regulates IL-10 Expression in Fibroblast-Like Synoviocytes from Patients with Tibia Plateau Fracture.
Neoplasms
Hydrostatic pressure induces expression of interleukin 6 and tumour necrosis factor alpha mRNAs in a chondrocyte-like cell line.
Neoplasms
Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3).
Neoplasms
Identification of self-epitopes recognized by T cells in rheumatoid arthritis demonstrates matrix metalloproteinases as a novel T cell target.
Neoplasms
IL-20 may contribute to the pathogenesis of human intervertebral disc herniation.
Neoplasms
Immunohistochemical expression of matrix metalloproteinases 1, 2, 9, and 14 in dermatofibrosarcoma protuberans and common fibrous histiocytoma (dermatofibroma).
Neoplasms
Immunohistological analysis of synovium treated with abatacept in rheumatoid arthritis.
Neoplasms
Immunolocalization of matrix metallo-proteinases and their tissue inhibitor in human mammary pathology.
Neoplasms
Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.
Neoplasms
Immunolocalization of selected cytokines and proteases in canine articular cartilage after transarticular loading.
Neoplasms
Immunolocalization of stromelysin, tumor necrosis factor (TNF) alpha, and TNF receptors in atrophied canine articular cartilage treated with hyaluronic acid and transforming growth factor beta.
Neoplasms
In vitro and in vivo matrix metalloproteinase expression after photodynamic therapy with a liposomal formulation of aminolevulinic acid and its methyl ester.
Neoplasms
In vitro effects of meloxicam on metabolism in articular chondrocytes from dogs with naturally occurring osteoarthritis.
Neoplasms
Increased backbone mobility in beta-barrel enhances entropy gain driving binding of N-TIMP-1 to MMP-3.
Neoplasms
Increased elastic modulus of the synovial membrane in a rat ACLT model of osteoarthritis revealed by atomic force microscopy.
Neoplasms
Increased expression and activity of matrix metalloproteinases characterize embolic cardiac myxomas.
Neoplasms
Increased expression of matrix metalloproteinase-3 (stromelysin-1) in cultured fibroblasts and basal cell carcinomas of nevoid basal cell carcinoma syndrome.
Neoplasms
Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone.
Neoplasms
Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma.
Neoplasms
Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis.
Neoplasms
Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer.
Neoplasms
Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
Neoplasms
Increased serum PCSK9, a potential biomarker to screen for periodontitis, and decreased total bilirubin associated with probing depth in a Japanese community survey.
Neoplasms
Increases of stromelysin messenger-RNA expression in ras-transformed ref cells in-vivo.
Neoplasms
Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3.
Neoplasms
Induction of macrophage matrix metalloproteinase biosynthesis by surfactant protein D.
Neoplasms
Induction of matrix metalloproteinase gene expression in an endothelial cell line by direct interaction with malignant cells.
Neoplasms
Induction of stromelysin gene expression by tumor necrosis factor alpha is inhibited by dexamethasone, salicylate, and N-acetylcysteine in synovial fibroblasts.
Neoplasms
Induction of stromelysin-1 and collagenase synthesis in fibrochondrocytes by tumor necrosis factor-alpha.
Neoplasms
Inflammation suppression by dexamethasone via inhibition of CD147-mediated NF-?B pathway in collagen-induced arthritis rats.
Neoplasms
Inflammatory Cytokine Expression and Sebum Production after Exposure of Cultured Human Sebocytes to Ultraviolet A Radiation and Light at Wavelengths of 650 nm and 830 nm.
Neoplasms
Inflammatory Cytokines and Matrix Metalloproteinases in the Synovial Fluid After Intra-articular Ankle Fracture.
Neoplasms
Inflammatory cytokines and matrix metalloproteinases in the synovial fluid after intra-articular elbow fracture.
Neoplasms
Influence of the Molecular Weight of Poly(Lactide-Co-Glycolide) on the In Vivo Cartilage Repair by a Construct of Poly(Lactide-Co-Glycolide)/Fibrin Gel/Mesenchymal Stem Cells/Transforming Growth Factor-?1.
Neoplasms
Inhibition of human MDA-MB-231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogen.
Neoplasms
Inhibition of JNK in synovium by treatment with golimumab in rheumatoid arthritis.
Neoplasms
Inhibition of MAP kinase in synovium by treatment with tocilizumab in rheumatoid arthritis.
Neoplasms
Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids.
Neoplasms
Inhibition of tumor growth and induction of apoptosis in prostate cancer cell lines by overexpression of tissue inhibitor of matrix metalloproteinase-3.
Neoplasms
Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review).
Neoplasms
Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment.
Neoplasms
Interactions of alpha2-HS-glycoprotein (fetuin) with MMP-3 and murine squamous cell carcinoma cells.
Neoplasms
Interferon-? protects first-trimester decidual cells against aberrant matrix metalloproteinases 1, 3, and 9 expression in preeclampsia.
Neoplasms
Interferon-beta induces metalloproteinase mRNA expression in human fibroblasts. Role of activator protein-1.
Neoplasms
Interleukin-1 or phorbol induction of the stromelysin promoter requires an element that cooperates with AP-1.
Neoplasms
Interleukin-12 deficiency is permissive for angiogenesis in UV radiation-induced skin tumors.
Neoplasms
Interleukin-1beta induced activation of nuclear factor-kappab can be inhibited by novel pharmacological agents in osteoarthritis.
Neoplasms
Interleukin-4 (IL-4) induces down-modulation and shedding of the p55 tumour necrosis factor receptor and inhibits TNF alpha's effect on rheumatoid synovial fibroblasts.
Neoplasms
Interleukin-6 involvement in brain arteriovenous malformations.
Neoplasms
Interplay between epidermal growth factor receptor and Janus kinase 3 regulates polychlorinated biphenyl-induced matrix metalloproteinase-3 expression and transendothelial migration of tumor cells.
Neoplasms
Intra-Articular Platelet-Rich Plasma Combined With Hyaluronic Acid Injection for Knee Osteoarthritis Is Superior to Platelet-Rich Plasma or Hyaluronic Acid Alone in Inhibiting Inflammation and Improving Pain and Function.
Neoplasms
Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion.
Neoplasms
Invasive tumors induce c-ets1 transcription factor expression in adjacent stroma.
Neoplasms
Investigation of Cytokine Changes in Osteoarthritic Knee Joint Tissues in Response to Hyperacute Serum Treatment.
Neoplasms
Investigation of the role of MMP3 -1171insA polymorphism in cutaneous malignant melanoma - a preliminary study.
Neoplasms
Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
Neoplasms
Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNgamma-based cancer therapy in mice.
Neoplasms
Isolation and characterization of human monoclonal antibodies specific to MMP-1A, MMP-2 and MMP-3.
Neoplasms
Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts.
Neoplasms
Isolation, characterization, and expression of feline stromelysin-1 in naturally developing tumors in cats.
Neoplasms
Isolation, characterization, and expression of stromelysin-1 in primary tumors of dogs.
Neoplasms
Kadsura heteroclita stem suppresses the onset and progression of adjuvant-induced arthritis in rats.
Neoplasms
Kaempferitrin inhibits proliferation, induces apoptosis, and ameliorates inflammation in human rheumatoid arthritis fibroblast-like synoviocytes.
Neoplasms
Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts.
Neoplasms
l-Glutathione enhances antioxidant capacity of hyaluronic acid and modulates expression of pro-inflammatory cytokines in human fibroblast-like synoviocytes.
Neoplasms
LINC00963 affects the development of colorectal cancer via MiR-532-3p/HMGA2 axis.
Neoplasms
LINC01534 Promotes the Aberrant Metabolic Dysfunction and Inflammation in IL-1?-Simulated Osteoarthritic Chondrocytes by Targeting miR-140-5p.
Neoplasms
Lipoma arborescens co-existing with psoriatic arthritis releases tumour necrosis factor alpha and matrix metalloproteinase 3.
Neoplasms
Loss of JunB activity enhances stromelysin 1 expression in a model of the epithelial-to-mesenchymal transition of mouse skin tumors.
Neoplasms
Macrophages regulate tumor necrosis factor-alpha expression in adipocytes through the secretion of matrix metalloproteinase-3.
Neoplasms
Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1.
Neoplasms
Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies.
Neoplasms
Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis.
Neoplasms
Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: A pilot study.
Neoplasms
Matrix metalloproteinase (MMP)-1 and MMP-3 induce macrophage MMP-9: evidence for the role of TNF-alpha and cyclooxygenase-2.
Neoplasms
Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis.
Neoplasms
Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: An overview.
Neoplasms
Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices.
Neoplasms
Matrix Metalloproteinase Expressions Play Important role in Prediction of Ovarian Cancer Outcome.
Neoplasms
Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse.
Neoplasms
Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material.
Neoplasms
Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha.
Neoplasms
Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features.
Neoplasms
Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation.
Neoplasms
Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
Neoplasms
Matrix Metalloproteinase-3 is Key Effector of TNF-?-Induced Collagen Degradation in Skin.
Neoplasms
Matrix metalloproteinase-3 secretion from human pancreatic periacinar myofibroblasts in response to inflammatory mediators.
Neoplasms
Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
Neoplasms
Matrix metalloproteinase-induced fibrosis and malignancy in breast and lung.
Neoplasms
Matrix metalloproteinases and their inhibitors in gastric cancer.
Neoplasms
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Neoplasms
Matrix metalloproteinases in blood vessel development in human fetal skin and in cutaneous tumors.
Neoplasms
Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
Neoplasms
Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
Neoplasms
Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.
Neoplasms
Matrix-degrading metalloproteinases in tumor progression.
Neoplasms
Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study.
Neoplasms
Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assay.
Neoplasms
Mechanism of signal transduction in tumor necrosis factor-like weak inducer of apoptosis-induced matrix degradation by MMP-3 upregulation in disc tissues.
Neoplasms
Mechanistic Insights into Side Effects of Troglitazone and Rosiglitazone Using a Novel Inverse Molecular Docking Protocol.
Neoplasms
Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression by IL-1beta and TNFalpha.
Neoplasms
Mesenchymal stromal cells versus betamethasone can dampen disease activity in the collagen arthritis mouse model.
Neoplasms
Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma.
Neoplasms
Metalloprotease activity, phospholipase A2 activity and cytokine concentration in osteoarthritis synovial fluids.
Neoplasms
Metalloproteinase and TIMP expression by the human breast carcinoma cell line 8701-BC.
Neoplasms
Metalloproteinases 1 and 3 as Potential Biomarkers in Breast Cancer Development.
Neoplasms
Microdermabrasion with and without aluminum oxide crystal abrasion: a comparative molecular analysis of dermal remodeling.
Neoplasms
Microdermabrasion: a molecular analysis following a single treatment.
Neoplasms
MicroRNA-18a-5p Suppresses Tumor Growth via Targeting Matrix Metalloproteinase-3 in Cisplatin-Resistant Ovarian Cancer.
Neoplasms
MicroRNA-21-5p are involved in apoptosis and invasion of fibroblast-like synoviocytes through PTEN/PI3K/AKT signal.
Neoplasms
Mid-trimester amniotic fluid pro-inflammatory biomarkers predict the risk of spontaneous preterm delivery in twins: a retrospective cohort study.
Neoplasms
Minimally invasive colorectal resection is associated with significantly elevated levels of plasma matrix metalloproteinase 3 (MMP-3) during the first month after surgery which may promote the growth of residual metastases.
Neoplasms
MIR-140-5p affects chondrocyte proliferation, apoptosis, and inflammation by targeting HMGB1 in osteoarthritis.
Neoplasms
miR-522 Modulated the Expression of Proinflammatory Cytokines and Matrix Metalloproteinases Partly via Targeting Suppressor of Cytokine Signaling 3 in Rheumatoid Arthritis Synovial Fibroblasts.
Neoplasms
Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties.
Neoplasms
MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.
Neoplasms
MMP-3 Deficiency Alleviates Endotoxin-Induced Acute Inflammation in the Posterior Eye Segment.
Neoplasms
MMP-3 mRNA and MMP-3 and MMP-1 proteins in bladder cancer: a comparison with clinicopathologic features and survival.
Neoplasms
MMP3 and CXCL1 are potent stromal protein markers of dysplasia-carcinoma transition in sporadic colorectal cancer.
Neoplasms
Molecular determinants of glioma cell migration and invasion.
Neoplasms
Molecular mechanisms of malignant conversion in skin carcinogenesis.
Neoplasms
Molecular regulation of ovarian cancer cell invasion.
Neoplasms
Monoclonal antibodies against human collagenase and stromelysin.
Neoplasms
mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas.
Neoplasms
mu-Calpain is involved in the regulation of TNF-alpha-induced matrix metalloproteinase-3 release in a rheumatoid synovial cell line.
Neoplasms
Myelin Loss Associated With Neuroinflammation in Hypertensive Rats.
Neoplasms
Negative regulation of gene expression by TGF-beta.
Neoplasms
NFAT1 directly regulates IL-8 and MMP-3 to promote melanoma tumor growth and metastasis.
Neoplasms
Nitric oxide activates metalloprotease enzymes in articular cartilage.
Neoplasms
NLRP3 as a potentially novel biomarker for the management of osteoarthritis.
Neoplasms
No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in chinese.
Neoplasms
Nobiletin alleviates endometriosis via down-regulating NF-?B activity in endometriosis mouse model.
Neoplasms
Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis.
Neoplasms
Notch3 promotes prostate cancer-induced bone lesion development via MMP-3.
Neoplasms
Novel Anti-arthritic Mechanisms of Polydatin in Complete Freund's Adjuvant-Induced Arthritis in Rats: Involvement of IL-6, STAT-3, IL-17, and NF-?B.
Neoplasms
Oral administration of curcumin suppresses production of matrix metalloproteinase (MMP)-1 and MMP-3 to ameliorate collagen-induced arthritis: inhibition of the PKCdelta/JNK/c-Jun pathway.
Neoplasms
Oral infection with Porphyromonas gingivalis and systemic cytokine profile in C57BL/6.KOR-ApoE(shl) mice.
Neoplasms
Osteoarthritis-related biomarkers profile in chronic anterior cruciate ligament injured knee.
Neoplasms
Overexpression of MMP-3 and uPA with Diminished PAI-1 Related to Metastasis in Ductal Breast Cancer Patients Attending a Public Hospital in Mexico City.
Neoplasms
Overexpression of protein kinase C-alpha and -beta isozymes by stromal dendritic cells in basal and squamous cell carcinoma.
Neoplasms
p38 MAP kinase pathway and stromelysin regulation in trabecular meshwork cells.
Neoplasms
Pachymic acid modified carbon nanoparticles reduced angiogenesis via inhibition of MMP-3.
Neoplasms
Parthenolide inhibits pro-inflammatory cytokine production and exhibits protective effects on progression of collagen-induced arthritis in a rat model.
Neoplasms
Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies.
Neoplasms
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.
Neoplasms
Phenotypic alterations in fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression. Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein.
Neoplasms
Phospholipase Cgamma1 stimulates transcriptional activation of the matrix metalloproteinase-3 gene via the protein kinase C/Raf/ERK cascade.
Neoplasms
Physiological mechanisms for metalloproteinase activation.
Neoplasms
Plasma Level of MMP-10 May Be a Prognostic Marker in Early Stages of Breast Cancer.
Neoplasms
Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease.
Neoplasms
Porphyromonas gingivalis lipids inhibit osteoblastic differentiation and function.
Neoplasms
Production of cytokines by chondrocytes and its role in proteoglycan degradation.
Neoplasms
Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
Neoplasms
Production of matrix metalloproteinases in specific subpopulations of human-patient breast cancer invading in three dimensional culture system.
Neoplasms
Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid.
Neoplasms
Profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases proteins in bladder urothelial carcinoma.
Neoplasms
Prognostic Impact of Tissue Inhibitor of Metalloproteinase-1 in Non-Small Cell Lung Cancer: Systematic Review and Meta-Analysis.
Neoplasms
Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer.
Neoplasms
Prognostic values of ETS-1, MMP-2 and MMP-9 expression and co-expression in breast cancer patients.
Neoplasms
Proinflammatory cytokine activities, matrix metalloproteinase-3 activity, and sulfated glycosaminoglycan content in synovial fluid of dogs with naturally acquired cranial cruciate ligament rupture.
Neoplasms
Proinflammatory Cytokines and Chemokines as Biomarkers of Persistent Arthralgia and Severe Disease After Chikungunya Virus Infection: A 5-Year Follow-Up Study in Southern Thailand.
Neoplasms
Proinflammatory cytokines induce stromelysin-1-mediated cell proliferation in dental pulp fibroblast-like cells.
Neoplasms
Prostaglandin EP2 receptor signalling inhibits the expression of matrix metalloproteinase 13 in human osteoarthritic chondrocytes.
Neoplasms
Prostate cancer-derived MMP-3 controls intrinsic cell growth and extrinsic angiogenesis.
Neoplasms
Prostate tumor cell invasion: a comparison of orthotopic and ectopic models.
Neoplasms
Protective Effect of Super-Critical Carbon Dioxide Fluid Extract from Flowers and Buds of Chrysanthemum indicum Linnén Against Ultraviolet-Induced Photo-Aging in Mice.
Neoplasms
Protective effects of cilengitide on inflammation in chondrocytes under excessive mechanical stress.
Neoplasms
Protein kinase C isotypes required for phorbol-ester induction of stromelysin-1 in rat fibroblasts.
Neoplasms
Protein kinase C-independent expression of stromelysin by platelet-derived growth factor, ras oncogene, and phosphatidylcholine-hydrolyzing phospholipase C.
Neoplasms
Protein kinase D1 mediates synergistic MMP-3 expression induced by TNF-? and bradykinin in human colonic myofibroblasts.
Neoplasms
Protein kinase regulation of tumor necrosis factor alpha stimulated collagenase and stromelysin message levels in chondrocytes.
Neoplasms
Proteinases, their inhibitors, and cytokine profiles in acute wound fluid.
Neoplasms
Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines.
Neoplasms
Proteolysis in human breast and colorectal cancer.
Neoplasms
Proteolysis of the matricellular protein hevin by matrix metalloproteinase-3 produces a SPARC-like fragment (SLF) associated with neovasculature in a murine glioma model.
Neoplasms
Proteolyzed matrix as a template for the regulation of tumor progression.
Neoplasms
Pulsed Electromagnetic Field Modulates Tendon Cells Response in IL-1?-Conditioned Environment.
Neoplasms
Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members.
Neoplasms
Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line.
Neoplasms
Purification of a gelatin-degrading type IV collagenase secreted by ras oncogene-transformed fibroblasts.
Neoplasms
Quantification of matrix metalloproteinase activity in plasma of patients enrolled in a BAY 12-9566 phase I study.
Neoplasms
Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor ? inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.
Neoplasms
Reactive oxygen species-mediated switching expression of MMP-3 in stromal fibroblasts and cancer cells during prostate cancer progression.
Neoplasms
Recapitulation of a normal cellular growth program in early invasive breast-cancer.
Neoplasms
Redox regulation of MMP-3/TIMP-1 ratio in intestinal myofibroblasts: Effect of N-acetylcysteine and curcumin.
Neoplasms
Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1beta and tumor necrosis factor-alpha.
Neoplasms
Regulation of expression of stromyelysin-1 by proinflammatory cytokines in mouse brain astrocytes.
Neoplasms
Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?
Neoplasms
Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester.
Neoplasms
Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells.
Neoplasms
Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells.
Neoplasms
Regulation of matrix metalloproteinases: an overview.
Neoplasms
Relationships between early inflammatory response to bleomycin and sensitivity to lung fibrosis: a role for dipeptidyl-peptidase I and tissue inhibitor of metalloproteinase-3?
Neoplasms
Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis.
Neoplasms
Remitting seronegative symmetrical synovitis with pitting edema syndrome complicated with primary lung cancer.
Neoplasms
Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study.
Neoplasms
Resveratrol inhibits matrix metalloproteinase-1 and -3 expression by suppressing of p300/NF?B acetylation in TNF-?-treated human dermal fibroblasts.
Neoplasms
Retroviral vector-producer cell-mediated in vivo gene transfer of TIMP-3 restricts angiogenesis and neuroblastoma growth in mice.
Neoplasms
Roflumilast prevents lymphotoxin ? (TNF-?)-induced inflammation activation and degradation of type 2 collagen in chondrocytes.
Neoplasms
Role of MMP-3 and MMP-9 and their haplotypes in risk of bladder cancer in North Indian cohort.
Neoplasms
Screening of stress enhancer based on analysis of gene expression profiles: enhancement of hyperthermia-induced tumor necrosis by an MMP-3 inhibitor.
Neoplasms
Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin.
Neoplasms
Sensitive electrochemical immunosensor for matrix metalloproteinase-3 based on single-wall carbon nanotubes.
Neoplasms
Sequences coding for part of oncogene-induced transin are highly conserved in a related rat gene.
Neoplasms
Sequential dynamics of inflammatory cytokine, angiogenesis inducing factor and matrix degrading enzymes during spontaneous resorption of the herniated disc.
Neoplasms
Serum and Saliva MMP-3 in Patients with OLP and Oral SCC.
Neoplasms
Serum and synovial fluid concentrations of matrix metalloproteinases 3 and its tissue inhibitor 1 in juvenile idiopathic arthritides.
Neoplasms
Serum levels of the proinflammatory cytokine interleukin-6 vary based on diagnoses in individuals with lumbar intervertebral disc diseases.
Neoplasms
Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chronic liver disease.
Neoplasms
Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma.
Neoplasms
Serum matrix metalloproteinases-3 levels in patients with ankylosing spondylitis.
Neoplasms
Serum metalloproteinases and their inhibitors: markers for malignant potential.
Neoplasms
Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts.
Neoplasms
Signal transducer and activator of transcription 1 and matrix metalloproteinase 3 genetic expression and clinical significance on urothelial tumors after renal transplantation.
Neoplasms
Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.
Neoplasms
Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers.
Neoplasms
Smooth Muscle Peroxisome Proliferator-Activated Receptor ? Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo.
Neoplasms
Soluble biomarkers may differentiate psoriasis from psoriatic arthritis.
Neoplasms
Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.
Neoplasms
Solution structures of stromelysin complexed to thiadiazole inhibitors.
Neoplasms
Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down-regulation of matrix metalloproteinase-3/-9/-14 and CD44.
Neoplasms
Spinal matrix metalloproteinase 3 mediates inflammatory hyperalgesia via a tumor necrosis factor-dependent mechanism.
Neoplasms
Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium.
Neoplasms
Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium.
Neoplasms
Spontaneous metastasis in matrix metalloproteinase 3-deficient mice.
Neoplasms
SPR Biosensing in crude serum using ultralow fouling binary patterned peptide SAM.
Neoplasms
Steady-state mRNA levels of interleukin-1, integrins, cJun, and cFos in hairless mouse skin during short-term chronic UV exposure and the effect of topical tretinoin.
Neoplasms
Stress-induced cartilage degradation does not depend on NLRP3 inflammasome in osteoarthritis.
Neoplasms
Stromal expression of c-Ets1 transcription factor correlates with tumor invasion.
Neoplasms
Stromelysin (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase (TIMP-1) mRNA expression in scleritis.
Neoplasms
Stromelysin in tumor progression and metastasis.
Neoplasms
Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo.
Neoplasms
Stromelysin-1 and mesothelin are differentially regulated by Wnt-5a and Wnt-1 in C57mg mouse mammary epithelial cells.
Neoplasms
Stromelysin-1 expression is activated in vivo by Ets-1 through palindromic head-to-head Ets binding sites present in the promoter.
Neoplasms
Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors.
Neoplasms
Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.
Neoplasms
Structural studies of the MMP-3 interaction with triple-helical collagen introduce new roles for the enzyme in tissue remodelling.
Neoplasms
Structure and expression of the human gene for the matrix metalloproteinase matrilysin.
Neoplasms
Sudachitin Inhibits Matrix Metalloproteinase-1 and -3 Production in Tumor Necrosis Factor-?-Stimulated Human Periodontal Ligament Cells.
Neoplasms
Suppression of hyaluronan synthesis alleviates inflammatory response in murine arthritis and in human rheumatoid synovial fibroblasts.
Neoplasms
Synergistic effect of l-ascorbic acid and hyaluronic acid on the expressions of matrix metalloproteinase-3 and -9 in human chondrocytes.
Neoplasms
Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not.
Neoplasms
Synovial Fluid Profile at the Time of Anterior Cruciate Ligament Reconstruction and Its Association With Cartilage Matrix Composition 3 Years After Surgery.
Neoplasms
Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model.
Neoplasms
Systemic Th17-like cytokine pattern in gangrenous appendicitis but not in phlegmonous appendicitis.
Neoplasms
Taraxasterol suppresses inflammation in IL-1?-induced rheumatoid arthritis fibroblast-like synoviocytes and rheumatoid arthritis progression in mice.
Neoplasms
Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes.
Neoplasms
TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1.
Neoplasms
The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
Neoplasms
The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients.
Neoplasms
The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins.
Neoplasms
The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression.
Neoplasms
The chondroprotective drugs, Arteparon and sodium pentosan polysulphate, increase collagenase activity and inhibit stromelysin activity in vitro.
Neoplasms
The collagenase gene family in humans consists of at least four members.
Neoplasms
The complexity of molecular processes in osteoarthritis of the knee joint.
Neoplasms
The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer.
Neoplasms
The effects of dopamine receptor 2 expression on B cells on bone metabolism and TNF-? levels in rheumatoid arthritis.
Neoplasms
The expression of proinflammatory cytokines and matrix metalloproteinases in the synovial membranes of patients with osteoarthritis compared with traumatic knee disorders.
Neoplasms
The IGF-I Receptor Can Alter the Matrix Metalloproteinase Repertoire of Tumor Cells through Transcriptional Regulation of PKC-{alpha}
Neoplasms
The inhibitor of kappa B kinase-epsilon regulates MMP-3 expression levels and can promote lung metastasis.
Neoplasms
The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.
Neoplasms
The matrix metalloproteinase system in oral squamous cell carcinoma.
Neoplasms
The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors.
Neoplasms
The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer.
Neoplasms
The role of lipolysis in mediating the proinflammatory effects of very low density lipoproteins in mouse peritoneal macrophages.
Neoplasms
The role of stromelysin-1 in stromal-epithelial interactions and cancer.
Neoplasms
The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas.
Neoplasms
The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity.
Neoplasms
The Stromal Overexpression of CD10 in Invasive Breast Cancer and its Association with Clincophathologic Factors.
Neoplasms
The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis.
Neoplasms
Therapeutic Effects of the Addition of Platelet-Rich Plasma to Bioimplants and Early Rehabilitation Exercise on Articular Cartilage Repair.
Neoplasms
Therapeutic efficacy of infused molecular hydrogen in saline on rheumatoid arthritis: a randomized, double-blind, placebo-controlled pilot study.
Neoplasms
Thyroid hormone regulates stromelysin expression, protease secretion and the morphogenetic potential of normal polarized mammary epithelial cells.
Neoplasms
Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas.
Neoplasms
Tissue inhibitor of matrix metalloproteinase-3 levels in the extracellular matrix of lung, kidney, and eye increase with age.
Neoplasms
Tissue inhibitor of matrix metalloproteinases-3 (TIMP-3) lacks involvement in bacterial collagenase-induced intracerebral hemorrhage in mouse.
Neoplasms
TNF-? induces phenotypic modulation in cerebral vascular smooth muscle cells: implications for cerebral aneurysm pathology.
Neoplasms
TNIIIA2, The Peptide of Tenascin-C, as a Candidate for Preventing Articular Cartilage Degeneration.
Neoplasms
Toll-Like Receptor 3 Deficiency Leads to Altered Immune Responses to Chlamydia trachomatis Infection in Human Oviduct Epithelial Cells.
Neoplasms
Tranexamic acid has positive effect in early period of tendon healing by stimulating the tumor necrosis factor-alpha and matrix metalloproteinase-3 expression levels.
Neoplasms
Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone.
Neoplasms
Transcriptional regulation of stromelysin-1 gene expression is altered during progression of mouse mammary epithelial cells from functionally normal to malignant.
Neoplasms
Transforming growth factor beta 1 and cAMP inhibit transcription of epidermal growth factor- and oncogene-induced transin RNA.
Neoplasms
Treatment with dextromethorphan improves endothelial function, inflammation and oxidative stress in male heavy smokers.
Neoplasms
Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model.
Neoplasms
Tripterygium wilfordii Hook F extract suppresses proinflammatory cytokine-induced expression of matrix metalloproteinase genes in articular chondrocytes by inhibiting activating protein-1 and nuclear factor-kappaB activities.
Neoplasms
Tumor cell expression of MMP3 as a prognostic factor for poor survival in pancreatic, pulmonary, and mammary carcinoma.
Neoplasms
Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase.
Neoplasms
Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers.
Neoplasms
Tumor induced by Moloney sarcoma virus causes periosteal osteogenesis engaging osteopontin, fibronectin, stromelysin-1 and tenascin.
Neoplasms
Tumor necrosis factor alpha and epidermal growth factor regulation of collagenase and stromelysin in adult porcine articular chondrocytes.
Neoplasms
Tumor necrosis factor-?- and interleukin-1?-dependent matrix metalloproteinase-3 expression in nucleus pulposus cells requires cooperative signaling via syndecan 4 and mitogen-activated protein kinase-NF-?B axis: implications in inflammatory disc disease.
Neoplasms
Tumor necrosis factor-?-accelerated degradation of type I collagen in human skin is associated with elevated matrix metalloproteinase (MMP)-1 and MMP-3 ex vivo.
Neoplasms
Tumor necrosis factor-alpha (TNF-alpha) in canine osteoarthritis: Immunolocalization of TNF-alpha, stromelysin and TNF receptors in canine osteoarthritic cartilage.
Neoplasms
Tumor promoters induce a transient expression of tumor-associated genes in both basal and differentiated cells of the mouse epidermis.
Neoplasms
Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway.
Neoplasms
Tumour-targeting properties of antibodies specific to MMP-1A, MMP-2 and MMP-3.
Neoplasms
Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Neoplasms
Ultraviolet B radiation increases steady-state mRNA levels for cytokines and integrins in hairless mouse skin: modulation by topical tretinoin.
Neoplasms
Unregulated and independent expression of collagenase and transin related to tumor progression.
Neoplasms
Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients.
Neoplasms
Upregulation of serum vascular endothelial growth factor and matrix metalloproteinase-3 in patients with oral squamous cell carcinoma.
Neoplasms
Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis.
Neoplasms
Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours.
Neoplasms
Various modes of gene regulation by nuclear receptors for steroid and thyroid hormones.
Neoplasms
Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes.
Neoplasms
Venlafaxine alleviates complete Freund's adjuvant-induced arthritis in rats: Modulation of STAT-3/IL-17/RANKL axis.
Neoplasms
Zeta PKC plays a critical role during stromelysin promoter activation by platelet-derived growth factor through a novel palindromic element.
Neoplasms
[(18)F-Fluorodeoxyglucose positron emission tomography and serum cytokines and matrix metalloproteinases in the assessment of disease activity in Takayasu's arteritis].
Neoplasms
[Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer]
Neoplasms
[Changes in markers of proliferation, neoangiogenesis and plasminogen activation system in rectal cancer tissue].
Neoplasms
[Clinical significance of functional variants of matrix metalloproteinase genes in thyroid cancer]
Neoplasms
[Clinical study of etanercept for treating ankylosing spondylitis]
Neoplasms
[Correlation analysis of bone marrow edema degree and serum inflammatory factors change with knee joint pain symptoms in patients with bone contusion around the knee joint].
Neoplasms
[Cytokines, prostaglandin E2, phospholipase A and metalloproteases in synovial fluid in osteoarthritis]
Neoplasms
[Detection of stromelysin mRNA expression in human hepatocellular carcinoma by in situ hybridization]
Neoplasms
[Effect of fire needling on mild to moderate knee osteoarthritis and related serum inflammatory cytokines].
Neoplasms
[Effect of Warm-needle-moxibustion on Behavior Reactions and TNF-? and MMP-3 Contents in Knee Cartilage of Rabbits with Knee Osteoarthritis].
Neoplasms
[Effects of tumor necrosis factor-? on release of MMP-3, MMP-9, and interleukin-17 in mouse bone marrow-derived mast cells in vitro].
Neoplasms
[Experimental study on replicating knee osteoarthritis by modified Hulth's modeling method]
Neoplasms
[Expression of dishevelled-2 in cartilage of rheumatoid arthritis and its effect on cartilage destruction].
Neoplasms
[Expression of matrix metalloproteinases in metastatic lesions of cutaneous squamous cell carcinoma]
Neoplasms
[Role of matrix metalloproteinase-3 in joint destruction in rheumatoid arthritis]
Neoplasms
[Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis]
Neoplasms
[Urothelial tumors and the extracellular matrix]
Nephritis
Association between Serum Matrix Metalloproteinase- (MMP-) 3 Levels and Systemic Lupus Erythematosus: A Meta-analysis.
Nephritis
Clinical significance of matrix metalloproteinase-3 in systemic lupus erythematosus patients: a potential biomarker for disease activity and damage.
Nephritis
The gene expression profile of matrix metalloproteinases and their inhibitors in children with Henoch-Schönlein purpura.
Nephritis
[Matrix metalloproteinase-3 in patients with systemic lupus erythematosus and its significance in differentiating disease activity from pulmonary infections].
Nephritis, Hereditary
Dysregulation of renal MMP-3 and MMP-7 in canine X-linked Alport syndrome.
Nephritis, Hereditary
Stage-Specific Action of Matrix Metalloproteinases Influences Progressive Hereditary Kidney Disease.
Nephrosis
Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
Nervous System Diseases
Matrix metalloproteinase-3 in myasthenia gravis compared to other neurological disorders and healthy controls.
Nervous System Diseases
Serum levels of matrix metalloproteinases: implications in clinical neurology.
Neuralgia
Up-regulation of matrix metalloproteinase-3 in the dorsal root ganglion of rats with paclitaxel-induced neuropathy.
Neuroblastoma
Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US.
Neuroblastoma
Retroviral vector-producer cell-mediated in vivo gene transfer of TIMP-3 restricts angiogenesis and neuroblastoma growth in mice.
Neurodegenerative Diseases
Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
Neurodegenerative Diseases
Matrix metalloproteinase-3 is increased and participates in neuronal apoptotic signaling downstream of caspase-12 during ER stress.
Neurodegenerative Diseases
MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson's disease.
Neurodegenerative Diseases
Role of Matrix Metalloproteinase-3 in Neurodegeneration.
Neuroendocrine Tumors
Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease.
Neurofibroma
Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression.
Neurofibroma, Plexiform
Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression.
Neuroinflammatory Diseases
Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation.
Neuroinflammatory Diseases
Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.
Neuroinflammatory Diseases
Hemorrhagic transformation after ischemic stroke in animals and humans.
Neuroinflammatory Diseases
Matrix metalloproteinases as therapeutic targets for stroke.
Neuroinflammatory Diseases
Matrix Metalloproteinases, New Insights into the Understanding of Neurodegenerative Disorders.
Neuroinflammatory Diseases
MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson's disease.
Neuroinflammatory Diseases
MMP-3 Deficiency Alleviates Endotoxin-Induced Acute Inflammation in the Posterior Eye Segment.
Neuroinflammatory Diseases
Papaverine inhibits ?-synuclein aggregation by modulating neuroinflammation and matrix metalloproteinase-3 expression in the subacute MPTP/P mouse model of Parkinson's disease.
Neuroinflammatory Diseases
Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation.
Neuroinflammatory Diseases
The Role of Matrix Metalloproteinase 3 and 9 in the Pathogenesis of Acute Neuroinflammation. Implications for Disease Modifying Therapy.
Neuroinflammatory Diseases
Tightening the retinal glia limitans attenuates neuroinflammation after optic nerve injury.
neutrophil collagenase deficiency
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response.
Non-ST Elevated Myocardial Infarction
Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development.
Obesity
Distinct effects of calorie restriction on adipose tissue cytokine and angiogenesis profiles in obese and lean mice.
Obesity
Effect of high fat diet and excessive compressive mechanical force on pathologic changes of temporomandibular joint.
Obesity
Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation.
Obesity
Role of MMP-1 (-519A/G, -1607 1G/2G), MMP-3 (Lys45Glu), MMP-7 (-181A/G), and MMP-12 (-82A/G) Variants and Plasma MMP Levels on Obesity-Related Phenotypes and Microvascular Reactivity in a Tunisian Population.
Obstetric Labor, Premature
Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor.
Obstetric Labor, Premature
Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity.
Obstetric Labor, Premature
Matrix metalloproteinases-2, -3 and tissue inhibitors of metalloproteinases -1, -2 in placentas from preterm pregnancies and their association with one carbon metabolites.
Odontogenic Cysts
Effects of positive pressure in odontogenic keratocysts.
Oral Submucous Fibrosis
Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.
Oral Submucous Fibrosis
The functional (-1171 5A-->6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users.
Osteoarthritis
A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies.
Osteoarthritis
A Preliminary Study of Combined Detection of COMP, TIMP-1, and MMP-3 in Synovial Fluid: Potential Indicators of Osteoarthritis Progression.
Osteoarthritis
Activation of cartilage stromelysin-1 at acid pH and its relation to enzyme pH optimum and osteoarthritis.
Osteoarthritis
Alteration of matrix metalloproteinase-3 O-glycan structure as a biomarker for disease activity of rheumatoid arthritis.
Osteoarthritis
AMD3100 Attenuates Matrix Metalloprotease-3 and -9 Expressions and Prevents Cartilage Degradation in a Monosodium Iodo-Acetate-Induced Rat Model of Temporomandibular Osteoarthritis.
Osteoarthritis
Anti-inflammatory and anti-osteoarthritis effects of tectorigenin.
Osteoarthritis
Antiosteoarthritic effect of Punica granatum L. peel extract on collagenase induced osteoarthritis rat by modulation of COL-2, MMP-3, and COX-2 expression.
Osteoarthritis
Argatroban more effectively inhibits the thrombin activity in synovial fluid than naturally occurring thrombin inhibitors.
Osteoarthritis
Association of MMP-3 (-1612 5A/6A) polymorphism with knee osteoarthritis in Thai population.
Osteoarthritis
Cartilage oligomeric matrix protein and matrix metalloproteinase-3 expression in the serum and joint fluid of a reversible osteoarthritis rabbit model.
Osteoarthritis
CD11c+ macrophages and levels of TNF-? and MMP-3 are increased in synovial and adipose tissues of osteoarthritic mice with hyperlipidemia.
Osteoarthritis
Characterization of neopeptides in equine articular cartilage degradation.
Osteoarthritis
Clinical trials of a stromelysin inhibitor. Osteoarthritis, matrix metalloproteinase inhibition, cartilage loss, surrogate markers, and clinical implications.
Osteoarthritis
Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis.
Osteoarthritis
Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis. An immunohistochemical study.
Osteoarthritis
Correction: MMP-3 gene polymorphisms are associated with increased risk of osteoarthritis in Chinese men.
Osteoarthritis
Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3.
Osteoarthritis
Curcumin Inhibits Proliferation of Synovial Cells by Downregulating Expression of Matrix Metalloproteinase-3 in Osteoarthritis.
Osteoarthritis
CX3CL1 promotes MMP-3 production via the CX3CR1, c-Raf, MEK, ERK, and NF-?B signaling pathway in osteoarthritis synovial fibroblasts.
Osteoarthritis
Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis.
Osteoarthritis
Differential in vivo expression of collagenase messenger RNA in synovium and cartilage. Quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis.
Osteoarthritis
Distinct expression pattern of early- and late-response genes in normal and osteoarthritic human synovial membranes.
Osteoarthritis
Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis chondrocytes.
Osteoarthritis
Effect of nimesulide on the serum levels of hyaluronan and stromelysin-1 in patients with osteoarthritis: a pilot study.
Osteoarthritis
Effects of an aqueous extract of Eucommia on articular cartilage in a rat model of osteoarthritis of the knee.
Osteoarthritis
Effects of celecoxib on human chondrocytes--enhanced production of chemokines.
Osteoarthritis
Effects of Vitamin D Supplementation during the Induction and Progression of Osteoarthritis in a Rat Model.
Osteoarthritis
Elevated levels of synovial fluid PLA2, stromelysin (MMP-3) and TIMP in early osteoarthrosis after tibial valgus osteotomy in young beagle dogs.
Osteoarthritis
Elevated metalloproteinase and tissue inhibitor of metalloproteinase mRNA in human osteoarthritic synovia.
Osteoarthritis
Elevated plasma stromelysin levels in arthritis.
Osteoarthritis
Etanercept therapy leads to reductions in matrix metalloproteinase-3 in patients with erosive hand osteoarthritis.
Osteoarthritis
Evaluation of serum MMP-2 and MMP-3, synovial fluid IL-8, MCP-1, and KC concentrations as biomarkers of stifle osteoarthritis associated with naturally occurring cranial cruciate ligament rupture in dogs.
Osteoarthritis
Explore the variation of MMP3, JNK, p38 MAPKs, and autophagy at the early stage of osteoarthritis.
Osteoarthritis
Expression and significance of MMP3 in synovium of knee joint at different stage in osteoarthritis patients.
Osteoarthritis
Expression level of proteoglycan, collagen and type II collagen in osteoarthritis rat model is promoted and degradation of cartilage is prevented by glucosamine methyl ester.
Osteoarthritis
Expression of stromelysin and urokinase type plasminogen activator protein in resection specimens and biopsies at different stages of osteoarthritis of the knee.
Osteoarthritis
Ferulic acid suppresses interleukin-1?-induced degeneration of chondrocytes isolated from patients with osteoarthritis through the SIRT1/AMPK/PGC-1? signaling pathway.
Osteoarthritis
Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy.
Osteoarthritis
Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes.
Osteoarthritis
Higher levels of matrix metalloproteinase-3 in patients with RA reflect disease activity and structural damage.
Osteoarthritis
Histamine stimulates matrix metalloproteinase-3 and -13 production by human articular chondrocytes in vitro.
Osteoarthritis
Histone Methylation and STAT-3 Differentially Regulate Interleukin-6-Induced Matrix Metalloproteinase Gene Activation in Rheumatoid Arthritis Synovial Fibroblasts.
Osteoarthritis
Identification of new autolytic sites of recombinant truncated mature human fibroblast stromelysin by mass spectrometry.
Osteoarthritis
Identification of the metalloproteinase stromelysin in the physis.
Osteoarthritis
Immunofluorescence quantitation of stromelysin in human synovial fibroblasts by confocal laser scanning microscopy.
Osteoarthritis
In situ hybridization of stromelysin mRNA in the synovial biopsies from rheumatoid arthritis.
Osteoarthritis
In vitro suppression of the MMP-3 gene in normal and cytokine-treated human chondrosarcoma using small interfering RNA.
Osteoarthritis
Increased level of heme oxygenase-1 in rheumatoid arthritis synovial fluid.
Osteoarthritis
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Osteoarthritis
Increased secretion and activity of matrix metalloproteinase-3 in synovial tissues and chondrocytes from experimental osteoarthritis.
Osteoarthritis
Increased stromelysin-1 (MMP-3), proteoglycan degradation (3B3- and 7D4) and collagen damage in cyclically load-injured articular cartilage.
Osteoarthritis
Inflammatory cytokines induced down-regulation of m-calpain mRNA expression in fibroblastic synoviocytes from patients with osteoarthritis and rheumatoid arthritis.
Osteoarthritis
Influence of development and joint pathology on stromelysin enzyme activity in equine synovial fluid.
Osteoarthritis
Inhibitory Effects of IL-6-Mediated Matrix Metalloproteinase-3 and -13 by Achyranthes japonica Nakai Root in Osteoarthritis and Rheumatoid Arthritis Mice Models.
Osteoarthritis
Interferon regulatory factor 5 (IRF5) regulates the expression of matrix metalloproteinase-3 (MMP-3) in human chondrocytes.
Osteoarthritis
Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint.
Osteoarthritis
Interleukin-1beta induced activation of nuclear factor-kappab can be inhibited by novel pharmacological agents in osteoarthritis.
Osteoarthritis
Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis.
Osteoarthritis
Lectin-like oxidized LDL receptor-1 signal is a potent biomarker and therapeutic target for human rheumatoid arthritis.
Osteoarthritis
Levels of rheumatoid factor isotypes, metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in synovial fluid from various arthritides.
Osteoarthritis
LncRNA-CIR promotes articular cartilage degeneration in osteoarthritis by regulating autophagy.
Osteoarthritis
Long-term oral administration of glucosamine or chondroitin sulfate reduces destruction of cartilage and up-regulation of MMP-3 mRNA in a model of spontaneous osteoarthritis in Hartley guinea pigs.
Osteoarthritis
Low prevalence of knee chondrocalcinosis and its catabolic association by use of serum matrix metalloproteinase 3: A rural Japanese population study.
Osteoarthritis
Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis.
Osteoarthritis
Matrix metalloprotease-3 expression in the medial plica and pannus-like tissue in knees from patients with medial compartment osteoarthritis.
Osteoarthritis
Matrix Metalloproteinase 3: A Promoting and Destabilizing Factor in the Pathogenesis of Disease and Cell Differentiation.
Osteoarthritis
Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Osteoarthritis
Mechanically induced experimental knee osteoarthritis benefits from anti-inflammatory and immunomodulatory properties of simvastatin via inhibition of matrix metalloproteinase-3.
Osteoarthritis
Mechanism of basic calcium phosphate crystal-stimulated matrix metalloproteinase-13 expression by osteoarthritic synovial fibroblasts: inhibition by prostaglandin E2.
Osteoarthritis
Metalloprotease activity, phospholipase A2 activity and cytokine concentration in osteoarthritis synovial fluids.
Osteoarthritis
Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis.
Osteoarthritis
MT3-MMP (MMP-16) is downregulated by in vitro cytokine stimulation of cartilage, but unaltered in naturally occurring equine osteoarthritis and osteochondrosis.
Osteoarthritis
Naringenin regulates production of matrix metalloproteinases in the knee-joint and primary cultured articular chondrocytes and alleviates pain in rat osteoarthritis model.
Osteoarthritis
Niacinamide and undenatured type II collagen modulates the inflammatory response in rats with monoiodoacetate-induced osteoarthritis.
Osteoarthritis
Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro.
Osteoarthritis
Proline-Serine-Threonine Phosphatase-Interacting Protein 2 Alleviates Diabetes Mellitus-Osteoarthritis in Rats through Attenuating Synovial Inflammation and Cartilage Injury.
Osteoarthritis
Radiological and biochemical effects (CTX-II, MMP-3, 8, and 13) of low-level laser therapy (LLLT) in chronic osteoarthritis in Al-Kharj, Saudi Arabia.
Osteoarthritis
Regulatory effect of anti-gp130 functional mAb on IL-6 mediated RANKL and Wnt5a expression through JAK-STAT3 signaling pathway in FLS.
Osteoarthritis
Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis.
Osteoarthritis
Resistin as a factor in osteoarthritis: synovial fluid resistin concentrations correlate positively with interleukin 6 and matrix metalloproteinases MMP-1 and MMP-3.
Osteoarthritis
ROCK inhibition enhances aggrecan deposition and suppresses matrix metalloproteinase-3 production in human articular chondrocytes.
Osteoarthritis
Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors.
Osteoarthritis
Serum levels of collagenase, stromelysin-1, and TIMP-1. Age- and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis.
Osteoarthritis
Serum levels of matrix metalloproteinase 3 (stromelysin 1) for monitoring synovitis in rheumatoid arthritis.
Osteoarthritis
Serum levels of matrix metalloproteinase-3 and autoantibodies related to rheumatoid arthritis in the general Japanese population and their association with osteoporosis and osteoarthritis: the ROAD study.
Osteoarthritis
Serum levels of matrix metalloproteinase-3 in relation to the development of radiological damage in patients with early rheumatoid arthritis.
Osteoarthritis
Serum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis.
Osteoarthritis
Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor.
Osteoarthritis
Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.
Osteoarthritis
Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction.
Osteoarthritis
Sustained and distinctive patterns of gene activation in synovial fibroblasts and whole synovial tissue obtained from inflammatory synovitis.
Osteoarthritis
Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not.
Osteoarthritis
Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis.
Osteoarthritis
Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?
Osteoarthritis
Synovial TGF-?1 and MMP-3 levels and their correlation with the progression of temporomandibular joint osteoarthritis combined with disc displacement: A preliminary study.
Osteoarthritis
The effect of drugs used in the treatment of osteoarthrosis on stromelysin (proteoglycanase) of equine synovial cell origin.
Osteoarthritis
The effect of non-steroidal anti-inflammatory drugs on matrix metalloproteinases levels in patients with osteoarthritis.
Osteoarthritis
The effects of doxycycline on nitric oxide and stromelysin production in dogs with cranial cruciate ligament rupture.
Osteoarthritis
The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta(IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis.
Osteoarthritis
The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis.
Osteoarthritis
The involvement of matrix metalloproteinases and inflammation in lumbar disc herniation.
Osteoarthritis
The proteoglycanase from human cartilage and cultured rabbit chondrocytes and its relation to osteoarthritis.
Osteoarthritis
Transin/stromelysin expression in rheumatoid synovium. A transformation-associated metalloproteinase secreted by phenotypically invasive synoviocytes.
Osteoarthritis
Tumor necrosis factor-alpha (TNF-alpha) in canine osteoarthritis: Immunolocalization of TNF-alpha, stromelysin and TNF receptors in canine osteoarthritic cartilage.
Osteoarthritis
[A study of serum cartilage oligomeric matrixprotein and matrix metalloproteinase-3 concentration in osteoarthritic rabbit models].
Osteoarthritis
[Biochemical analysis of the synovial fluid of the shoulder joint in patients with and without rotator cuff tears]
Osteoarthritis
[Cytokines, prostaglandin E2, phospholipase A and metalloproteases in synovial fluid in osteoarthritis]
Osteoarthritis
[Effect of Gancao Fuzi Decoction on osteoarthritis and proteomics of articular cartilage in rats].
Osteoarthritis
[Effect of various intervention factors on MMP-3 and TIMP-1 level in synovial fluid in knee joints with osteroarthritis.]
Osteoarthritis
[Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis]
Osteoarthritis
[Matrix metalloproteinase (MMP)-3 is not effective for evaluating hemophilic arthropathy].
Osteoarthritis
[Stromelysin-1 (MMP-3) level in the sera from patients with rheumatoid arthritis and other connective tissue diseases--clinical significances in early onset rheumatoid arthritis]
Osteoarthritis, Hip
Catirlage oligomeric matrix protein, C-terminal cross-linking telopeptide of type II collagen, and matrix metalloproteinase-3 as biomarkers for knee and hip osteoarthritis (OA) diagnosis: a systematic review and meta-analysis.
Osteoarthritis, Hip
[Effects of naproxen (naprosyne) on the metabolism of arthrotic cartilage in man in vivo]
Osteoarthritis, Knee
Association of MMP-3 (-1612 5A/6A) polymorphism with knee osteoarthritis in Thai population.
Osteoarthritis, Knee
Cartilage oligomeric protein, matrix metalloproteinase-3, and Coll2-1 as serum biomarkers in knee osteoarthritis: a cross-sectional study.
Osteoarthritis, Knee
Effects of exercise therapy on knee joint function and synovial fluid cytokine levels in patients with knee osteoarthritis.
Osteoarthritis, Knee
Expression of stromelysin and urokinase type plasminogen activator protein in resection specimens and biopsies at different stages of osteoarthritis of the knee.
Osteoarthritis, Knee
Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy.
Osteoarthritis, Knee
Increased serum ADAMTS-4 in knee osteoarthritis: a potential indicator for the diagnosis of osteoarthritis in early stages.
Osteoarthritis, Knee
Inhalation therapy of calcitonin relieves osteoarthritis of the knee.
Osteoarthritis, Knee
Matrix metalloprotease-3 expression in the medial plica and pannus-like tissue in knees from patients with medial compartment osteoarthritis.
Osteoarthritis, Knee
Mechanically induced experimental knee osteoarthritis benefits from anti-inflammatory and immunomodulatory properties of simvastatin via inhibition of matrix metalloproteinase-3.
Osteoarthritis, Knee
MMP-3 in the peripheral serum as a biomarker of knee osteoarthritis, 40 years after open total knee meniscectomy.
Osteoarthritis, Knee
Serum levels of matrix metalloproteinase-3 as a prognostic marker for progression of cartilage injury in patients with knee osteoarthritis.
Osteoarthritis, Knee
Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis.
Osteoarthritis, Knee
[Effect of acupoint heat-sensitive moxibustion intervention on serum osteopontin and matrix metalloproteinase-3 in patients with acute knee pain].
Osteoarthritis, Knee
[Effect of Warm-needle-moxibustion on Behavior Reactions and TNF-? and MMP-3 Contents in Knee Cartilage of Rabbits with Knee Osteoarthritis].
Osteochondrosis
Influence of development and joint pathology on stromelysin enzyme activity in equine synovial fluid.
Osteolysis
Histologic and biochemical differences between osteolytic and nonosteolytic membranes around femoral components of an uncemented total hip arthroplasty.
Osteolysis
Mycoplasma bovis induces matrix metalloproteinase-3 expression in bovine synovial cells via up-regulation of interleukin-1? expression in mononuclear cells.
Osteonecrosis
MMP-3 and MMP-8 single-nucleotide polymorphisms are related to alcohol-induced osteonecrosis of the femoral head in Chinese males.
Osteophyte
The localization of matrix metalloproteinase-3 and tenascin in synovial membrane of the temporomandibular joint with internal derangement.
Osteophyte
[Experimental study on replicating knee osteoarthritis by modified Hulth's modeling method]
Osteoporosis
Associations of Changes in Serum Inflammatory Factors, MMP-3, 25(OH)D and Intestinal Flora with Osteoporosis and Disease Activity in Rheumatoid Arthritis Patients.
Osteoporosis
Connective tissue metabolism in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity, bone mineral density, and radiographic outcome.
Osteoporosis
Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis.
Osteoporosis
Identification of human serum protein targets of Qianggu Decoction () in primary type I osteoporosis based on tandem mass tag labeling and liquid chromatography-tandem mass spectrometry technology.
Osteoporosis
Serum levels of matrix metalloproteinase-3 and autoantibodies related to rheumatoid arthritis in the general Japanese population and their association with osteoporosis and osteoarthritis: the ROAD study.
Osteoporosis
Stromelysin (MMP-3) synthesis is up-regulated in estrogen-deficient mouse osteoblasts in vivo and in vitro.
Osteosarcoma
Discordant effects of activator protein-1 transcription factor on gene regulation, invasion, and metastasis in spontaneous, radiation-induced, and fos-induced osteosarcomas.
Osteosarcoma
Elevated expression of matrix metalloproteinase-3 in human osteosarcoma and its association with tumor metastasis.
Osteosarcoma
Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis.
Osteosarcoma
Expression of the transin, c-fos, and c-jun genes in rat transplantable osteosarcomas and malignant fibrous histiocytomas.
Osteosarcoma
Glucosamine sulfate suppresses the expression of matrix metalloproteinase-3 in osteosarcoma cells in vitro.
Osteosarcoma
MMP-3 gene polymorphisms and Osteosarcoma.
Osteosarcoma
Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
Osteosarcoma
Zinc-binding protein-89 (ZBP-89) cooperates with NF-?B to regulate expression of matrix metalloproteinases (MMPs) in response to inflammatory cytokines.
Otosclerosis
Aberration of the tissue collagenase system in association with otosclerosis.
Otosclerosis
Evidence of abnormal stromelysin mRNA expression in suspected carriers of otosclerosis. A possible molecular marker.
Ovarian Neoplasms
Matrix metalloproteinase 3 is a stromal marker for chicken ovarian cancer.
Ovarian Neoplasms
MicroRNA-18a-5p Suppresses Tumor Growth via Targeting Matrix Metalloproteinase-3 in Cisplatin-Resistant Ovarian Cancer.
Ovarian Neoplasms
Molecular regulation of ovarian cancer cell invasion.
Ovarian Neoplasms
Optical imaging of ovarian cancer using a matrix metalloproteinase-3-sensitive near-infrared fluorescent probe.
Ovarian Neoplasms
PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer.
Ovarian Neoplasms
Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
Ovarian Neoplasms
Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers.
Ovarian Neoplasms
The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer.
Ovarian Neoplasms
[Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer]
Pancreatic Neoplasms
Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
Pancreatic Neoplasms
Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease.
Pancreatic Neoplasms
HOXA10 Promotes Cell Invasion and MMP-3 Expression Via TGF?2-Mediated Activation of the p38 MAPK Pathway in Pancreatic Cancer Cells.
Pancreatic Neoplasms
RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells.
Pancreatitis
The influence of transforming growth factor beta 1 on the expression of genes coding for matrix metalloproteinases and tissue inhibitors of metalloproteinases during regeneration from cerulein-induced pancreatitis.
Pancreatitis, Chronic
Balance of expression of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in chronic pancreatitis.
Pancreatitis, Chronic
Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease.
Pancreatitis, Chronic
Plasma TGF-?1, MMP-1 and MMP-3 Levels in Chronic Pancreatitis.
Pancreatitis, Chronic
Role of matrix metalloproteinase 3 gene promoter polymorphism in chronic pancreatitis.
Papilloma
Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression.
Papilloma
The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors.
Papilloma
Transcriptional modulation of transin gene expression by epidermal growth factor and transforming growth factor beta.
Papilloma
v-jun oncogene suppresses both phorbol ester-induced cell invasion and stromelysin gene expression in a mouse papilloma cell line.
Paraneoplastic Syndromes
Remitting seronegative symmetrical synovitis with pitting edema syndrome complicated with primary lung cancer.
Parkinson Disease
A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP.
Parkinson Disease
Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
Parkinson Disease
Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
Parkinson Disease
Matrix metalloproteinase-3 is activated by HtrA2/Omi in dopaminergic cells: Relevance to Parkinson's disease.
Parkinson Disease
Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia.
Parkinson Disease
MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson's disease.
Parkinson Disease
Multifunctional Nanoprobe for the Delivery of Therapeutic siRNA and Real-Time Molecular Imaging of Parkinson's Disease Biomarkers.
Parkinson Disease
Papaverine inhibits ?-synuclein aggregation by modulating neuroinflammation and matrix metalloproteinase-3 expression in the subacute MPTP/P mouse model of Parkinson's disease.
Parkinson Disease
Role of Matrix Metalloproteinase-3 in Neurodegeneration.
Pemphigoid, Bullous
Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid.
Peptic Ulcer
Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.
Peptic Ulcer
[Role of Allelic Genes of Matrix Metalloproteinases and Their Tissue Inhibitors in the Peptic Ulcer Disease Development].
Periapical Periodontitis
The Expression of Semaphorin 7A in Human Periapical Lesions.
Perinatal Death
Stromelysin-1 (MMP-3) expression driven by a macrophage-specific promoter results in reduced viability in transgenic mice.
Periodontal Diseases
Advances in understanding cell interactions in tissue resorption. Relevance to the pathogenesis of periodontal diseases and a new hypothesis.
Periodontal Diseases
Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy.
Periodontal Diseases
Cytokine and metalloproteinases in gingival fluid from patients with chronic periodontitis.
Periodontal Diseases
Effects of interleukin-1 beta on matrix metalloproteinase-3 levels in human periodontal ligament cells.
Periodontal Diseases
Estimation of matrix metalloproteinase-3 levels in gingival crevicular fluid in periodontal disease, health and after scaling and root planing.
Periodontal Diseases
Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor 2, matrix metalloproteinase-3 and interleukin 1-? in patients with different periodontal diseases.
Periodontal Diseases
Immunolocalization of matrix metalloproteinases and TIMP-1 (tissue inhibitor of metalloproteinases) in human gingival tissues from periodontitis patients.
Periodontal Diseases
Infliximab Induced a Dissociated Response of Severe Periodontal Biomarkers in Rheumatoid Arthritis Patients.
Periodontal Diseases
Matrix metalloproteinase-1 and -3 gene promoter polymorphisms in Japanese patients with periodontitis.
Periodontal Diseases
Prostaglandin E2 regulates interleukin-1beta-induced matrix metalloproteinase-3 production in human gingival fibroblasts.
Periodontal Diseases
[Effects of baicalin on the expression of pro-MMP-1 and MMP-3 in human gingival fibroblasts and periodontal ligament cells]
Periodontitis
Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
Periodontitis
Association of Common Variants in MMPs with Periodontitis Risk.
Periodontitis
Association of matrix metalloproteinase (MMP-1, MMP-3 and MMP-9) and cyclooxygenase-2 gene polymorphisms and their proteins with chronic periodontitis.
Periodontitis
Comparison of matrix metalloproteinase-3 and tissue inhibitor of matrix metalloproteinase-1 levels in gingival crevicular fluid in periodontal health, disease and after treatment: A clinico biochemical study.
Periodontitis
Danzhi Jiangtang capsule alleviate hyperglycemia and periodontitis via Wnt/?-catenin signaling in diabetic rat.
Periodontitis
EVALUATION OF BONE RESORPTIVE POTENTIAL IN THE TREATMENT OF GENERALIZED PERIODONTITIS.
Periodontitis
Genetic Factors and the Risk of Periodontitis Development: Findings from a Systematic Review Composed of 13 Studies of Meta-Analysis with 71,531 Participants.
Periodontitis
Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population.
Periodontitis
Gingival crevicular stromelysin, collagenase and tissue inhibitor of metalloproteinases levels in healthy and diseased sites.
Periodontitis
Gingival Tissue and Crevicular Fluid Co-operation in Adult Periodontitis.
Periodontitis
Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3).
Periodontitis
Immunohistochemical analysis of the gingiva with periodontitis of type I plasminogen deficiency compared to gingiva with gingivitis and periodontitis and healthy gingiva.
Periodontitis
Interleukin-4 suppresses IL-1-induced expression of matrix metalloproteinase-3 in human gingival fibroblasts.
Periodontitis
Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis.
Periodontitis
Matrix metalloproteinase-1 and -3 gene promoter polymorphisms in Japanese patients with periodontitis.
Periodontitis
Matrix Metalloproteinase-3 -1171 5A/6A Polymorphism (rs35068180) is Associated with Risk of Periodontitis.
Periodontitis
Mechanistic features associated with induction of metalloproteinases in human gingival fibroblasts by interleukin-1.
Periodontitis
MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis.
Periodontitis
Pathogen profile and MMP-3 levels in areas with varied attachment loss in generalized aggressive and chronic periodontitis.
Periodontitis
Prostaglandin E2 regulates interleukin-1beta-induced matrix metalloproteinase-3 production in human gingival fibroblasts.
Periodontitis
[Expression of MMP-2 and MMP-3 in periodontal tissues of rat periodontitis model]
Pheochromocytoma
A novel nerve growth factor-responsive element in the stromelysin-1 (transin) gene that is necessary and sufficient for gene expression in PC12 cells.
Pheochromocytoma
The metalloproteinase stromelysin-1 (transin) mediates PC12 cell growth cone invasiveness through basal laminae.
Phlebitis
Stromelysin-1 5A/6A and eNOS T-786C Polymorphisms, MTHFR C677T and A1298C Mutations, and Cigarette-Cannabis Smoking: A Pilot, Hypothesis-Generating Study of Gene-Environment Pathophysiological Associations With Buerger's Disease.
Pleural Effusion
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma.
Pleural Effusion
Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
Pleural Effusion
Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.
Pleural Effusion
[Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion]
Pleural Effusion, Malignant
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma.
Pleurisy
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma.
Pleurisy
Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
Pneumonia
Lack of matrix metalloproteinase 3 in mouse models of lung injury ameliorates the pulmonary inflammatory response in female but not in male mice.
Polycythemia Vera
Importance of plasma matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinase (TIMP) in development of fibrosis in agnogenic myeloid metaplasia.
Polymyalgia Rheumatica
Analysis of the relationship between polymyalgia rheumatica and matrix metalloproteinase-3 levels during the first medical examination and during treatment.
Polymyalgia Rheumatica
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Polymyositis
Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy.
Porphyria Cutanea Tarda
Photosensitization of uroporphyrin augments the ultraviolet A-induced synthesis of matrix metalloproteinases in human dermal fibroblasts.
Porphyrias
Photosensitization of uroporphyrin augments the ultraviolet A-induced synthesis of matrix metalloproteinases in human dermal fibroblasts.
Pre-Eclampsia
Altered Maternal Serum Matrix Metalloproteinases MMP-2, MMP-3, MMP-9, and MMP-13 in Severe Early- and Late-Onset Preeclampsia.
Pre-Eclampsia
Expression, regulation and functional characterization of matrix metalloproteinase-3 of human trophoblast.
Pre-Eclampsia
Matrix metalloproteinase multiplex screening identifies increased MMP-2 urine concentrations in women predicted to develop preeclampsia.
Precancerous Conditions
Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis.
Pregnancy, Tubal
Differential Expression of EGFR-1, MMP-3, and MMP-9 in Spontaneous Abortions, Induced Abortions, and Tubal Pregnancies.
Pressure Ulcer
Analysis of Gene Expression in Experimental Pressure Ulcers in the Rat with Special Reference to Inflammatory Cytokines.
Primary Myelofibrosis
Importance of plasma matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinase (TIMP) in development of fibrosis in agnogenic myeloid metaplasia.
Progeria
Age-Dependent Loss of MMP-3 in Hutchinson-Gilford Progeria Syndrome.
Prostatic Neoplasms
Aquaporin 3 promotes prostate cancer cell motility and invasion via extracellular signal-regulated kinase 1/2-mediated matrix metalloproteinase-3 secretion.
Prostatic Neoplasms
Assessment of 54 biomarkers for biopsy-detectable prostate cancer.
Prostatic Neoplasms
Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expression.
Prostatic Neoplasms
Estrogen receptor ? in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3.
Prostatic Neoplasms
Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Prostatic Neoplasms
Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes.
Prostatic Neoplasms
IL-7/IL-7 receptor axis stimulates prostate cancer cell invasion and migration via AKT/NF-?B pathway.
Prostatic Neoplasms
Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Prostatic Neoplasms
Inhibition of tumor growth and induction of apoptosis in prostate cancer cell lines by overexpression of tissue inhibitor of matrix metalloproteinase-3.
Prostatic Neoplasms
Platelet-activating factor receptor activation promotes prostate cancer cell growth, invasion and metastasis via ERK1/2 pathway.
Prostatic Neoplasms
Prostate cancer-derived MMP-3 controls intrinsic cell growth and extrinsic angiogenesis.
Prostatic Neoplasms
Reactive oxygen species-mediated switching expression of MMP-3 in stromal fibroblasts and cancer cells during prostate cancer progression.
Proteinuria
Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
Proteinuria
Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis.
Proteinuria
Matrix metalloproteinase (stromelysin-1) increases the albumin permeability of isolated rat glomeruli.
Proteinuria
[The effect of tripterine in prevention of glomerulosclerosis in lupus nephritis mice]
Pseudoxanthoma Elasticum
Cysteine protease characteristics of the proteoglycanase activity from normal and pseudoxanthoma elasticum (PXE) fibroblasts.
Pseudoxanthoma Elasticum
Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential.
Psoriasis
Analysis of clinical, radiological and laboratory variables in psoriatic arthritis with 25 Japanese patients.
Psoriasis
Efficacy of methotrexate and tumor necrosis factor inhibitors in Japanese patients with active psoriatic arthritis.
Psoriasis
Expression of microRNA-21 and TIMP-3 in paradoxical psoriasiform reactions during treatment with antitumor necrosis factor agents.
Psoriasis
Narrowband ultraviolet B light treatment changes plasma concentrations of MMP-3, MMP-9 and TIMP-3 in psoriatic patients.
Psoriasis
ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients.
Psoriasis
Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study.
Psoriasis
Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy.
Psoriasis
Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis.
Psoriasis
Soluble biomarkers may differentiate psoriasis from psoriatic arthritis.
Psoriasis
Ultrasound assessment, unlike clinical assessment, reflects enthesitis in patients with psoriatic arthritis.
Psoriasis
Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.
Pterygium
Cyclosporine A Downregulates MMP-3 and MMP-13 Expression in Cultured Pterygium Fibroblasts.
Pterygium
Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13.
Pterygium
Involvement of SPARC and MMP-3 in the pathogenesis of human pterygium.
Pterygium
Overexpression of collagenase (MMP-1) and stromelysin (MMP-3) by pterygium head fibroblasts.
Pterygium
Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines.
Pterygium
The Nuclear-Factor Kappa B Pathway is Activated in Pterygium.
Pulmonary Disease, Chronic Obstructive
Carcinogenesis-related changes in iron metabolism in chronic obstructive pulmonary disease subjects with lung cancer.
Pulmonary Disease, Chronic Obstructive
Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Induced sputum metalloproteinases and their inhibitors in relation to exhaled nitrogen oxide and sputum nitric oxides and other inflammatory cytokines in patients with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase 3 polymorphisms as a potential marker of enhanced susceptibility to lung cancer in chronic obstructive pulmonary disease subjects.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase gene polymorphisms: lack of association with chronic obstructive pulmonary disease in a Brazilian population.
Pulmonary Disease, Chronic Obstructive
MMP-3 (-1171 5A/6A; Lys45Glu) variants affect serum levels of matrix metalloproteinase (MMP)-3 and correlate with severity of COPD: A study of MMP-3, MMP-7 and MMP-12 in a Tunisian population.
Pulmonary Disease, Chronic Obstructive
MMP-9 genetic polymorphism may confer susceptibility to COPD.
Pulmonary Disease, Chronic Obstructive
Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
The correlation of age and body mass index with the level of both protease MMP3 and anti-protease TIMP-1 among Indonesian patients with chronic obstructive pulmonary disease: a preliminary findings.
Pulmonary Edema
Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells.
Pulmonary Fibrosis
Matrix Metalloproteinase 3 Is a Mediator of Pulmonary Fibrosis.
Pulmonary Fibrosis
Protein Tyrosine Phosphatase ? Mediates Profibrotic Signaling in Lung Fibroblasts through TGF-? Responsiveness.
Pulmonary Fibrosis
The importance of matrix metalloproteinase-3 in respiratory disorders.
Pulpitis
Cholinoceptor modulation on nitric oxide regulates prostaglandin E(2) and metalloproteinase-3 production in experimentally induced inflammation of rat dental pulp.
Pulpitis
Down-regulation of inflammatory mediator synthesis and infiltration of inflammatory cells by MMP-3 in experimentally induced rat pulpitis.
Pulpitis
The anti-inflammatory effects of matrix metalloproteinase-3 on irreversible pulpitis of mature erupted teeth.
Pulpitis
Tissue levels of matrix metalloproteinases in pulps and periapical lesions.
Radiculopathy
Chemokine profile of disc degeneration with acute or chronic pain.
Refractive Errors
Assessment of the association of matrix metalloproteinases with myopia, refractive error and ocular biometric measures in an Australian cohort.
Refractive Errors
Myopia and polymorphisms in genes for matrix metalloproteinases.
Renal Insufficiency
The significance of metalloproteinase 3 (MMP-3), chemokine CXC ligand 13 (CXCL-13) and complement component C5a in different stages of ANCA associated vasculitis.
Reperfusion Injury
Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures.
Retinal Detachment
Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy.
Retinoblastoma
HOXB5 promotes retinoblastoma cell migration and invasion via ERK1/2 pathway-mediated MMPs production.
Rheumatic Diseases
Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Rheumatic Diseases
Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Rheumatic Diseases
Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis.
Rheumatic Diseases
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Rheumatic Diseases
Influence of Matrix metalloproteinase 1 and 3 genetic variations on susceptibility and severity of juvenile idiopathic arthritis.
Rheumatic Diseases
Prolonged matrix metalloproteinase-3 high expression after cyclic compressive load on human synovial cells in three-dimensional cultured tissue.
Rheumatic Diseases
Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?
Rheumatic Fever
Serum matrix metalloproteinase-3 in hemodialysis patients with dialysis-related amyloidosis.
Rheumatic Heart Disease
Myocardial matrix metalloproteinase-3 and matrix metalloproteinase inhibitor-1 expression in congestive heart failure.
Rheumatoid Nodule
Matrix metalloproteinase gene polymorphisms in patients with rheumatoid arthritis.
Rheumatoid Nodule
MMP expression in rheumatoid inflammation: the rs11568818 polymorphism is associated with MMP-7 expression at an extra-articular site.
Rosacea
Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant.
Sacroiliitis
Analysis of clinical, radiological and laboratory variables in psoriatic arthritis with 25 Japanese patients.
Sacroiliitis
Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateral sacroiliitis.
Sacroiliitis
Pannus inflammation in sacroiliitis following immune pathological injury and radiological structural damage: a study of 193 patients with spondyloarthritis.
Sacroiliitis
Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis.
Sarcoidosis
Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.
Sarcoma
Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis.
Sarcoma
Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes.
Sarcoma
Tumor induced by Moloney sarcoma virus causes periosteal osteogenesis engaging osteopontin, fibronectin, stromelysin-1 and tenascin.
Sarcoma, Avian
Gene transfer of metalloproteinase transin induces aberrant behavior of cultured mesangial cells.
Sarcoma, Avian
Purification and properties of extracellular matrix-degrading metallo-proteinase overproduced by Rous sarcoma virus-transformed rat liver cell line, and its identification as transin.
Sarcoma, Endometrial Stromal
Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis.
Sarcoma, Synovial
Essential role of mitogen-activated protein kinases in IL-17A-induced MMP-3 expression in human synovial sarcoma cells.
Sarcopenia
Matrix metalloprotease 3 is associated with sarcopenia in rheumatoid arthritis - results from the CHIKARA study.
Scleritis
Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
Scleritis
Stromelysin (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase (TIMP-1) mRNA expression in scleritis.
Scleroderma, Diffuse
[Stromelysin-1 (MMP-3) level in the sera from patients with rheumatoid arthritis and other connective tissue diseases--clinical significances in early onset rheumatoid arthritis]
Scleroderma, Localized
Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts.
Scleroderma, Systemic
Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.
Scleroderma, Systemic
Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis.
Scleroderma, Systemic
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Scleroderma, Systemic
Plasma Glycosaminoglycan Profiles in Systemic Sclerosis: Associations with MMP-3, MMP-10, TIMP-1, TIMP-2, and TGF-Beta.
Scleroderma, Systemic
Serum matrix metalloproteinase-3 in systemic sclerosis.
Scleroderma, Systemic
Stromelysin promoter polymorphism is associated with systemic sclerosis.
Scoliosis
Association Between IL-6 and MMP-3 Common Genetic Polymorphisms and Idiopathic Scoliosis in Bulgarian Patients: A Case-Control Study.
Scoliosis
Association between IL-6 and MMP-3 gene polymorphisms and adolescent idiopathic scoliosis: a case-control study.
Scoliosis
Association of IL-6 and MMP-3 gene polymorphisms with susceptibility to adolescent idiopathic scoliosis: a meta-analysis.
Scoliosis
Lack of Association Between the Promoter Polymorphisms of MMP-3 and IL-6 Genes and Adolescent Idiopathic Scoliosis: A Case-Control Study in a Chinese Han Population.
Scoliosis
Polymorphisms in promoter regions of MMP-3 and IL-6 genes are not associated to adolescent idiopathic scoliosis (AIS) gender bias.
Sepsis
Elevated Plasma Levels of Matrix Metalloproteinase-3 and Tissue-Inhibitor of Matrix Metalloproteinases-1 Associate with Organ Dysfunction and Mortality in Sepsis.
Sepsis
The effect of gender and genetic polymorphisms on MMPs and TIMPs plasma levels in different infectious and non-infectious conditions.
Sepsis
[Effects of glutamine on matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-3 expressions in myocardium of rats with sepsis]
Silicosis
[Relationship between genetic polymorphisms of matrix metalloproteinase-2 and -3 and susceptibility to silicosis].
Sjogren's Syndrome
Autoantibody and Biopsy Grading Are Associated with Expression of ICAM-1, MMP-3, and TRAIL in Salivary Gland Mononuclear Cells of Chinese Patients with Sjogren's Syndrome.
Sjogren's Syndrome
[Stromelysin-1 (MMP-3) level in the sera from patients with rheumatoid arthritis and other connective tissue diseases--clinical significances in early onset rheumatoid arthritis]
Skin Diseases
Erosive pustular dermatosis of the scalp arising concomitantly with elevation of serum matrix metalloproteinase-3 in a patient with rheumatoid arthritis.
Skin Neoplasms
Increased expression of stromelysin-3 in basal cell carcinomas.
Skin Ulcer
[Effect of Shengji Huayu Recipe on the expression of MMP-3 and TIMP-1 in skin ulcer tissue of diabetic rats].
Soft Tissue Injuries
The MMP3 gene in musculoskeletal soft tissue injury risk profiling: A study in two independent sample groups.
Spasm
Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women.
Spinal Cord Injuries
Jmjd3 mediates blood-spinal cord barrier disruption after spinal cord injury by regulating MMP-3 and MMP-9 expressions.
Spinal Cord Injuries
Matrix metalloproteinase-3 promotes early blood-spinal cord barrier disruption and hemorrhage and impairs long-term neurological recovery after spinal cord injury.
Spinal Cord Injuries
MMP-3 secreted from endothelial cells of blood vessels after spinal cord injury activates microglia, leading to oligodendrocyte cell death.
Spinal Cord Injuries
Multi-Potent Adult Progenitor Cells, but not Tissue Inhibitor of Matrix Metalloproteinase-3, Increase Tissue Sparing and Reduce Urological Complications following Spinal Cord Injury.
Spinal Cord Injuries
Transplantation of fibroblasts that overexpress matrix metalloproteinase-3 into the site of spinal cord injury in rats.
Spinal Stenosis
The increased expression of matrix metalloproteinases associated with elastin degradation and fibrosis of the ligamentum flavum in patients with lumbar spinal stenosis.
Spondylarthritis
Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor ? inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.
Spondylarthropathies
Serum levels of matrix metalloproteinase-3 in undifferentiated spondyloarthropathy.
Spondylitis, Ankylosing
ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNF? inhibitors.
Spondylitis, Ankylosing
Association study between matrix metalloproteinase-3 gene (MMP3) polymorphisms and ankylosing spondylitis susceptibility.
Spondylitis, Ankylosing
Changes of serum levels of MMP-3, sRANKL, and OPG in juvenile-onset ankylosing spondylitis patients carrying different HLA-B27 subtypes.
Spondylitis, Ankylosing
Circulating Levels of Soluble Receptor Activator of NF- ? B Ligand and Matrix Metalloproteinase 3 (and Their Antagonists) in Asian Indian Patients with Ankylosing Spondylitis.
Spondylitis, Ankylosing
Expression of TNF-?, VEGF, and MMP-3 mRNAs in synovial tissues and their roles in fibroblast-mediated osteogenesis in ankylosing spondylitis.
Spondylitis, Ankylosing
Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis.
Spondylitis, Ankylosing
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Spondylitis, Ankylosing
Lack of association of matrix metalloproteinase 3 (MMP3) genotypes with ankylosing spondylitis susceptibility and severity.
Spondylitis, Ankylosing
Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis.
Spondylitis, Ankylosing
Matrix metalloproteinase expression in the spondyloarthropathies.
Spondylitis, Ankylosing
Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis.
Spondylitis, Ankylosing
Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis.
Spondylitis, Ankylosing
Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFalpha antagonist therapy.
Spondylitis, Ankylosing
Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.
Spondylitis, Ankylosing
Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
Spondylitis, Ankylosing
Serum matrix metalloproteinases-3 levels in patients with ankylosing spondylitis.
Spondylitis, Ankylosing
Serum MMP-3 Level as a Biomarker for Monitoring and Predicting Response to Etanercept Treatment in Ankylosing Spondylitis.
Spondylitis, Ankylosing
The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases.
Spondylitis, Ankylosing
[Clinical study of etanercept for treating ankylosing spondylitis]
Spondylitis, Ankylosing
[Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis]
Spondylitis, Ankylosing
[Serum metalloproteinase-3 levels in assessing efficacy of Etanercept in patients with ankylosing spondylitis].
Spondylolisthesis
Matrix metalloproteinase-3 on ligamentum flavum in degenerative lumbar spondylolisthesis.
Spondylosis
Exploration about changes of IL-10, NF-?B and MMP-3 in a rat model of cervical spondylosis.
Spondylosis
[Effects of Chiropractics on Intervertebral Disk Extracell Matrix and Metabolic Enzymes in Rats with Cervical Spondylosis].
Squamous Cell Carcinoma of Head and Neck
Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract.
Squamous Cell Carcinoma of Head and Neck
Cyr61 increases matrix metalloproteinase-3 expression and cell motility in human oral squamous cell carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
Expression of ?v?6 integrin and collagen fibre in oral squamous cell carcinoma: association with clinical outcomes and prognostic implications.
Squamous Cell Carcinoma of Head and Neck
Expression of ets-1 transcription factor in human head and neck squamous cell carcinoma and effect of histamine on metastatic potential of invasive tumor through the regulation of expression of ets-1 and matrix metalloproteinase-3.
Squamous Cell Carcinoma of Head and Neck
Matrix metalloproteinase 3 polymorphism: a predictive factor of response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Requirement of MMP-3 in anchorage-independent growth of oral squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
Serum and Saliva MMP-3 in Patients with OLP and Oral SCC.
Squamous Cell Carcinoma of Head and Neck
Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.
Squamous Cell Carcinoma of Head and Neck
The 2G allele of promoter region of Matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Upregulation of serum vascular endothelial growth factor and matrix metalloproteinase-3 in patients with oral squamous cell carcinoma.
ST Elevation Myocardial Infarction
Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development.
ST Elevation Myocardial Infarction
Serum and Echocardiographic Markers May Synergistically Predict Adverse Cardiac Remodeling after ST-Segment Elevation Myocardial Infarction in Patients with Preserved Ejection Fraction.
Starvation
Differential regulation of collagenase and stromelysin mRNA in late passage cultures of human fibroblasts.
Starvation
Forkhead factor, FOXO3a, induces apoptosis of endothelial cells through activation of matrix metalloproteinases.
Still's Disease, Adult-Onset
Elevated levels of soluble Fas (APO-1, CD95), soluble Fas ligand, and matrix metalloproteinase-3 in sera from patients with active untreated adult onset Still's disease.
Stomach Neoplasms
Elevated Serum Matrix Metalloproteinase-3 and -7 in H. pylori-Related Gastric Cancer Can Be Biomarkers Correlating with a Poor Survival.
Stomach Neoplasms
Expression of MMP-3 and TIMP-3 in gastric cancer tissue and its clinical significance.
Stomach Neoplasms
Heterozygosity of stromelysin-1 (rs3025058) promoter polymorphism is associated with gastric cancer.
Stomach Neoplasms
Involvement of microRNAs-MMPs-E-cadherin in the migration and invasion of gastric cancer cells infected with Helicobacter pylori.
Stomach Neoplasms
KITENIN is associated with tumor progression in human gastric cancer.
Stomach Neoplasms
Matrix metalloproteinase gene expressions might be oxidative stress targets in gastric cancer cell lines.
Stomach Neoplasms
Matrix metalloproteinases and their inhibitors in gastric cancer.
Stomach Neoplasms
Silencing of the MMP-3 gene by siRNA transfection in gastric cancer AGS cells.
Stomach Ulcer
Elevated Serum Matrix Metalloproteinase-3 and -7 in H. pylori-Related Gastric Cancer Can Be Biomarkers Correlating with a Poor Survival.
Stomach Ulcer
Potential role for matrix metalloproteinase-3 in gastric ulcer healing.
Stomach Ulcer
Spatial and temporal pattern of expression of interstitial collagenase, stromelysin/transin, gelatinase A, and TIMP-1 during experimental gastric ulcer healing.
Stomach Ulcer
[Role of Allelic Genes of Matrix Metalloproteinases and Their Tissue Inhibitors in the Peptic Ulcer Disease Development].
Stomatitis
Involvement of matrix metalloproteinases (MMP-3 and MMP-9) in the pathogenesis of irinotecan-induced oral mucositis.
Stomatitis, Aphthous
Collagenase and stromelysin in recurrent aphthous ulcers (RAU).
Stroke
Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion.
Stroke
Association of blood active matrix metalloproteinase-3 with carotid plaque score from a community population in Taiwan.
Stroke
Association of matrix metalloproteinase-3 gene 5A/6A polymorphism with the recurrence of ischemic stroke: A prospective observational study.
Stroke
Association of tumor necrosis factor-? and matrix metalloproteinase-3 gene variants with stroke.
Stroke
Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
Stroke
Matrix metalloproteinase-3 and intracranial arterial dolichoectasia.
Stroke
Matrix metalloproteinase-3 in myasthenia gravis compared to other neurological disorders and healthy controls.
Stroke
Peroxynitrite-Induced Tyrosine Nitration Contributes to Matrix Metalloprotease-3 Activation: Relevance to Hyperglycemic Ischemic Brain Injury and Tissue Plasminogen Activator.
Stroke
Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.
Stroke
Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor.
Stroke
Proinflammatory genetic profiles in subjects with history of ischemic stroke.
Stroke
Serum levels of matrix metalloproteinases: implications in clinical neurology.
Stroke
Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice.
Stroke
Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein.
stromelysin 1 deficiency
Altered neuronal architecture and plasticity in the visual cortex of adult MMP-3-deficient mice.
stromelysin 1 deficiency
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response.
stromelysin 1 deficiency
MMP-3 Deficiency Alleviates Endotoxin-Induced Acute Inflammation in the Posterior Eye Segment.
stromelysin 1 deficiency
The effect of matrix metalloproteinase-3 deficiency on pulmonary surfactant in a mouse model of acute lung injury.
Subarachnoid Hemorrhage
Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage.
Synovitis
Alterations in Synovial Fluid Biomarker Levels in Knees With Meniscal Injury as Compared With Asymptomatic Contralateral Knees.
Synovitis
Association of synovial inflammation and inflammatory mediators with glenohumeral rotator cuff pathology.
Synovitis
Bone edema determined by magnetic resonance imaging reflects severe disease status in patients with early-stage rheumatoid arthritis.
Synovitis
Decline after immobilisation and recovery after remobilisation of synovial fluid IL1, TIMP, and chondroitin sulphate levels in young beagle dogs.
Synovitis
Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.
Synovitis
Detection of synovial inflammation in rheumatic diseases using superb microvascular imaging: Comparison with conventional power Doppler imaging.
Synovitis
Effect of p38 Mitogen Activated Protein Kinase Inhibitor on Temporomandibular Joint Synovitis Induced by Occlusal Alteration.
Synovitis
Expression of metalloproteinases in pigmented villonodular synovitis.
Synovitis
High serum matrix metalloproteinase 3 is characteristic of patients with paraneoplastic remitting seronegative symmetrical synovitis with pitting edema syndrome.
Synovitis
Increased levels of proteoglycan fragments and stromelysin in hip joint fluid in Legg-Calvé-Perthes disease.
Synovitis
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Synovitis
Influence of Matrix metalloproteinase 1 and 3 genetic variations on susceptibility and severity of juvenile idiopathic arthritis.
Synovitis
Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
Synovitis
Pathological features of established osteoarthritis with hydrathrosis are similar to rheumatoid arthritis.
Synovitis
Predictors of Cardiovascular Affection in Patients with Active Rheumatoid Arthritis: Secondary Analysis of a Randomized Controlled Trial.
Synovitis
Relationship between arthroscopic findings of synovitis and levels of tumour necrosis factor-alpha and matrix metalloproteinases in synovial lavage fluid from patients with unilateral high mandibular condyle fractures.
Synovitis
Remitting seronegative symmetrical synovitis with pitting edema syndrome complicated with primary lung cancer.
Synovitis
Serum levels of matrix metalloproteinase 3 (stromelysin 1) for monitoring synovitis in rheumatoid arthritis.
Synovitis
Serum matrix metalloproteinase 3 in detecting remitting seronegative symmetrical synovitis with pitting edema syndrome: A case report.
Synovitis
Serum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis.
Synovitis
Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis.
Synovitis
Sustained and distinctive patterns of gene activation in synovial fibroblasts and whole synovial tissue obtained from inflammatory synovitis.
Synovitis
Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?
Synovitis
The Relationship between Remitting Seronegative Symmetrical Synovitis with Pitting Edema and Vascular Endothelial Growth Factor and Matrix Metalloproteinase 3.
Synovitis
[Stromelysin-1 in inflammatory disease: significance, specificity, and regulation elements]
Synovitis, Pigmented Villonodular
Expression of metalloproteinases in pigmented villonodular synovitis.
Taste Disorders
Measurements of several metallic elements and matrix metalloproteinases (MMPs) in saliva from patients with taste disorder.
Temporomandibular Joint Disorders
MMP-3 activation is a hallmark indicating an early change in TMJ disorders, and is related to nitration.
Temporomandibular Joint Disorders
Prolonged matrix metalloproteinase-3 high expression after cyclic compressive load on human synovial cells in three-dimensional cultured tissue.
Tendinopathy
Additional evidence supports association of common genetic variants in MMP3 and TIMP2 with increased risk of chronic Achilles tendinopathy susceptibility.
Tendinopathy
Association of the matrix metalloproteinase 3 (MMP3) single nucleotide polymorphisms with tendinopathies: case-control study in high-level athletes.
Tendinopathy
Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy.
Tendinopathy
Enhanced tendon restoration effects of anti-inflammatory, lactoferrin-immobilized, heparin-polymeric nanoparticles in an Achilles tendinitis rat model.
Tendinopathy
Multiple changes in gene expression in chronic human Achilles tendinopathy.
Tendinopathy
Photobiomodulation therapy on collagen type I and III, vascular endothelial growth factor, and metalloproteinase in experimentally induced tendinopathy in aged rats.
Tendinopathy
Trigger finger, tendinosis, and intratendinous gene expression.
Tendinopathy
Variants within the MMP3 gene are associated with Achilles tendinopathy: Possible interaction with the COL5A1 gene.
Tenosynovitis
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern.
Tetralogy of Fallot
Modulating effects of matrix metalloproteinase-3 and -9 polymorphisms on aortic stiffness and aortic root dilation in patients after tetralogy of Fallot repair.
Thromboangiitis Obliterans
Immunohistochemical properties in the patients with Buerger's disease-possible role of plasminogen activator inhibitor-1 for preservation of vessel wall architecture.
Thromboangiitis Obliterans
Stromelysin-1 5A/6A and eNOS T-786C Polymorphisms, MTHFR C677T and A1298C Mutations, and Cigarette-Cannabis Smoking: A Pilot, Hypothesis-Generating Study of Gene-Environment Pathophysiological Associations With Buerger's Disease.
Thrombocytosis
Importance of plasma matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinase (TIMP) in development of fibrosis in agnogenic myeloid metaplasia.
Thrombophlebitis
Matrix metalloproteinases in the vein wall.
Thrombosis
Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
Thrombosis
Expression changes and roles of matrix metalloproteinases in a rat model of traumatic deep vein thrombosis.
Thrombosis
MMP-3-1612 polymorphism--a risk factor for deep venous thrombosis formation.
Thrombosis
Vascular and Cardiac Impairments in Rats Inhaling Ozone and Diesel Exhaust Particles.
Thyroid Neoplasms
CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production.
Thyroiditis
Association of heterogeneity of the thyroid gland with matrix metalloproteinase-3 in rheumatoid arthritis patients with Hashimoto's thyroiditis.
Triple Negative Breast Neoplasms
Zerumbone Suppresses IL-1?-induced Cell Migration and Invasion by Inhibiting IL-8 and MMP-3 Expression in Human Triple-negative Breast Cancer Cells.
Tuberculosis
Early Secretory Antigenic Target-6 Drives Matrix Metalloproteinase-10 Gene Expression and Secretion in Tuberculosis.
Tuberculosis
Expression kinetics of metalloproteinases and their tissue inhibitors in experimental murine pulmonary tuberculosis.
Tuberculosis
In an in vitro model of human tuberculosis, monocyte-microglial networks regulate matrix metalloproteinase-1 and -3 gene expression and secretion via a p38 mitogen activated protein kinase-dependent pathway.
Urinary Bladder Neoplasms
Enhanced Expression but Decreased Specific Activity of Matrix Metalloproteinase 10 (MMP-10) in Comparison with Matrix Metalloproteinase 3 (MMP-3) in Human Urinary Bladder Carcinoma.
Urinary Bladder Neoplasms
Homeobox A10 promotes the proliferation and invasion of bladder cancer cells via regulation of matrix metalloproteinase-3.
Urinary Bladder Neoplasms
Matrix metalloproteinase polymorphisms and bladder cancer risk.
Urinary Bladder Neoplasms
MMP-3 mRNA and MMP-3 and MMP-1 proteins in bladder cancer: a comparison with clinicopathologic features and survival.
Urinary Bladder Neoplasms
Role of MMP-3 and MMP-9 and their haplotypes in risk of bladder cancer in North Indian cohort.
Urinary Bladder Neoplasms
The biochemical value of urinary metalloproteinases 3 and 9 in diagnosis and prognosis of bladder cancer in Egypt.
Urinary Incontinence
[MMP-1 and MMP-3 gene encoding polymorphism and the risk of the development of pelvic organ prolapse and stress urinary incontinence].
Uterine Cervical Neoplasms
Phloretin suppresses metastasis by targeting protease and inhibits cancer stemness and angiogenesis in human cervical cancer cells.
Uterine Hemorrhage
Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding.
Uveitis
MMP-3 Deficiency Alleviates Endotoxin-Induced Acute Inflammation in the Posterior Eye Segment.
Vaccinia
APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide.
Varicose Ulcer
Induction of MMP-1, MMP-3 and TIMP-1 in normal dermal fibroblasts by chronic venous leg ulcer wound fluid*.
Varicose Ulcer
Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds.
Varicose Veins
Comparison of extracellular matrix in skin and saphenous veins from patients with varicose veins: does the skin reflect venous matrix changes?
Varicose Veins
Decreased production of collagen Type III in cultured smooth muscle cells from varicose vein patients is due to a degradation by MMPs: possible implication of MMP-3.
Varicose Veins
Matrix metalloproteinases in the vein wall.
Varicose Veins
Pathogenesis of primary varicose veins.
Varicose Veins
Polymorphism of matrix metalloproteinase genes (MMP1 and MMP3) in patients with varicose veins.
Vascular Calcification
Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetes in a Korean population.
Vascular Diseases
Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression.
Vascular System Injuries
Role of the fibrinolytic and matrix metalloproteinase systems in arterial neointima formation after vascular injury.
Vasculitis
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Vasculitis
The significance of metalloproteinase 3 (MMP-3), chemokine CXC ligand 13 (CXCL-13) and complement component C5a in different stages of ANCA associated vasculitis.
Vasospasm, Intracranial
Differential regulation of matrix-metalloproteinases and their tissue inhibitors in patients with aneurysmal subarachnoid hemorrhage.
Venous Thrombosis
MMP-3-1612 polymorphism--a risk factor for deep venous thrombosis formation.
Ventricular Dysfunction, Left
Circulating Stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction.
Ventricular Dysfunction, Left
Matrix Metalloproteinase 3 Gene Polymorphism and Its Level Predict Morbidity After Acute Myocardial Infarction.
Virus Diseases
Association of genetic polymorphisms with histological grading of necroinflammation, staging of fibrosis, and liver function in mexicans with chronic hepatitis C virus infection.
Vitelliform Macular Dystrophy
Age-related macular degeneration: a perspective on genetic studies.
Vitreous Detachment
[Posterior vitreous detachment induced by intravitreal injection of the combination of chondroitinase ABC and matrix metalloproteinase-3.]
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
3.4.24.17 stromelysin 1
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
